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Abstract 
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The role of surfactant type and level on protein conformational stability, as 
assessed by calorimetry, and on protein size stability as assessed by 
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Control and analysis of protein aggregation is an increasing challenge to 
biopharmaceutical research and development. Therefore it is important to 
understand the interactions, causes and analysis of particles in order to 
control protein aggregation to enable successful biopharmaceutical 
formulations.   
This work investigates the role of different non-ionic surfactants on protein 
conformational stability, as assessed by HSDSC, and on protein size stability 
as assessed by Dynamic Light Scattering (DLS), HIAC and MFI. BSA and 
IgG2 were used as model proteins. Thermal unfolding experiments indicated 
a very weak surfactant-immunoglobulin IgG2 interaction, compared to much 
stronger interactions for the BSA surfactant systems.  
The DLS results showed that BSA and IgG2 with different surfactants and 
concentration produced different levels of particle size growth. The heat 
treatment and aging of samples in the presence of Tween 20, Tween 80, Brij 
35 and Pluronic F-68 surfactants led to an increase in the populations of 
larger particles for BSA samples, whereas IgG2 systems did not notably 
aggregate under storage conditions 
MFI was shown to be more sensitive than HIAC technique for measuring 
sub-visible particles in protein surfactant systems. Heat treatment and 
  
  ii 
storage stress showed a significant effect on BSA and IgG2 protein sub-
visible particle size stability.  
This work has demonstrated that both proteins with different Tween 20, 
Tween 80, Brij 35 and Pluronic F-68 concentrations, have different level of 
conformational and size stability. Also aging samples and heating stress 
bears the potential to generate particles, but this depends on surfactant type.  
Poor predictive correlations between the analytical methods were 
determined. 
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1.1 General Introduction 
 
Aggregation and particle formation have become the focus of increased 
attention for the biopharmaceutical industry recently due to increasing 
concerns about their impact on the safety and efficacy of biological products. 
The effect of surfactants on minimizing and preventing the formation of sub-
visible and visible particles is not yet fully understood. This question is an 
open emphasis across the industry and academic organizations. 
In the past two decades significant advances have been made in 
understanding the mechanism of many chemical degradation pathways of 
protein-based solutions. However to understand particle formation and 
prevention of particles forming still remains relatively poor. Protein 
aggregates and particulates form in a wide range of sizes from few 
nanometres to centimetre and shapes, which makes it extremely challenging 
to fully characterize particles in biopharmaceutical formulations. 
 
1.2  Mechanisms of aggregation and particle formation 
 
Proteins can form a large variety of aggregates starting from a dimer species 
to multimers. Dimers and other smaller size aggregates are soluble in nature 
and typically range in size from a few nanometres to tens of nanometres. 
Some of the multimers can grow large in size and may eventually appear as 
visible particles. Although all multimeric species including dimers are 
generally termed as aggregates, the phrase particles or particulates refers to 
the large size aggregates that are in the size range of tens of microns or 
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even larger species that are visibly detected. More broadly defined, particles 
refer to species encompassing both the visible and sub-visible size ranges. 
Aggregates and particles cover a size range from few nanometers to 
hundreds of micometers (Figure1.1): 
 Aggregates 
10 nm – 0.1 µm (> dimers = oligomers, soluble) 
 Particles 
0.1 – 1 µm (sub-micron, often soluble aggregates) 
10 – 150 µm (sub-visible, often soluble aggregates) 
 Visible particles 
125 µm (internal definition) to 1 mm (insoluble) 
 
Figure 1.1. Aggregates and Particles size range (Krishnan, 2009). 
Protein aggregates and particles can be induced by different mechanical 
stresses, therefore protein particles and aggregates have been classified 
based on different aspects. Cromwell et al. classified particles into 4 groups 
(Cromwell et al., 2006):  
 Soluble/insoluble aggregates; 
 Covalent/non-covalent aggregates; 
 Reversible/irreversible aggregates; 
 Native/denatured aggregates. 
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Soluble aggregates are usually described as discrete, not visible particles 
and may be easily removed by 0.22 µm pore size filters. Where insoluble 
aggregates are usually visible to unaided eye and can be removed by 
filtration.  
Covalent aggregates can arise due to the chemical bond formation between 
2 or more monomers (Cromwell et al., 2006). Most common mechanisms for 
covalent aggregation have been described as disulfide bond formation and 
oxidation of tyrosines (Andya et al., 2003; Shahrokh et al., 1994). 
Reversible aggregates arise due to weak non covalent protein interactions. 
Cromwell et al. stated that reversibility can be indicative of the presence of 
equilibrium between the monomers and higher order forms and that this 
equilibrium can shift due to the change in solution conditions such as a 
decrease in protein concentration or pH change (Cromwell et al., 2006). 
Protein denaturation is described as a change of protein shape which is 
caused by applying external stresses such as heat or acid. 
Just as there are many types of interactions that can cause protein 
aggregation, particle formation can be induced by a variety of different 
conditions such as temperature, pH,  protein concentration, ionic strength, 
mechanical stresses such as shaking, stirring, pumping, freezing and thawing 
and also formulation (Mahler et al., 2008). 
Figure 1.2 shows that proteins can aggregate and form particles through 
different mechanisms.  
 
  
  5
 
Figure 1.2. Proteins aggregation and particle formation through 
different mechanisms (Krishnan, 2009). 
 
1.3  Conformational stability: Thermal unfolding 
 
Thermal unfolding is often found to be a rate-limiting step for aggregation 
(Roberts et al., 2011).  Most therapeutic proteins are prone to aggregation 
because of their partially or fully unfolded conformational states.  
It has been previously reported (Flaugh et al., 2005 a, b; Feire et al., 1992), 
that proteins with multi domains have multi unfolding profiles which make it 
more difficult to investigate. Also it is more likely that just a small fraction of 
multi domain proteins can be aggregation prone. Therefore, it may be that 
increasing or decreasing in unfolding free energy may not have any effect on 
aggregate formation (Roberts et al., 2011). 
Taking into account all the above issues, unfolding temperature Tm can still 
be predictive in protein aggregation. In this scenario, Roberts et al., (2011) 
described that “aggregation proceeds during thermal unfolding with the 
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aggregation prone monomer population”, which is “continuously being 
depleted as monomers convert to aggregates”. 
However it is not known which unfolding transitions correspond to the region 
of aggregation prone protein and also which Tm values are potentially 
relevant for predicting protein aggregation. Scientists described few 
approaches to investigate the above. One of them is to consider that 
unfolding profiles are dependant on thermal scan rate and if aggregation will 
be forming during the unfolding then unfolding temperature Tm will shift to 
higher levels. However Tm values could also increase when the scan rate is 
too fast comparing to unfolding rates in the absence of aggregation (Roberts 
et al., 2011).  
Another approach reported by Remmele et al. (1999) and Sahin et al. (2010) 
is to assess the reversibility and the extent of re-folding by reheating of the 
same sample. This approach is often used because the reversibility could 
inform if the unfolding endotherm is related to protein aggregation. This 
theory assures that Tm will not be indicative of relative aggregation due to 
other factors such as slow unfolding or sample misfolding without 
aggregation.  
The alternative approach suggested by Sahin et al. (2010) and Btummitt et 
al. (2011) is to try to monitor aggregation for those samples, which have been 
thermally scanned to different temperatures and directly assign the unfolding 
transitions with the loss of monomer. 
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1.4    Analytical technique for characterising protein conformational 
stability – HSDSC 
 
When proteins are being developed as therapeutics, it is important to 
evaluate protein conformational and long shelf-life stability. As mentioned 
before, there are many factors which could affect protein stability and 
reversibility and cause protein aggregation. Therefore it is very important to 
understand and investigate these effects in order to help developing new 
analytical methods to assist in protein and antibody formulation. High 
sensitivity differential scanning calorimetry (HSDSC) is a potential technique 
to do that.  
HSDSC is commonly used method in assessing thermal and conformational 
stability in protein and antibody formulations.  This analytical technique has 
an advantage not just by measuring the unfolding temperature and 
reversibility, but also it provides the unfolding profiles for multi domain 
proteins and antibodies, which have multi unfolding transitions.  
1.5   Analytical techniques to characterise aggregates and particulates  
 
There are a wide number of analytical methods available to characterize and 
quantify protein aggregates and particles (Figure 1.3). The methods include: 
 Laser Diffraction Technology 
 Analytical Ultracentrifugation (AUC) 
 Field Flow Fractionation (FFF) 
 Multiangle Light Scattering (MALS) 
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 Size Exclusion Chromatography (SEC) 
 Dynamic Light Scattering (DLS) 
 Light Obscuration 
 Microscopy: Micro-flow imaging (MFI), Flow Particle Image Analysis 
(FPIA) 
 Visual Inspection 
 Raman Spectroscopy 
In this review, an overview of some of the methods is presented. 
 
 
Figure 1.3. Analytical methods to characterize and quantify protein 
aggregates and particles. Shaded region – sub-visible particles (Jiang, 
2009). 
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1.5.1 Laser Diffraction Technology 
 
Laser Diffraction technology (LD) is an absolute technique, which doesn’t 
need any calibration. This method is quick and easy to use, has a high 
reproducibility and covers a wide particle size range from few nanometres to 
millimetres. Virden describes this technique as a method which provides a 
result for the whole sample, rather then building up distributions from data for 
individual particles (Virden, 2010).  
Figure 1.4 presents schematic structure of Laser Diffraction technology.  
 
 Figure 1.4. Schematic picture of a laser diffraction instrument 
(Beckman Coulter, 2008) 
The LD instrument performing process starts when a light source generates 
monochromatic beam. Firstly, this beam goes through few optical 
components and gets conditioned. That creates an expanded and collimated 
beam which illuminates the particles. The particles scatter light over a range 
of different angles. Larger particles generate a high scattering intensity at 
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narrow angles and smaller particles generate lower intensity, but at wider 
angles to the incident beam (Virden, 2010). 
These unique scattering patterns (I(Ø)) are Fourier transformed into a spatial 
intensity pattern (I(r)), which is detected by a photo detector array. Then data 
is processed and digitized creating an intensity flux pattern (f(Ø)), which is 
utilized and converted into a particle size  distribution (q(d)) (Beckman 
Coulter, 2008).  
There are two Laser Diffraction theories: Mie and Fraunhofer. Virden states 
that both models provide similar results for larger particles, but Mie method is 
more accurate for finer materials. Also inaccuracies arising from Fraunhofer 
model are unpredictable (Virden, 2010).   
1.5.2 Analytical Ultracentrifugation (AUC) 
 
Analytical Ultracentrifugation (AUC) is another technique widely used to 
study protein aggregation (Liu et al., 2006; Liu et al., 1999; Schuch, 2003; 
Berkowitz, 2006; Gabrielson et al., 2007; Mahler et al., 2008).  AUC method 
measures the sedimentation rate, which provides information of molecular 
mass, the size and shape of molecules.  Alliance Protein Laboratories 
scientists stated 8 points why AUC is a valuable method to use for (Alliance 
Protein Laboratories Inc, 2014): 
 Verifying whether a sample is entirely homogeneous in mass and 
conformation; 
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 Detecting aggregates in protein samples and quantifying the amount 
of aggregate; 
 Comparing the conformations for samples from different lots, 
manufacturing processes, or expression systems (comparability 
studies), or comparing different engineered variants of the sample 
protein/peptide; 
 Establishing whether the native state of protein or peptide is a 
monomer, dimmer, trimer, etc.; 
 Determining the overall shape of non-glycosylated protein and peptide 
molecules in solution (are they approximately spherical or highly 
extended and rod-like; 
 Measuring the distribution of sizes in samples which contain a very 
broad range of sizes; 
 Detecting changes in protein conformation, for example partial 
unfolding or transitions to “molten globule” states; 
 Studying the formation and stoichiometry of tight complexes between 
proteins. 
The AUC method can be used for a wide range of pH, temperature and ionic 
strength conditions. There is very little or no sample preparation involved and 
technique can be used for a wide range of sample concentration up to 40 
mg/ml (Mahler et al., 2009). 
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1.5.3 Field Flow Fractionation (FFF)  
 
Field-flow fractionation (FFF) is a separation technique and is used to 
determine the size of particles. Fraunhofer et al, Reschiglian et al. and 
Giddings have described FFF as a technique which is able to separate 
particles in the range of small molecules measuring few nanometres to large 
particles measuring in micrometers (Fraunhofer et al., 2004; Reschiglian et 
al., 2005; Giddings, 1993).   
FFF separates molecules depending on their molar mass and size by 
employing applied field force, which forces molecules to different velocity 
regions within a channel. The molecules separation process is initiated by 
injecting the sample into a carrier fluid within a thin channel and then the fluid 
is pumped through this channel and perpendicular to this parabolic flow an 
external generated field is applied (Mahler et al., 2008). Depending on the 
field applied FFF can be divided in few forms: flow FFF, Asymetric Flow, 
Centrifugal, Sedimentation, Thermal, Electrical and Magnetic FFF. 
When one of these fields is applied the sample components move towards 
accumulation wall where molecules closest to the wall are located in the 
slowest velocity of the flow and elute out slower compared to the molecules 
found in the fastest velocity region (Mahler et al., 2008). 
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1.5.4 Multiangle Light Scattering (MALS) 
 
Multiangle light scattering (MALS) technique measures particles’ average 
size and absolute molar mass (Mahler et al., 2008). 
The MALS method has been extensively used by scientists to determine 
particles and aggregates molecular weight. This method detects laser 
scattered light at different angles. The technique doesn’t require any 
calibration and the only parameters required to calculate absolute molecular 
weight are each elution fraction concentration and differential refractive index 
increment (Mahler et al., 2008). 
 
1.5.5 Size Exclusion Chromatography (SEC) 
 
Size-Exclusion Chromatography (SEC) is commonly used technique to 
detect and quantify protein aggregates. SEC separates particles depending 
on their hydrodynamic size, diffusion coefficient and surface properties.  
Figure 1.5 illustrates SEC experimental process. 
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Figure 1.5. Illustration of SEC experiment (Analytical Ventura, 2013). 
Figure 1.5 illustrates the principle by following a sample containing large 
(blue) and small (red) particles on injection into a size exclusion column, 
where stationary phase beads (black) were present. As the time passes, 
small (red) particles enter the pores on the stationary phase beads (black). 
However, the blue particles, because of their bigger size were not able to 
penetrate the pores of black beads, therefore they get excluded from the 
packing pore volume and get eluted (Barth, 2004). 
There are various size exclusion columns available, depending on 
experimental needs, such as sample concentration, chemical and physical 
properties. The SEC technique, like some of the other particle counting 
techniques, should be used with light scattering methods as for example the 
previously mentioned MALS, and also combined with Light Obscuration or 
Dynamic Light Scattering techniques. 
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1.5.6 Dynamic Light Scattering (DLS) 
 
Dynamic light scattering (DLS) is a well-established, commonly used 
technique to measure small molecules and particles from few nanometres 
size.  
Arakawa et al. describes the DLS method as a technique which studies 
particle size distribution by intensity of light scattered from protein solution 
over time (Arakawa et al., 2007). 
The principle of DLS Brownian motion is that larger particles move slower 
than smaller ones, therefore scattering fluctuations time scale gives particle 
size parameter – hydrodynamic diameter (Figure 1.6). 
 
Figure 1.6. Reported hydrodynamic diameter (Malvern Instruments 
Ltd, 2011). 
Hydrodynamic diameter is described as the radius of spherical particle, which 
has the same translational diffusion coefficient as protein molecule (particle) 
measured (Arakawa et al., 2007). 
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1.5.7 Light Obscuration and Microscopic Particle Count 
 
There are two procedures to determine sub-visible particle contamination:  
 Light Obscuration Particle Count; 
 Microscopic Particle Count. 
 
The Light Obscuration method is often used when only a sub-visible particle 
count is required. However it is usually necessary to additionally experiment 
with one of the Microscopic Count methods. Not all protein or antibody 
formulations can be examined for sub-visible particles by one of these 
methods, as an example due to sample high viscosity, Light Obscuration can 
not always be applied. Also if air or gas bubbles are present in the sample, 
Microscopic particle count testing is required.  
Most analytical measurements for particle sizing use either a spherical 
approximation for shape or indirect methods and a mathematical algorithm to 
extract shape information. Microscopic methods, however, provide direct 
visualization of morphology in addition to size information. More recently, 
dynamic imaging capability is used by multiple manufacturers in sizing 
equipments for not only size and shape analysis but also for video imaging. 
The optical microscopes are generally limited to size particles of 
approximately 0.5 μm and higher (ISO, 2006). Dynamic imaging offers the 
benefits of measuring images in real time and under conditions when 
particles remain suspended - an advantage over static imaging. This may 
allow superior imaging of extremely irregular shaped particles, and 
monitoring the dynamic behaviour of particles if the size distribution is 
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changing over time. Such information is valuable during formulation 
development of biologics to characterize any particulates formed and to 
identify potential preventive measures. It should be noted, however, that it is 
inherently complex to determine a true size distribution from the 
dynamic/static imaging data, especially for biologic particles (for example, 
irregular shaped fibrils). It is not straightforward to directly compare size 
distribution (or counts) from dynamic imaging to that obtained from light 
obscuration or laser diffraction analyses (Das et al., 2007). 
 
1.5.7.1 Light Obscuration (HIAC) 
 
The light obscuration (LO) liquid particle counting system relies on light 
obscuration to detect and quantify the number of particles and their size 
range in a test sample. Introduced in 1969, the first and current instruments 
operate on the interaction of an intense collimated and focused beam of light 
with a particle suspended in a liquid medium (Barber, 2000). Particles are 
forced to pass through a narrow view volume between the light and 
photodiode detector (Figure 1.7). The presence of a particle is detected and 
measured by the variation in light intensity, which is then translated to a 
voltage signal. 
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Figure 1.7. Diagram of Light Obscuration particle counter (Solids Wiki, 
2013). 
The principle of light obscuration is used to detect particles in the range of 
greater than 2 µm to up to 100 µm. The sensors are used to measure the 
size of the particles through their full dynamic range, resulting in unsurpassed 
resolution and count efficiency (Barber, 2000).  
 
1.5.7.2 Micro-flow imaging (MFI) 
 
Micro-flow imaging (MFI) is a flow microscopy technique, which captures 
bright field images in the frames while continuous sample stream passes 
through a flow cell (Sharma et al., 2010).  
The instrument configuration is shown in Figure 1.8. 
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Figure 1.8. Micro-flow imaging instrument configuration (Sharma et al., 
2010). 
 
The MFI process starts when a sample is directly inverted from a pipette tip 
through the flow cell. Both, system magnification and flow-cell depth 
determine the accuracy of the concentration measurement. Concentration 
and parameter measurements are absolute but may be re-verified using 
particle standards. Usually sample volumes range from less than 0.25 mL to 
tens of millilitres. In the detection zone, immediate visual images of a particle 
population is provided.  
The MFI system software is extracting particle images by using a sensitive 
threshold to identify and define each particle. All particle images are analysed 
straight away in real time. From the analysed images the MFI system 
provides particle count, size, concentration and shape information. Also this 
method is supported by image filtering to be able to selectively extract similar 
  
  20 
particles from all the population, thus allowing the isolation and independent 
analysis of those sub-populations (Sharma et al., 2010).  
In general, the MFI method has many advantages over indirect obscuration 
or scattering measurements. This method doesn’t rely on a correlation 
between particle size and the scattered optical signal magnitude. 
 
 
1.5.7.3 Flow particle image analysis (FPIA) 
 
Flow particle image analysis (FPIA) method produces high resolution 
analysis of particle shape and size from 0.8 µm to 300 µm.  
This technique requires minimal sample preparation and provides particle 
size and shape distributions in a short time. 
Figure 1.9 illustrates the process of FPIA method. 
 
 
Figure 1.9. FPIA sample dispersion and image capture (Malvern 
Instruments Ltd, 2010). 
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After inverting the required sample through a jet nozzle, the sample goes 
through a sneath-flow cell, where a particle suspension is transformed into a 
flat flow. This ensures that particles present in a sample lie in the same line 
and are facing the CCD camera (Figures 1.9, 1.10).  
 
 
Figure 1.10. Scheme of particle flow (Malvern Instruments Ltd, 2010). 
60 particle images per second are captured by FPIA and after removing the 
noise and the background correction, the number of morphological 
parameters are calculated: particle diameter, perimeter, length, width and 
distance.  
FPIA software is able to analyse the data and to compare and identify 
multiple records (Malvern Instruments Ltd, 2010). 
 
1.5.8 Visual Inspection 
 
The visual inspection test is intended to provide a simple procedure for the 
visual inspection of larger aggregates.  
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The visual inspection apparatus consists of: 
 a matt black panel; 
 a non-glare white panel; 
 an adjustable lamp holder (Mahler et al., 2008).  
Visual inspection is often subjective and results are in high variability. 
Visualization of particles not only depends on an inspector’s visual capability, 
but also on a size, number and type of particles, the light conditions, 
magnifying lenses used, observation time, distance from inspected samples, 
the background used.  
Although no strict size limit can be assigned for when particles become 
visible to the human eye, it is generally recognized that particles of > 100 μm 
size are detected with relatively high probability when appropriate testing 
conditions are employed (Das et al., 2007). 
 
1.5.9 Raman Spectroscopy 
 
The use of Raman spectroscopy has been a valuable approach to identify 
foreign particulates in parenteral dosage forms, especially in aqueous based 
systems due to non-interference of water in Raman measurements (unlike 
Infra-Red spectroscopy) (Warterwig et al., 2005). With recent advancements 
in this field, Raman spectrometers provide adequate sensitivity to collect 
good quality spectrum in a short period of time allowing better throughput in 
assays. One application of such a throughput method is the automated 
characterization of particulates (micron and larger size) by optical imaging 
and Raman identification. A parenteral formulation is filtered to collect the 
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foreign matter as well as intrinsic particulates, and Raman identification is 
conducted either for all or a statistically relevant number of particulates to 
understand the nature and distribution of particulates (Vankeirsblick et al., 
2002). Most foreign particulates have unique Raman spectral fingerprint, and 
the protein particulates display backbone amide spectra characteristic of 
secondary structure. Fluorescence is often a problem (high background) with 
Raman measurements of biologics formulations, however, chemical 
identification of at least a part of the particulate populations can provide 
valuable clue to its source (Warterwig et al., 2005). 
 
1.6  Gaps in the control and analysis of particles 
 
Mechanisms of protein aggregation and its relevance to biopharmaceuticals 
has been reviewed and discussed by several researchers (Cromwell et al., 
2006; Hermeling et al., 2004; Shire et al., 2004; Stefani et al., 2004; Wang et 
al., 2007 ; Chi et al., 2003). The biochemical events that are implicated to 
initiate aggregation include protein denaturation, misfolding, and partial 
unfolding. Quite often exposure of hydrophobic regions of proteins is 
believed to initiate aggregation. Additionally, the presence of trace quantity of 
non-native species may also provide nucleation; however, detection of such 
non-native species in native state (N) ensemble is very challenging by using 
classical analytical techniques. Figure 1.11 shows a simplified scheme 
depicting possible pathways of aggregation from non-native (N*), 
intermediate (I), and unfolded (U) protein species. It should be noted that the 
aggregation process often follows more complicated pathways possibly 
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involving a wide variety of intermediates. Therefore figure 1.11 should be 
considered as a conceptual depiction of representative steps in the 
aggregation process. How small aggregates lead to formation of particulates 
is a debatable topic (Das et al., 2007).  
 
Figure 1.11.  Aggregation process. N – native protein state, I – 
intermediate protein state, U – unfolded protein state, N* - non-native 
protein state ( Das et al., 2007). 
Researchers often use the nucleation concept in explaining particulate 
formation, although as discussed before in the General Introduction, the 
process of particulate formation via nucleation in biologic systems is poorly 
understood. 
Usually the recommended tests by European Pharmacopoeia for particulate 
matter in parenteral solution (intravenous) are visual inspection, and sub-
visible testing (light obscuration and light microscope). Light obscuration is 
the preferred method, and light microscopy is conducted when light 
obscuration test either fails or can not be applied.  
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Visual inspection is often subjective and results present a high variability of 
data. Visualization of particles not only depends on an inspector's visual 
acuity, but also on the nature of the particle (e.g. transparency) and test 
conditions used. Although no strict size limit can be assigned for when 
particles become visible to human eye, it is generally recognized that 
particles of >100 μm size are detected with relatively high probability when 
appropriate testing conditions (e.g. light intensity and background). 
Small aggregates of proteins remain soluble in the formulation and are 
typically detectable by conventional separation techniques such as size-
exclusion chromatography. For example, a monoclonal antibody 
(approximately 10 nm in size) and some of its aggregated species (say, 
dimer through tetramer) can be conveniently separated using standard size-
exclusion columns. Between the sizes of a few tens of nanometres (small 
soluble) and 50-100 micron (visible) there exists a wide size range that is 
relatively more difficult to explore primarily because of a lack of robust 
techniques that can perform adequate detection and characterization for the 
whole size range. For example, when particulates appear in a biologics 
formulation it might be natural to consider involvement of higher order 
structures and sub-visible intermediates (although not always detectable) in 
a mechanistic approach. The event that occur in the sub-visible size range 
might hold important clues to decipher the origin of visible particulate 
formation. Although the sub-visible range traditionally refers to a size range 
of tens of microns, for the purpose of this review the entire size range of 
submicron to tens of microns is being referred to as the sub-visible gap. 
Dynamic Light Scattering (DLS) is a convenient method for measurement of 
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soluble or suspended particles in solution. It is a useful technique - in 
principle - to cover a wide size range (nanometres to few microns), however 
it provides only limited information due to: 
(a) poor size resolution;  
(b) artefacts from dust particles;  
(c) "masking" of intensity from smaller size particles in the presence of 
significant quantity of larger particles; 
(d) lack of shape information. 
In order to mitigate the 'sub-visible gap' it is important to detect and 
characterize the particulates with wider coverage of size range, and to 
identify composition when possible. 
Therefore, with light scattering methods it is often necessary to have some 
means of knowing that the signals really come from protein and not dust. For 
static scattering, that is usually accomplished by using the detector in flow 
mode, following separation by SEC or FFF (which presumably separates 
dust from the protein) (Arakawa et al., 2007). 
Laser diffraction analysis uses the principle that when a laser beam is 
incident on particles of differing size, light is scattered and the direction and 
intensity of scattered light are related to particle size. The traditional laser 
light diffraction analyzers typically use an array of detectors to cover a size 
range of approximately 0.5 μm – 2000 μm. The detectors when placed at low 
angle, can size large particles with good accuracy; however, their 
performance is inadequate for smaller size particles.  
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When conducting measurement in any of the size ranges, if aggregates 
and particulates are dynamic in nature, special care should be taken to 
study the reversibility and transience of formation. 
Most analytical measurements for particle sizing (small or large) use either 
spherical approximation for shape or indirect methods and mathematical 
algorithm to extract shape information. Microscopy methods, however, 
provide direct visualization of morphology in addition to size information. 
More recently, dynamic imaging capability is made available for not only size 
and shape analysis but also for video imaging. The optical microscopes are 
generally limited to size of approximately 0.5 μm and higher. Dynamic 
imaging offers the benefits of measuring images in real time and under 
conditions when particles remain suspended - an advantage over static 
imaging. This may allow superior imaging of extremely irregular shaped 
particles, and monitoring the dynamic behaviour of particles if the size 
distribution is changing over time. Such information is valuable during 
formulation development of biologics to characterize the particles produced 
and in finding potential preventive measures. It should be noted, however, 
that it is inherently complex to determine a true size distribution from the 
dynamic/static imaging data. It is not straightforward to directly compare size 
distribution (or counts) from dynamic imaging to that obtained from light 
obscuration or laser diffraction analyses (ISO, 2006). 
The use of Raman spectroscopy has been a valuable approach to identify 
foreign particulates, especially in aqueous based systems due to non-
interference of water in Raman measurements (unlike InfraRed 
spectroscopy). With recent advances in this field, Raman spectrometers 
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provide adequate sensitivity to collect good quality spectrum in a short period 
of time allowing better throughput in assays. One application of such 
throughput method is automated characterization of particulates (micron and 
larger size) by optical imaging and Raman identification. A parenteral 
formulation is filtered to collect the foreign matter as well as intrinsic 
particulates, and Raman identification is conducted either for all or a 
statistically relevant number of particulates to understand the nature and 
distribution of particulates. Most foreign particulates have unique Raman 
spectral fingerprint, and the protein particulates display backbone amide 
spectra characteristic of secondary structure. Fluorescence is often a 
problem (high background) with Raman measurements, however, chemical 
identification of at least a part of the particulate populations can provide 
valuable clue to its source (Warterwig et al., 2005; Vankeirsblick et al., 2002). 
Regarding the analysis of particles and their formation it is desirable to 
conduct suitable stress tests and use appropriate detection and 
characterization techniques. 
Aggregation continues to be one of the major concerns in development of 
biopharmaceuticals. However, understanding of aggregation pathways and 
inhibition of aggregation remain relatively poorly understood. Protein 
particulates form in a wide range of size and shape, and it is extremely 
challenging to comprehensively characterize the whole size range of 
particulates.  
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1.7 Protein formulation. Use of surfactants 
 
The formulation of recombinant proteins and their long stability and 
reproducible activity is very important in biopharmaceuticals.  
Kerwin states, that in order to maintain biological activity proteins need to be 
maintained in their multi dimensional conformation and that this conformation 
is only marginally stable and that any minor disruptions can cause loss of 
biological activity (Kerwin, 2007).  Author’s described disruptions are usually 
induced when producing proteins by filtering, freeze-thawing, lyophilisation, 
spray drying. Also storage and transportation can have a negative effect on 
proteins stability and can induce protein aggregation (Kerwin, 2007). 
Therefore non-ionic surfactants are widely used in formulation of protein 
pharmaceuticals to prevent protein aggregation and minimize surface 
absorption of proteins during their development (Maggio, 2012). 
It has been reported that by adding surfactants into protein formulations, the 
surfactant can act to unfold protein and together they can form a protein – 
surfactant complex (Narayanan, 1999; Valstar et al., 1999; Valstar et al., 
2000; Sahu et al., 2005). Chodankar stated that surfactant molecules while 
interacting with the non polar amino acids are responsible for causing the 
protein to unfold (Chodankar, 2007). 
This author sated three main models for protein – surfactant complexes: 
 “Rod-like model” – it describes the complex as a rigid rod with the 
length proportional to the molecular weight of the protein; 
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 “Flexible helix model” – it describes the complex as a flexible 
cylindrical micelle formed by the micelle on the surface of which 
hydrophilic segments of the protein are bound; 
 “Necklace model” – proposes that protein is unfolded with micelle-like 
clusters bounded to the polypeptide chain of the protein (Chodankar, 
2007). 
 
1.7.1 Structure and behaviour of surfactants 
 
Surfactants are usually described as surface active molecules with polar and 
nonpolar domains that have aqueous solubility as aggregate and monomers. 
Surfactants are very useful in protein delivery. They have capability to reduce 
interfacial surface tension in formulations by adsorbing to interfaces (Rosen, 
2004). That is related to surfactant structure: the polar hydrophilic part of the 
surfactant molecule – “hydrophilic head group” and nonpolar – “hydrophobic 
tail” (Figure 1.12). 
 
Figure 1.12. Figure of a surfactant monomer (Garq, 2012). 
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Depending on surfactant hydrophilic group surfactants can be divided into 3 
groups: 
 Ionic surfactants – denaturating surfactants. These type of surfactants 
disrupt molecular protein – protein interactions; 
 Non ionic surfactants have uncharged hydrophilic head groups. They 
are non denaturating. These type surfactants disrupt protein-lipid and 
lipid-lipid interactions rather than protein-protein interactions. 
 Zwitterionic surfactants contain both a positive and negative charge in 
their hydrophilic head group. These compounds are electrically neutral 
like the nonionic surfactants, but can often disrupt protein-protein 
interactions like the ionic surfactants (Malvern Instruments Ltd, 2006). 
 
1.7.2 Micellization. Critical Micelle Concentration (CMC) 
  
Surfactants interact with proteins as micelles. Micellization occurs when 
surfactant concentration is increased and molecules are forced to aggregate 
and form monolayers at interfaces and micelles (Figure 1.13).  
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Figure 1.13. Micellization (Rangel-Yaguil et al., 2005). 
 
This happens when a non polar group is inverted into the aqueous solution, 
the hydrogen bonding is disrupted and then water molecules put themselves 
around the non polar group to satisfy hydrogen bonds (Anatrace Inc, 2008). 
Usually micelle diameter is just a few nanometres and micelles molecular 
weight is less than 100 kDa. 
Each surfactant is characterised by its CMC, which is the surfactant 
concentration above which monomers self assemble and form non covalent 
aggregates as so called micelles.  
When the total surfactant concentration is below CMC, monomers are free in 
bulk solution. However, as more surfactant is added above the CMC, all 
additional detergent monomers will go into micelles (Figure 1.14).  
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Figure 1.14. The self assembly mechanism of micelle formation with 
increasing concentration of surfactant (Behan, 1999).  
There are several physical-chemical factors that can affect the CMC of 
surfactants. Generally, the CMC decreases as the hydrophobicity of the 
surfactant increases. Other properties that directly affect the CMC are the 
characteristics of the hydrophobic and hydrophilic groups and solution 
additives such as electrolytes (Malvern Instruments Ltd, 2006). 
 
 
1.8 Choice of materials 
1.8.1 Phosphate buffered saline 
 
Phosphate buffered saline (PBS) is a buffer solution commonly used in 
pharmaceutical research. It is a water based salt solution containing sodium 
chloride, sodium phosphate, and in some formulations potassium chloride 
and potassium phosphate. The buffer helps to maintain a constant pH. 
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1.8.2 Bovine Serum Albumin 
 
Bovine serum albumin (BSA) is one of the most widely used and studied 
single chain protein with a typical concentration of 5 g/100 ml (Das et al., 
2004). 
BSA is composed of 582 amino acids and has 3 homologous domains: I, II 
and III. All domains are connected through helical extensions creating the 
two longest helices in albumin. Also domains are divided into 9 loops by 17 
disulfide bonds (Wei et al., 2006). 
Much research has been conducted using BSA because of its stability and 
low cost. Also this protein is commonly used to determine the quantity and 
interactions with other proteins and in order to understand how BSA affects 
their functionality (Adel et al., 2007). 
 
1.8.3 Antibody IgG2 
 
The research and development of monoclonal antibodies is a rapidly 
progressing field. It has been reported that in the past years more than 30 
immunoglobulins (IgGs) have been approved for use as biopharmaceuticals. 
Also many studies are looking at the different antibodies structure and 
interactions, investigating their stability and binding (Beck et al., 2008). 
However the avoidance of aggregation and particle formation in antibody 
formulations is a major issue that is a focus in drug development. IgG 
antibodies play a big role in mature immune response. 
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IgG antibodies are Y shaped molecules. Figure 1.15 illustrates the structure 
of IgG antibody. 
 
 
Figure 1.15. Schematic drawing of IgG antibody (Mayer, 2009). 
 
IgG structure is divided into two heavy chains and two light chains, which are 
joined by disulfide linkages (Wang, 2006).  The IgG molecule can be broken 
down into two regions, the Fc and Fab. The Fc region, so called because it is 
the fragment of the IgG molecule that most readily crystallizes, is involved in 
effecting the physiological roles the antibody must play. Two identical Fab 
fragment are present at the ends of the "Y" in every IgG structure. The Fab 
region is named as such because it is the IgG fragment that contains the 
antibody binding site. The Fab region contains a region of highly conserved 
amino acids as well as a region of highly variable amino acids (Fv). These 
variable sequences are confined to 6 protein loops (or complementarity 
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determining regions) that cluster together at the end of the Fab fragments to 
form a continuous hypervariable surface. It is this region that is responsible 
for the binding of foreign antigens (Wang, 2006).  
  
1.8.4 Nonionic surfactants: Tween 20, Tween 80, Brij 35 and Pluronic 
F-68 
 
Non-ionic surfactants are widely used in the formulation of protein 
pharmaceuticals to prevent aggregation and minimize surface absorption of 
proteins, both during the manufacturing process and in the final product 
formulation (Maggio, 2012). 
The most commonly used non-ionic surfactants in protein formulation are the 
polysorbates PS 20 and PS 80 also known as Tween 20 and Tween 80. It 
has been reported that more than 70 % of the marketed formulations of 
monoclonal antibody products contain one or both these two surfactants 
(Maggio, 2012). Tween 20 and Tween 80 are comprised of mixtures of 
structurally-related fatty acid esters of polyoxyethylene sorbitan and lauric 
acid or oleic acid. In the case of Tween 20, the monolaurate fraction 
comprises 40% to 60% of the alkyl chains, with alkyl groups of different chain 
length making up the remainder of the molecules. Tween 80 has 
approximately 60% of the alkyl chains which are derived from oleic acid with 
the remainder of the esters derived from other fatty acids. Tween 20 and 
Tween 80 structures are shown in Figure 1.16. 
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Figure 1.16. Chemical structure of polysorbates 20 and 80. w+x+y+z 
refers to the total number of oxyyethylene subunits on each surfactant 
molecule and may not exceed 20 (Kerwin, 2008). 
Other non-ionic surfactants commonly used in pharmaceutical formulations 
include Brij 35 (polyoxy-ethylene alkyl ether) and Pluronic F-68. 
Brij 35 is a polyethoxylated lauryl alcohol (yielding a lauryl ether). Lauryl is 
another name for a chain consisting of mostly a 12 carbons, straight chain, 
primary alcohol, dodecanol (Stavroudis, 2009). The ethyxolate chain 
averages 23 repeating units (Figure 1.17). 
 
Figure 1.17. Brij 35 structure (Stavroudis, 2009). 
Pluronic F-68 non-ionic surfactant has been used to stabilize recombinant 
human growth hormone (rhGH) against aggregation as injectable as well as 
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in the extended action formulation (Katakam et al., 1995; Wei et al., 2007).  
As a surfactant Pluronic F-68 has two hydrophilic poly (ethylene oxide) (PEO) 
chains and one hydrophobic poly (propylene oxide) (PPO) chain (Figure 
1.18).  
 
Figure 1.18. Pluronic F-68 structure (Santander-Ortega et al., 2006). 
In general, the surfactants are very important and have a valuable role in 
pharmaceutical biotechnology. They are widely utilized in various drug 
dosage forms to stability and bioavailability.  Also it is important to notice, that 
some surfactants are quite unstable from the thermodynamic point of view 
and frequently form large aggregates. Association colloids such as micelles, 
on the other hand, can form self-assembling systems, and are 
thermodynamically more stable towards both dissociation and aggregation 
(Rangel-Yagui et al., 2005).  Therefore, the study of surfactants and their role 
in biopharmaceuticals is very important for protein aggregation. In this work 
we analyse the role of Tween 20, Tween 80, Brij 35 and Pluronic F-68 
surfactants on proteins BSA and IgG2 conformational and size stabilities. 
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1.9 Aims and objectives 
 
The overall aim of this project was to identify improved methods of particle 
characterisation and understanding of the mechanisms of their formation in 
protein formulations. The project scope would include evaluation of the effect 
of different surfactants on minimising and preventing the formation of sub 
visible particles. Moreover, characterising and understanding mechanisms of 
particle formation to improve drug development. 
To achieve this, the effect of Tween 20, Tween 80, Brij 35 and Pluronic F-68 
surfactants at below, around and above  their CMC on bovine serum albumin 
(BSA) and immunoglobulin IgG2 conformational and particle size stability 
was studied. 
Experiments were performed in order to achieve the following research 
questions: 
 Do all four surfactants behave the same way regarding 
prevention/inhibition of particle formation; 
 Is surfactant behaviour with regard to particulate formation protein 
specific; 
 Is there a relationship between the structure of nonionic surfactants 
and particle formation; 
 Is the concentration and CMC of  the surfactants significant for the 
effect; 
 Does Tm measured by HSDSC predict particle formation; 
 Does level of small particle size measured by DLS predict levels of 
larger particles measured by HIAC and MFI; 
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 Which method is the most appropriate to examine biopharmaceutical 
particles.  
 
1.10 Structure of thesis 
 
The thesis is structured as follows: 
 Chapter 2 gives details of all the materials used and methods 
employed during experimental work. 
 Chapter 3 investigates the effect of Tween 20, Tween 80, Brij 35 and 
Pluronic F-68 surfactants and their below, around and above CMC 
levels on protein BSA and antibody IgG2 conformational stability 
employing HSDSC method in a series of unfolding experiments.  
 Chapter 4 explores the sub-visible particle size range measured by 
Dynamic Light Scattering (DLS) method for BSA and IgG2. 
Investigating the effect of Tween 20, Tween 80, Brij 35 and Pluronic F-
68 surfactants and their different CMC levels on particle size 
distributions. The effect of heat treatment and storage is also 
assessed. 
 Chapter 5 investigates the effect of Tween 20, Tween 80, Brij 35 and 
Pluronic F-68 surfactants on BSA and IgG2 particle size per ml using 
Light Obscuration (HIAC) and Micro-Flow Imaging (MFI). The effect of 
heat treatment stress and storage on protein surfactant free and 
protein-surfactant systems is also investigated. 
 Chapter 6 discusses general findings within the thesis. 
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 Chapter 7 presents general conclusions and gives suggestions of 
further work.     
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Chapter 2 
Materials and Methods 
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2.1 Materials 
2.1.1 Sources of materials 
 
Table 2.1 shows all the materials used in the study and their suppliers. 
All water used was double distilled and deionised. 
Table 2.1. Table showing all the materials used in this study and their 
respective sources. 
Material Source Batch/Lot number 
Dulbecco’s Phosphate 
Buffered Saline (PBS) 
SIGMA Ltd, UK RNBB6734 
Bovine Serum Albumin 
(BSA) 
Sigma Life Science, UK 029K1447 
Antibody IgG2 MedImmune Ltd, 
Cambridge, UK 
NUT-184 
Polysorbate 20 (Tween 
20) 
Sigma-Aldrich Company 
Ltd, UK 
STBB2028M9 
Polysorbate 80 (Tween 
80) 
Sigma-Aldrich Company 
Ltd, UK 
S398616419 
Brij 35 Sigma-Aldrich Company 
Ltd, UK 
BCBC6472 
Pluronic F-68 Sigma-Aldrich Company 
Ltd, UK 
020M0029 
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2.1.2 Material processing 
 
2.1.2.1 Preparation of Bovine Serum Albumin (10 mg/ml) solution 
 
The required amount of BSA was weighed and dissolved in PBS buffer. 
Samples were stored in the fridge. 
 
2.1.2.2 Preparation of antibody IgG2 (10 mg/ml) solution 
 
Antibody IgG2 was used as received from MedImmune Ltd (Cambridge) and 
was dissolved into filtered PBS buffer. Samples were stored in the fridge. 
 
2.1.2.3 Preparation of BSA (10 mg/ml) and IgG2 (10 mg/ml) with non 
ionic Tween 20, Tween 80, Brij 35 and Pluronic F-68 surfactants 
solutions 
 
Tween 20, Tween 80, Brij 35 and Pluronic F-68 surfactants at different 
concentrations (below, around and above CMC) were weighed by Mettler 
Toledo Micro Balance scale XP26 and were added separately to BSA (10 
mg/ml) and IgG2 (10 mg/ml) solutions (Table 2.2). Samples were stored in 
the fridge. 
CMC values for Tween 20, Tween 80, Brij 35 and Pluronic F-68 were taken 
from the literature (Malvern Instruments Ltd, 2006). 
  
  45 
Table 2.2. Tween 20, Tween 80, Brij 35 and Pluronic F-68 CMC 
concentrations. 
CMC levels Tween 20  Tween 80 
 
Brij 35  Pluronic F-68  
10 times 
below CMC 
(mg/ml) 
0.006  0.0015  0.009  0.004  
Around 
CMC 
(mg/ml) 
0.06  0.015  0.09  0.04  
10 times 
above CMC 
(mg/ml) 
0.6  0.15  0.9  0.4  
 
2.1.2.4     Preparation of PBS buffer with Tween 20, Tween 80, Brij 35 
and Pluronic F-68 solutions 
 
Dulbecco’s PBS was mixed separately with different Tween 20, Tween 80, 
Brij 35 and Pluronic F-68 concentrations (Table 2.2). Samples were stored in 
the fridge. 
 
2.2 Methods 
 
2.2.1 Heat treatment stress method 
  
BSA (10 mg/ml) surfactant free and BSA (10 mg/ml) with Tween 20, Tween 
80, Brij 35 and Pluronic F-68 surfactants were held at elevated 66°C 
temperature for 25 minutes using a Thermovac sample thermostat. 
IgG2 (10 mg/ml) surfactant free and IgG2 (10 mg/ml) with all four surfactants 
were held at elevated 60°C temperature for 5 minutes.  
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2.2.2 Stability study 
 
Freshly prepared BSA (10 mg/ml) and IgG2 (10 mg/ml) surfactant free and BSA and 
IgG2 with Tween 20, Tween 80, Brij 35 and Pluronic F-68 surfactants were stored in 
the fridge at +4°C temperature for 8 weeks.  
2.2.3 High Sensitivity Differential Scanning Calorimetry (HSDSC) 
 
HSDSC is a suitable method to follow the thermal denaturation of proteins 
and is more convenient than conventional assay methods (Izutsu et al., 
1990). HSDSC is a very sensitive calorimetry technique that uses larger 
volume sample cells and slow heating rates which make it particularly 
suitable for the study of dilute solutions (Robson et al., 2000). 
A schematic diagram of a calorimetric unit is shown in Figure 2.1. 
 
 
 
Figure 2.1. Differential scanning calorimetric unit (Microcal system user 
manual). 
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The samples and reference solutions were pipetted into one Microcal VP – 
capillary DSC 96 well plate (Figure 2.2).  
 
 
Figure 2.2. Microcal VP – capillary DSC 96 well plate (Edge BioSystems 
Inc.). 
At first water was placed in both sample and reference compartments (Table 
2.3). HSDSC curve corresponding to water vs. lysozyme run was used as the 
instrumental calibration.  
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Table 2.3. Microcal VP – capillary DSC plate lay-out. 
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During the scan the cells are heated with constant power and the difference 
in temperature between the cells is closely monitored. The difference in 
power that has to be supplied to the cells during scan is recorded as a 
function of time and is a measure of the difference between the heat capacity 
of the sample and the reference sample. 
HSDSC analysis was performed using a Microcal VP-DSC.  
The calorimetric data was analyzed by using the software Origin 5.0, 
MicroCal Inc.. The parameter obtained from this analysis was temperature at 
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which maximum heat exchange occurs (Tm). This was obtained by linear 
connection of the baseline, normalizing concentration and fitting a non-two-
state model to the data after baseline correction.  
 
2.2.4 Dynamic Light Scattering (DLS) 
 
 
DLS measurements were performed using a Zetasizer nano-series (Malvern 
Instruments Ltd). The DLS instrument was left powered up for approximately 
30 minutes before measurements were made. This was to prevent any 
thermal equilibration problems affecting the measurement results (The 
NanoBiotechnology Centre, 2009) 
All experiments were performed at 173° scattering angle, which maximizes 
the detection of scattered light while maintaining signal quality. This provides 
exceptional sensitivity that is required for measuring the size of particles, 
such as surfactant micelles, at low concentration (Malvern Instruments Ltd, 
2006). A monochromatic coherent He-Ne laser with a fixed wavelength of 
633 nm was employed. The samples were measured un-filtered and un-
diluted to ensure that the sample composition is maintained in its original 
state. Samples were directly poured into a low volume quartz cuvette 
ZEN2112 (Figure 2.3, Table 2.4) and placed inside a constant temperature 
holder. All measurements in this study were taken at a temperature of 25°C. 
Each sample was equilibrated for 10 minutes and had three measurements. 
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Figure 2.3. Low volume quartz batch cuvette for size and molecular 
weight measurements for use with the Zetasizer Nano series (The 
Nanobiotechnology Centre, 2009). 
Table 2.4. Low volume quartz cuvette (ZEN2112) description (The 
Nanobiotechnology Centre, 2009). 
LOW VOLUME QUARTZ CUVETTE ZEN2112 
Typical solvent Water, most organic and inorganic solvents 
Optical quality Excellent 
Minimum sample 
volume 
12 µl 
Advantages Highest optical quality 
Can use nearly any dispersant 
Low sample volume 
Disadvantages Requires cleaning after measurement 
Requires careful filling to avoid bubbles 
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The intensity size distributions were obtained from analysis of the 
correlations functions using the Multiple Narrow Modes algorithm in the 
instrument software. 
 
2.2.5 Light Obscuration (HIAC) 
 
 
 
Light obscuration analysis is based on the reduction of light intensity due to 
reflection, absorption and scattering, if a particle crosses an incident laser 
beam. As the decrease in light intensity is proportional to the size of particles, 
particle size distributions assuming spherical particles can be generated 
(Mahler et al., 2009). 
All HIAC measurements were performed at Medimmune UK Cambridge Ltd 
formulation laboratory using the HIAC/ROYCO eight channel particle counter 
8000A and liquid syringe sample 3000A instrument. It has been reported by 
Mahler et al. (2009) that the HIAC instrument contains a laser diode and a 
photodiode detector to determine the residual light intensity of laser beam, 
after particles have passed the sensor-zone (Mahler et al., 2009). 
Between the measurements the HIAC instrument was cleaned and particle 
free fluid was flushed through the system to provide a clean baseline. The 
samples were gently inverted taking care not to introduce air bubbles. Six 
measurements were analyzed for each sample. The results from all 
measurements were reported as the number of particles per ml, and the 
average of the last three measurements was utilized for further evaluation. 
Appropriate negative controls were also measured to ascertain the effects of 
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sample handling. The instrument was set up to measure particles greater 
than or equal to 2, 5, 10, 25, 50 and 100 µm, as appropriate.  
 
2.2.6 Micro-flow Imaging (MFI) 
 
MFI is a flow microscopic technology which operates by capturing images of 
suspended particles in a flowing stream. Different magnification set-points 
are available to suit the desired particle size range and image quality 
(Brightwell Technologies Inc., 2006). 
Micro-flow imaging (MFI) measurements were performed at Medimmune UK 
using the MFI DPA4200 series instrument. Samples and PBS buffer were 
allowed to stand for 10 minutes at atmospheric pressure and room 
temperature to assist in removing any air bubbles which may have been 
formed after sample preparation. Prior to each sample analysis, particle free 
fluid was flushed through the system to provide a clean baseline. Clean 
baselines were achieved by flushing for 2 minutes between sample runs. A 
typical image frame from a proteinaceous sample is shown in Figure 2.4. As 
described in the “Application of MFI to the Analysis of Particles in Parenteral 
Fluids”, the sample volume in each frame is precisely defined by the flow cell 
geometry so the particle concentrations can be determined absolutely 
(Brightwell Technologies Inc., 2006). 
No calibration is required and all critical system parameters are automatically 
pre-set to eliminate run-to run and user-dependent variations.  
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The system software proceeds measurement of area, equivalent circular 
diameter, perimeter, intensity, circularity and maximum Feret’s diameter for 
each sample. 
 
Figure 2.4. Typical image frame (Brightwell Technologies Inc., 2006). 
Dulbecco’s filtered PBS buffer was used to optimize the illumination. The 
samples were gently inverted taking care not to introduce air bubbles. For 
each sample two separate runs of 1 ml each were analysed and then 
averaged for further analysis. The MFI instrument measured particles greater 
than or equal to 2, 10, 25, 50 and 100 µm per ml.   
 
2.2.7  Statistical data analysis 
 
Collected data was analysed using SPSS (Statistical Package for the Social 
Sciences) software (Version 20.0).  
Data normality was assessed.  
Statistical tests were used: 
 One-Way ANOVA, post-hoc Bonferroni test was applied for testing the 
significance of differences between  different sample groups; 
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 Pearson Correlation test was used to measure the “degree of linearity” 
and relationship between pair of variables on a scale from -1.00 to 
+1.00; 
 T-test – Student’s t-test was used to determine if two sets of data are 
significantly different from each other. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  55 
 
 
 
 
 
 
 
Chapter 3 
Effect of surfactant and surfactant concentration on 
the thermal unfolding of BSA and Igg2 in solution 
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3.1 Introduction  
 
One of the crucial problems of protein-based biopharmaceuticals is their 
long-term stability or so called shelf life. Comprehensive knowledge about 
prediction of protein stability can facilitate the development of optimal 
formulations (Ahrer et al., 2006). Protein stability is important for formulation 
development and also during the whole production process of the therapeutic 
protein to prevent process-induced aggregation. Aggregation is one of the 
major problems in pharmaceutical industry since proteins are relatively 
unstable in solution (Ahrer et al., 2006).  
One of the common methods of protein solution stabilization is the addition of 
surfactants for their ability to prevent protein aggregation. Maximum 
protection occurs at concentrations close to the critical micelle concentration 
(CMC) independent of the initial protein concentration (Krielgaard et al., 
2000). 
High sensitivity differential scanning Calorimetry (HSDSC) is a powerful 
method, which can be used for optimising the stability of proteins in solution. 
It is therefore an essential tool in the development of pharmaceutical proteins 
(Remmele et al., 1998; Krielgaard et al., 2000; Vidanovic et al., 2003; Michnik 
2003; Wissing et al., 2000). HSDSC operates on a similar principle to 
conventional DSC, but HSDSC is around 10 – 100-fold more sensitive and is 
able to detect baseline changes below 1 µW (Wissing et al., 2000). 
The Tm value measured by HSDSC is commonly used as a stability indicator 
for proteins (Cueto et al. 2003) and has been reported comprehensively in 
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the literature (Cueto et al., 2003; Branchu et al., 1999; Larsericsdotter et al., 
2004; Michnik, 2003; Wissing et al., 2000; Ahrer et al., 2006; Garidel et al., 
2009). 
Given the sensitivity associated with HSDSC, it was accordingly decided to 
use HSDSC to investigate the effects that Tween 20, Tween 80, Brij 35 and 
Pluronic F-68 – (non-ionic surfactants) at different concentrations have on the 
thermal stability of bovine serum albumin and immunoglobulin IgG2. 
 
3.2 Objective 
 
The main objective of the HSDSC experiments was to investigate the effect 
of Tween 20, Tween 80, Brij 35 and Pluronic F-68 non-ionic surfactants and 
their different concentrations on the unfolding transition temperature of 
bovine serum albumin BSA and immunoglobulin IgG2. 
 
3.3 Experimental 
 
Thermal unfolding of proteins was monitored with a high sensitivity 
differential scanning calorimeter, model VP-DSC, from MicroCal Inc. 
Thermograms were obtained between 25 and 95°C, at a scan rate of 
1°C/min. Both – bovine serum albumin and immunoglobulin IgG2 were 
analyzed at concentrations of 10 mg/ml.  
Samples of BSA and IgG2 alone were scanned to produce a thermal profile 
along with protein samples containing surfactants at below, around and 
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above CMC levels to allow comparison of protein-surfactant free and protein-
surfactant systems. 
Thermal unfolding measurements were carried out as described in Chapter 
2, Section 2.2.3. 
The experiments were repeated two times to show reproducibility of the 
results.  
The reversibility of the thermally induced transition was checked by reheating 
the sample solution in the calorimetric cell after cooling from the first run. 
The calorimetric data was analyzed by using the software Origin 5.0, 
MicroCal Inc. as described in Chapter 2, Section 2.2.3. 
 
3.4 Results and Discussion 
3.4.1 Thermal unfolding experiments of bovine serum albumin 
 
Figure 3.1 shows the HSDSC thermal unfolding profile of bovine serum 
albumin (10 mg/ml in PBS buffer). The Tm value for the protein was taken as 
the peak maxima.  
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Figure 3.1. Thermal unfolding profile of BSA (10 mg/ml in PBS buffer). 
Black line represents normalised calorimetric data for the thermal 
denaturation of BSA. Red line represents the results of fitting 
experimental curves to a non-two-state model. 
The average of the unfolding temperature Tm BSA was 66.91 ± 0.085°C this 
is similar to the published value of 67°C (Nishimura et al., 2001).  
Thermal analysis of BSA (10mg/ml) alone and BSA (10mg/ml) with different 
added levels of Tween 20, Tween 80, Brij 35 and Pluronic F-68 surfactants 
showed that the denaturation process is irreversible, probably due to 
aggregation of unfolded protein molecules at high temperatures. This 
behaviour has been previously reported in the literature (Michnik, 2003, Pico, 
1997, Giancola et al., 1997). 
Table 3.1 shows the results obtained for the thermal unfolding profiles of BSA 
(10 mg/ml) and BSA (10 mg/ml) with different Tween 20, Tween 80, Brij 35 
and Pluronic F-68 concentrations (See Appendix 1-12). 
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Table 3.1. Results of thermal unfolding profiles of BSA (10 mg/ml in 
PBS buffer) and BSA (10 mg/ml) with different Tween 20, Tween 80, Brij 
35 and Pluronic F-68 concentrations. 
SOLUTION Tm (°C) Standard 
deviation 
BSA (10 mg/ml) 66.91 ±0.085 
BSA (10 mg/ml) with Tween 20 
below CMC 
61.79 ±0.057 
BSA (10 mg/ml) with Tween 20 
around CMC 
60.24 ±0.255 
BSA (10 mg/ml) with Tween 20 
above CMC 
60.68 ±0.042 
BSA (10mg/ml) with Tween 80 below 
CMC 
61.09 ±0.099 
BSA (10 mg/ml) with Tween 80 
around CMC 
61.66 ±0.184 
BSA (10 mg/ml) with Tween 80 
above CMC 
64.70 ±0.071 
BSA (10 mg/ml) with Brij 35 below 
CMC 
61.20 ±0.042 
BSA (10 mg/ml) with Brij 35 around 
CMC 
65.54 ±0.085 
BSA (10 mg/ml)  with Brij 35 above 
CMC 
65.99 ±0.028 
BSA (10 mg/ml) with Pluronic F-68 
below CMC 
61.42 ±0.042 
BSA (10 mg/ml) with Pluronic F-68 
around CMC 
61.46 ±0.042 
BSA (10 mg/ml) with Pluronic F-68 
above CMC 
62.29 ±0.071 
 
Figure 3.2 represents the results from table 3.1 to identify if any trends are 
present. 
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Figure 3.2. Unfolding temperatures (Tm) of BSA (10mg/ml) with different 
Tween 20, Tween 80, Brij 35 and Pluronic F-68 concentrations. 
From the data shown in Table 3.1 and Figure 3.2 it can be clearly seen that 
the presence of all of the surfactants at any concentration lowers Tm and 
promotes the thermal unfolding of BSA. The average Tm of BSA with Tween 
20 and Tween 80 surfactants are lower than that reported by Garidel et al. 
(Garidel et al., 2009). These discrepancies are due to the difference in used 
concentrations, which were higher. The other difference that may have 
contributed was the albumin sample. In the pre-cited study (Garidel et al., 
2009) the sample was Human Serum Albumin (HSA).  
At the concentrations employed, the average Tm of BSA (10 mg/ml) with 
Tween 20 and Pluronic F-68 was lower then that produced by Tween 80 and 
Brij 35. Tm was maximal for BSA in the presence of Tween 80 at a 
concentration above its CMC (64.70 ± 0.012°C) and similarly for Brij 35 at 
concentrations around (65.54 ± 0.019°C) and above its CMC (65.99 ± 
0.015°C). This finding would indicate that Tween 80 and Brij 35 at 
  
  62 
concentrations above their CMC had a weaker interaction with BSA than 
Tween 20 and Pluronic F-68 at higher concentrations relative to CMC, 
because they reduced Tm to the least extent compared to the surfactant-free 
BSA sample. 
One-way ANOVA analysis showed a significant effect of all the surfactants at 
all concentrations on the unfolding temperature Tm of BSA (10 mg/ml) (P< 
0.01). Post-hoc tests, using the Bonferroni correction, showed a significant 
reduction in the Tm (°C) of BSA (10 mg/ml) with all four surfactants at the 
concentrations employed compared to BSA (10 mg/ml) surfactant free 
solution. The mean difference was significant at the 0.001 level (P<0.001) for 
BSA with Tween 20, Tween 80, Pluronic F-68 surfactants at all CMC levels 
and Brij 35 at below and above CMC. Brij 35 around CMC the mean 
difference was significant at 0.01 (P<0.01) level compared to BSA surfactant 
free solution. Figure 3.3 illustrates these findings. 
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Figure 3.3. The effect of different concentrations of Tween 20, Tween 
80, Brij 35 and Pluronic F-68 surfactants on BSA (10 mg/ml) unfolding 
temperature Tm (°C) measured by HSDSC. Data is expressed as the 
mean ± Std. Deviation. ** P<0.01 - *** P<0.001; significant decrease in 
BSA with surfactants unfolding temperature Tm compared with BSA (10 
mg/ml) surfactant free solutions. 
In Figure 3.4 the effect on Tm of different surfactant concentration relative to 
CMC is shown. 
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Figure 3.4 Effect of surfactant concentration relative to CMC on the Tm 
of BSA for Tween 20, Tween 80, Brij 35 and Pluronic F-68 surfactants. (1 
– 10 times below CMC; 2 – around CMC; 3 – 10 times above CMC) 
From Figure 3.4 BSA Tm values increased with increasing concentration for 
Tween 80, Brij 35 and Pluronic F-68 surfactants. Interestingly, for the Tween 
20 system, Tm was maximal at its lowest concentration.  
It is noticeable that when the concentration of surfactant in solution is below 
CMC there is a general decrease in Tm for Tween 80, Brij 35 and Pluronic F-
68 surfactant systems.  
One-way ANOVA analysis showed significant differences of Tm between the 
Tween 20, Tween 80, Brij 35 and Pluronic F-68 surfactant groups at 
concentrations below CMC, around CMC and above CMC levels. For all  four 
surfactants at concentrations below their CMC, the Tm (°C) difference was 
statistically significant at 0.01 level (P<0.01) At around CMC and above CMC 
concentrations, the Tm difference between surfactants was statistically 
significant at 0.001 level (P<0.001). 
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3.4.2   Thermal unfolding experiments of monoclonal antibody IgG2 
  
The thermal unfolding of IgG2 (10 mg/ml), is notably different to that of 
bovine serum albumin (10 mg/ml), over the temperature range 30 – 95°C. It 
is characterised by two endothermic transitions (Figure 3.5), which is the 
result of the melting of two independent domains of the immunoglobulin 
(Ionescu et al., 2007). Typical applications concerning immunoglobulin are 
studies describing the complex unfolding of antibodies by the denaturation of 
two individual domains. The complexity of the unfolding is given by the 
structure of the IgG2 molecule, which  consists of four polypeptide chains 
that are linked by disulphide bonds and grouped in two identical Fab and one 
Fc fragment forming an Y-shaped conformation (Ahrer et al., 2006). These 
authors reported that immunoglobulin Fc fragments having different 
glycosylation pattern show differences in the thermodynamic properties 
(Ahrer et al., 2006). 
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Figure 3.5. Thermal unfolding profile of IgG2 (10 mg/ml). Black line 
represents normalised calorimetric data for the thermal denaturation of 
IgG2 (10 mg/ml). Red lines represent the two peaks of fitting 
experimental curves to a non-two-state model.  
Results of the thermal unfolding of IgG2 in absence and presence of different 
CMC levels of Tween 20, Tween 80, Brij 35 and Pluronic F-68 surfactants 
are shown in Appendixes 13-24 and are summarised in Table 3.2 and Figure 
3.6.  
The best fit parameters returned from the data fits are consistent with a 
transition at 69.38 ± 0.057°C (Tm1) and another at 77.53 ± 0.113°C (Tm2) 
(Table 3.2). Kravchuk et al., (1998) presented similar Tm unfolding peaks for 
IgG2. 
Under these conditions, the transitions were irreversible and no thermal 
transitions were noted on subsequent scans of the same samples after 
cooling.  
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Table 3.2. Results of thermal unfolding profiles of IgG2 (10 mg/ml) and 
IgG2 (10 mg/ml) with different Tween 20, Tween 80, Brij 35 and Pluronic 
F-68 concentrations. 
SOLUTION Tm1 (ºC) 
Mean ±STDEV 
Tm2 (ºC) 
Mean ±STDEV 
Igg2 69.38±0.057 77.53±0.113 
Igg2 with Tween 20 below 69.61±0.042 77.50±0.141 
Igg2 with Tween 20 around 69.22±0.311 77.60±0.042 
Igg2 with Tween 20 above 69.13±0.042 77.63±0.071 
Igg2 with Tween 80 below 69.31±0.057 76.70±0.156 
Igg2 with Tween 80 around 69.61±0.169 77.65±0.071 
Igg2 with Tween 80 above 69.60±0.057 77.63±0.028 
Igg2 with Brij 35 below 68.60±0.042 76.49±0.099 
Igg2 with Brij 35 around 69.11±0.028 76.78±0.042 
Igg2 with Brij 35 above 68.88±0.014 76.68±0.057 
Igg2 with F-68 below 68.82±0.042 76.93±0.071 
Igg2 with F-68 around 68.12±0.042 76.12±0.028 
Igg2 with F-68 above 68.75±0.071 77.02±0.028 
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Figure 3.6. Thermal unfolding temperatures (Tm1 and Tm2) of IgG2 (10 
mg/ml) with different Tween 20, Tween 80, Brij 35 and Pluronic F-68 
concentrations. 
Data presented in Table 3.2 shows that the first thermal unfolding peak (Tm1) 
is shifted to lower temperatures, opposite to what is observed for the second 
peak (Tm2). In any case, the difference between Tm1 and Tm2 comprises 
around 9 degrees. This relates to thermal unfolding of two IgG2 individual 
domains (Tischenko et al., 1998, Tischenko et al., 2003). 
In general, the different levels of Tween 20, Tween 80, Brij 35 and Pluronic 
F-68 surfactants lowered the Tm for IgG2.  The analysis of the thermal 
unfolding curves shows that the presence of all surfactants at different 
concentrations is negligible (Figure 3.6). 
One-way ANOVA analysis showed significant differences of Tm1 between the 
IgG2 surfactant free and IgG2 with Tween 20, Tween 80, Brij 35 and Pluronic 
F-68 surfactants at different concentrations. However post-hoc comparison 
between individual groups corrected for repeated analysis using Bonferroni 
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test indicated no significant differenced for Tween 20 and Tween 80 below, 
around and above CMC and Brij 35 around CMC surfactants comparing to 
IgG2 (10 mg/ml) surfactant free solution. Bonferroni test showed that the Tm1 
mean difference was significant: at the 0.001 level (P<0.001) for Brij 35 
below its CMC and Pluronic F-68 at around its CMC, at the 0.01 level 
(P<0.01) for Pluronic F-68 above its CMC, at the 0.05 level (P<0.05) for Brij 
35 above and Pluronic F-68 below their CMC compared to the transition of 
IgG2 in surfactant free solution (Figure 3.7). 
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Figure 3.7. The effect of different CMC levels of Tween 20, Tween 80, 
Brij 35 and Pluronic F-68 surfactants on IgG2 unfolding temperature 
Tm1 (°C) measured by HSDSC. Data are expressed as the mean ± Std. 
deviation. NS – no significant difference, * - P<0.05, ** - P<0.01, *** - 
P<0.001 significant decrease in unfolding temperature Tm1 for IgG2 with 
surfactants compared with IgG2 surfactant free solution. 
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One-way ANOVA analysis showed a significant effect of all the surfactants at 
concentrations below, around and above their CMC levels on the IgG2 
unfolding temperature Tm2. However post-hoc, Bonferroni test showed that 
there is no significant difference in Tm2 between IgG2 surfactant free and 
IgG2 with Tween 20 below, around and above its CMC and Tween 80 at 
around and above its CMC solutions. 
The unfolding temperature Tm2 difference was significant at the 0.001 
(P<0.001) level for Tween 80 below, Brij 35 below, around and above CMC 
and Pluronic F-68 around CMC levels compared to IgG2 surfactant free 
solution. The mean difference for Pluronic F-68 below and above 
concentrations was significantly different at 0.01 (P<0.01) level compared to 
IgG2 (10 mg/ml) (Figure 3.8). 
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Figure 3.8. The effect of different CMC levels of Tween 20, Tween 80, 
Brij 35 and Pluronic F-68 surfactants on IgG2 unfolding temperature 
Tm2 (°C) measured by HSDSC. Data are expressed as the mean ± Std. 
deviation. NS – no significant difference, ** - P<0.01, *** - P<0.001 
significant decrease in Tm2 for IgG2 with surfactants compared with 
IgG2 surfactant free solution. 
Figure 3.9 illustrates the effect on Tm1 of different CMC levels of surfactants. 
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Figure 3.9. The effect of different surfactant concentration levels on 
Tm1. (1 – below CMC; 2 – around CMC; 3 – above CMC) 
By introducing a trend line into the data it is possible to see that there are 
some differences between the behaviour of the surfactants over the range of 
concentrations. It is noticeable that at the lowest concentration level, Tween 
20 and Tween 80 systems have the highest Tm1 comparing with Brij 35 and 
Pluronic F-68 systems. However, with increase in surfactant concentration, 
Tm1 values increased for Tween 80 systems, and decreased with Tween 20. 
For the Brij 35 system Tm1 is maximal at around its CMC, whereas Pluronic 
F-68 has the lowest Tm1 at around its CMC. 
Similar results were obtained for Tm2 with Brij 35 and Pluronic F-68 systems 
(Figure 3.10). 
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Figure 3.10. The effect of different CMC concentration levels on Tm2. (1 
– below CMC; 2 – around CMC; 3 – above CMC) 
Tm2 values increase with increase in concentration of Tween 20 and Tween 
80.  
No notable changes of Tm are observed between different concentrations of 
surfactants. The present results indicate a very weak surfactant-
immunoglobulin interaction, compared to the much stronger interactions 
described for bovine serum albumin-Tween 20, Tween 80, Brij 35 and 
Pluronic F-68 systems (Table 3.1, Figure 3.1). 
One – way ANOVA analysis, post-hoc analysis showed significant 
differences for both Tm1 and Tm2 between BSA with Tween 20, Tween 80, 
Brij 35 and Pluronic F-68 surfactants groups at below, around and above 
CMC concentrations. The mean difference was significant at the 0.05 
(P<0.05) level.  
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A comparison of Tm1 and Tm2 measured by HSDSC for fresh IgG2 (10 
mg/ml) with Tween 20, Tween 80, Brij 35 and Pluronic F-68 surfactants at 
below, around and above CMC levels are summarised in Figure 3.11. 
 
 
Figure 3.11. Scatter plot of unfolding temperatures Tm1 and Tm2 
measured by HSDSC for IgG2-surfactant systems. 
Statistical analysis, using Pearson correlation was used to describe the 
relationship between IgG2 unfolding temperatures Tm1 and Tm2 measured by 
HSDSC. The Pearson Correlation significance value was found to be 0.000, 
which means that correlation between variables is significant at 0.01 level 
(P<0.01). The finding is indicative that for this  protein both variables Tm1 and 
Tm2 rise and fall sympathetically and denotes a near-perfect linear 
relationship (Figure 3.11). 
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3.5 General Discussion 
 
HSDSC thermal unfolding experiments showed that for BSA (10 mg/ml) in 
PBS a single unfolding peak is observed: Tm=66.91 ± 0.085°C. The presence 
of Tween 20, Tween 80, Brij 35 and Pluronic F-68 surfactants induced Tm-
shifts to lower temperatures for bovine serum albumin.  The interaction of 
Tween 80 at above its CMC and Brij 35 at around and above its CMC with 
BSA was less pronounced compared with other surfactants. 
The thermal unfolding curve of the immunoglobulin IgG2 was represented by 
and best fitted by two overlapping endotherms: Tm1=69.38 ± 0.057°C and 
Tm2=77.53 ± 0.113°C. The exact position of the unfolding temperatures is 
depending on the environmental conditions and immunoglobulin subtype 
(Weichel et al., 2008; Garidel et al., 2008). 
The results showed that the presence of any surfactant at different 
concentrations with immunoglobulin IgG2 was negligible. No notable 
changes of the Tm1 and Tm2 were observed.  
Thermal unfolding experiments indicated a very weak surfactant-
immunoglobulin IgG2 interaction, compared to much stronger interactions for 
the bovine serum albumin-surfactant systems. These results are consistent 
with published results (Garidel et al., 2009), who found out that the binding of 
surfactants on IgG2 is negligible. 
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Chapter 4 
Effect of different concentrations of Tween 20, Tween 
80, Brij 35 and PLuronic F-68 surfactants on size 
stability by Dynamic Light Scattering 
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4.1 Introduction 
 
In the biopharmaceutical industry, protein aggregation is encountered 
routinely during purification, refolding, sterilization, shipping, and storage 
processes because of the presence of chemical and physical stresses 
(Bermundez et al., 2004). The presence of aggregates in protein and 
antibody formulation influences a decrease in the efficiency of the drug and 
causes potential problems in its intravenous administration (Bermundez et 
al., 2004). Even if the protein preparation may be aggregate-free after a last 
polishing step has been completed, aggregates can form during storage 
(Bermundez et al., 2004). 
Proteins are being utilized directly in the pharmaceutical industry as active 
agents in medicines. The size of the molecule and its association state can 
be used as a quality control measure. Also during the production of 
nanoparticles, the particle size can be used as a quality attribute in a quality 
control process (Kaszuba et al., 2007). It is obvious that if we want to provide 
accurate information on protein aggregation the use of light scattering 
technique is needed (Bermundez et al., 2004). In part, this is because  there 
are only a few techniques available for the direct measurement of small 
molecules and particles in solution such as Analytical Ultracentrifugation 
(AUC), Field Flow Fractionation (FFF), Multiangle Light Scattering (MALS), 
Size Exclusion Chromatography (SEC) and Dynamic Light Scattering (DLS). 
Dynamic light scattering (DLS) is a technique for characterising the size of 
particles and particle size distribution, which utilizes the illumination of a 
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suspension of particles or molecules undergoing Brownian motion by a laser 
beam (Kaszuba, 2007). 
DLS has been widely used to study various types of proteins (Mahler et al., 
2005; Ye 2006; Demeule et al., 2007; Qian et al., 1997; Georgalis et al., 
1993; Onuma et al., 2003; Onuma et al., 2005; Plakoutsi et al., 2005, Liu et 
al., 2009). DLS is mainly used to determine particle size by measuring the 
diffusion coefficient of the particles in a solution and then using the diffusion 
coefficient to determine the size. As DLS is used to determine particle size, it 
has become very useful to investigate protein aggregation (Bermudez et al., 
2004). That is, in DLS we can achieve a mathematical separation of large 
from small components because they produce scattering fluctuations on 
different time scales. Also DLS is useful for comparing one formulation 
sample to another formulation approach (Arakawa et al., 2007). 
The aim of this chapter is to explore that part of the sub-visible particle size 
range which is measurable by dynamic light scattering. The test systems 
used are bovine serum albumin (BSA) and immunoglobulin IgG2 treated with 
different levels of Tween 20, Tween 80, Brij 35, Pluronic F-68 surfactant 
systems under heat stress and storage conditions. 
   
4.2 Objective 
 
To study how particle size distribution measured by Dynamic light scattering 
is affected by the concentration of Tween 20, Tween 80, Brij 35 and Pluronic 
F-68 surfactants, and in relation to CMC. 
  
  79 
To investigate how heat treatment stress affects the particle size distribution 
for different surfactants and at different concentration. 
To investigate how particle size distribution changes under storage. 
 
4.3 Experimental 
 
Dynamic light scattering (DLS) measurements were performed at BSA and 
IgG2 concentrations of 10 mg/ml with below, around and above CMC levels 
of Tween 20, Tween 80, Brij 35 and Pluronic F-68 surfactants (See Table 2.2 
Chapter 2 for details).  
Measurements of all samples were made on a Malvern Zetasizer Nano 
series (Malvern Instruments Ltd., UK) as described in Section 2.2.4 Chapter 
2.  
 
4.4 Results and Discussion 
4.4.1 Particle size distribution measurements for freshly prepared 
BSA-surfactants systems 
 
DLS intensity particle size distribution histograms of freshly prepared 
samples of BSA (10 mg/ml) in the absence and presence of Tween 20, 
Tween 80, Brij 35 and Pluronic F-68 surfactants at different CMC levels are 
shown in figures 2 – 6. The plots have been configured using the software 
dialogue to display a size distribution by intensity histogram, with a 
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logarithmic x-axis and a linear y-axis. The x-axis is the absolute size of the 
scatter obtained by a multimodal fitting of the time correlation function. The y-
axis is the intensity average of the scattered light. The distribution histograms 
show the percentage of the scattering intensity that arises from species at 
each size (d.nm). 
 
Figure 4.1. Particle size distribution by intensity obtained for freshly 
prepared BSA (10 mg/ml). Average n=3. 
From figure 4.1 the particle size by intensity obtained for freshly prepared 
BSA (10 mg/ml) samples gave trimodal distribution with the main peak at 7.7 
nm (48.5 % intensity), a second peak at 3755 nm  (37.1 % intensity) and a 
third peak at 322.7 nm diameter (14.4 % intensity). Our findings are 
consistent with a main BSA protein peak of diameter at 7.8 nm as reported 
previously by Yu et al (2011). 
 
 
 
 
 
  
  81 
(A) 
 
(B) 
 
(C) 
 
Figure 4.2. Particle size distribution by intensity obtained for BSA (10 
mg/ml) fresh samples with: (A) Tween 20 below CMC; (B) Tween 20 
around CMC; (C) Tween 20 above CMC. 
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From Figure 4.2 the particle size distributions for BSA (10 mg/ml) in the 
presence of Tween 20 surfactant at all CMC concentrations produced three 
peaks with the main peak mode consistently around 8 nm. When Tween 20 
concentration was above CMC, a greater percentage of larger particles 
formed than Tween 20 below and around CMC and BSA alone (Figure 4.2 
(C)).  
Running DLS analysis on the Tween 20 surfactant alone in the presence of 
with PBS buffer, with no protein present, for Tween 20 below and around 
CMC levels no peak at around 10 nm was detected (See Appendix 25-27). At 
Tween 20 concentration around CMC, DLS results produced a 100 % 
intensity peak at an average of 499 nm diameter. The corresponding data for 
the Tween 20 concentration above CMC showed bimodal peaks with 59.5 % 
intensity peak at diameter of 7.0 nm, and 40.5 % intensity peak at 86.0 nm 
diameter. The control experiment suggests that some micellar interference at 
this concentration needs to be taken into account.  Figure 4.3 schematically 
represents these findings that at low concentrations, surfactant molecules are 
unassociated monomers. As the concentration of surfactant is increased, the 
molecules cause self-aggregation to occur resulting in the formation of 
monolayers or micelles (Figure 4.3). 
  
  83 
 
Figure 4.3. The surfactant can exist as different phases depending upon 
the concentration of the sample (Malvern Instruments Ltd., 2006). 
BSA (10 mg/ml) with Tween 80 surfactant at below, around and above CMC, 
gave very similar trimodal distribution with the main peak consistently around 
8 nm diameter (Figure 4.4). 
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(B) 
 
(C) 
 
Figure 4.4. Particle size distribution by intensity obtained for BSA (10 
mg/ml) with: (A) Tween 80 below CMC; (B) Tween 80 around CMC; (C) 
Tween 80 above CMC. 
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The second largest peak by intensity for BSA (10 mg/ml) with Tween 80 at all 
concentrations had a consistent diameter of around 4000 nm. BSA in the 
presence of  Tween 80 above its CMC produced by DLS a main peak at 7.8 
nm, the highest compared to BSA with added Tween 80 below its CMC (7.6 
nm diameter) and BSA with Tween 80 at around its CMC (7.8 nm diameter). 
The finding may result from the contribution of surfactant micelles at the 
higher Tween 80 concentration, where the diameter of the Tween 80 micelle 
was determined to be 10.7 nm from control experiments (See Appendix 28-
30) (Malvern Instruments Ltd., 2006). 
Similar findings were obtained for BSA (10 mg/ml) with Brij 35 at different 
concentrations (Figure 4.5). The main DLS peak diameter for BSA obtained 
from surfactant concentrations below, around and above CMC was around 8 
nm. Brij 35 above CMC had the highest diameter of 8.2 nm at the main peak 
intensity of 82 % comparing to below and around CMC concentrations.  Once 
again surfactant micellar contribution at high Brij 35 levels may have 
contributed. Our evidence stems from that DLS analysis of Brij 35 above its 
CMC with PBS buffer and no protein produced a the main intensity peak at 
8.8 nm diameter (88.9 % intensity), where Brij concentrations below and 
around its CMC did not produce any intensity peak around 10 nm diameter 
(See Appendix 31-33). The literature value for a Brij 35 micelle is 8 nm 
diameter (Malvern Instruments Ltd., 2006).  
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(A) 
 
(B) 
 
(C) 
 
Figure 4.5. Particle size distribution by intensity obtained for BSA (10 
mg/ml) with: (A) Brij 35 below CMC; (B) Brij 35 around CMC; (C) Brij 35 
above CMC. 
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The DLS particle size distributions by intensity obtained for the analysis of 
BSA (10 mg/ml) in the presence of Pluronic F-68 are shown in Figure 4.6. 
Concentrations of Pluronic at below and above its CMC level produced a 
main peak at around 8 nm diameter. Pluronic F-68 at around and above 
CMC concentrations produced a main peak diameter and intensity that was 
higher than that obtained for Pluronic F-68 at below CMC levels (Figure 4.6). 
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(A) 
 
(B) 
 
(C) 
 
Figure 4.6. Particle size distribution by intensity obtained for BSA (10 
mg/ml) with: (A) Pluronic F-68 below CMC; (B) Pluronic F-68 around 
CMC; (C) Pluronic F-68 above CMC. 
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Running F-68 at all concentrations just with PBS buffer no peak around 10 
nm was detected (See Appendix 34-36). At below, around and above 
concentrations DLS results showed just one peak with 100 % intensity and 
407.5 nm for below CMC, 286.8 nm for around CMC and 256.1 nm for above 
CMC concentrations. This finding is consistent with the increase in diameter 
of the second and third peaks shown in Figure 4.6.  
The particle size diameter (nm) of the main peak with greatest intensity for 
fresh BSA (10 mg/ml) with below, around and above CMC levels of Tween 
20, Tween 80, Brij 35 and Pluronic F-68 surfactants are summarised in Table 
4.1 and Figure 4.7. 
Table 4.1. Particle size diameter (nm) of the peak with greatest intensity 
(Peak 1) for fresh BSA (10 mg/ml) with below, around and above CMC 
levels of Tween 20, Tween 80, Brij 35 and Pluronic F-68 surfactants. 
FRESH SAMPLES PEAK POSITION WITH 
GREATEST INTESITY DIAMETER 
(nm) 
BSA (10mg/ml)  7.689 
Tween 20 below CMC 7.895 
 around CMC 8.004 
 above CMC 7.549 
Tween 80  below CMC 7.597 
 around CMC 7.763 
 above CMC 7.791 
Brij 35  below CMC 7.823 
 around CMC 7.811 
 above CMC 8.224 
Pluronic F-68 below CMC 7.700 
 around CMC 8.322 
 above CMC 8.089 
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Figure 4.7. Particle size diameter (nm) of the peak with greatest 
intensity (Peak 1) for fresh BSA (10 mg/ml) with below, around and 
above CMC levels of Tween 20, Tween 80, Brij 35 and Pluronic F-68 
surfactants. 
Analysing particle size diameter of the main peak for fresh samples, it can be 
seen that the highest intensity peak diameter (nm) increased for 
concentration of Tween 20 below and around CMC and slightly decreased by 
0.14 nm for Tween 20 above CMC compared to BSA alone (10 mg/ml). 
Tween 80 below CMC – main peak diameter was slightly smaller and Tween 
80 around and above slightly bigger than that obtained for surfactant free 
BSA (10 mg/ml). The greatest increase in diameter (nm) was detected for 
samples with Brij 35 above its CMC and the sample containing  Pluronic F-68 
at around and above its CMC (Figure 4.7). It is likely that the high 
concentrations of Brij 35 and Pluronic F-68 surfactants produce larger micelle 
size of entities that contribute to this result. 
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Statistical analysis – t-test (See Chapter 2, Section 2.2.7) showed that the 
difference between fresh surfactant - free BSA (10 mg/ml) and Tween 20, 
Tween 80, Brij 35 and Pluronic F-68 surfactants at below, around and above 
CMC levels, was statistically significant at the 95 % level (P < 0.05). 
Figure 4.8 illustrates the comparison of the diameter in nm of the main 
(highest intensity) peak at below, around and above CMC levels for Tween 
20, Tween 80, Brij 35 and Pluronic F-68 surfactants. 
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Figure 4.8. A plot of the highest intensity peak diameter (nm) obtained 
at below (1), around (2) and above (3) CMC levels for Tween 20, Tween 
80, Brij 35 and Pluronic F-68 surfactants.  
From Figure 4.8 it can be clearly seen that all four surfactants at below, 
around and above CMC levels differ in the particle size diameter (nm) for the 
highest intensity peak. 
There is a decrease in the main peak measured size diameter as the Tween 
20 surfactant concentration increases. Tween 80 shows gradual increase in 
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diameter (nm) with concentration. Similar results are observed for Brij 35 and 
Pluronic F-68. It can be seen the high concentration of Tween 20 produced 
the lowest main peak particle size diameter (nm) compared to other 
surfactants.  
 
4.4.2 Particle size distribution measurements for heat stressed BSA-
surfactants systems 
  
Figure 4.9 shows data for BSA (10 mg/ml) after heat stress as described in 
Chapter 2 section 2.2.1. The scattering intensity for the main peak of the 
stressed BSA sample was almost double than that of the starting material. 
The main intensity peak reached 76.9 % intensity compared to fresh BSA 
main peak intensity at 48.5 % (Figure 4.1). As shown by the size distribution, 
the difference arises from an increase in scattering for main intensity peak. 
For this heat stressed BSA (10 mg/ml) sample the main peak was 26.9 nm 
diameter compared to a fresh BSA sample (10 mg/ml) of main peak diameter 
7.7 nm. An increase in hydrodynamic size of heated BSA samples was 
previously reported by Kelly et al. (1993), Adel et al. (2008).  
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Figure 4.9. Particle size distribution by intensity obtained for heated 
(66°C) BSA (10 mg/ml). 
Heat treatment of BSA (10 mg/ml) in the presence of Tween 20, Tween 80, 
Brij 35 and Pluronic F-68 surfactants led to an increase in the populations of 
larger particles compared to freshly prepared samples (Figures 4.10 – 4.13). 
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(A) 
 
(B) 
 
(C) 
 
Figure 4.10. Particle size distribution by intensity obtained for heated 
samples for BSA (10 mg/ml) with: (A) Tween 20 below CMC; (B) Tween 
20 around CMC; (C) Tween 20 above CMC. 
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The main peak diameter increased to around 27 nm for heated BSA in the 
presence of Tween 20 at concentrations. Further, heated BSA with Tween 20 
present showed bimodal size distributions, whereas unheated samples had 
produced a trimodal distribution (Figure 4.2). Moreover, there is a notable 
increase in intensity of the most intense peak (Figure 4.10), which has shifted 
to the right indicating and increase in particle size, probably due to 
aggregation of the heat stressed samples.  
Similar results were observed for heated BSA with Tween 80 at 
concentrations below, around and above its CMC (Figure 4.11). 
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(A) 
 
(B) 
 
(C) 
 
Figure 4.11. Particle size distribution by intensity obtained for heated 
samples for BSA (10 mg/ml) with: (A) Tween 80 below CMC; (B) Tween 
80 around CMC; (C) Tween 80 above CMC. 
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Again, the main peak diameter has increased to around 27 nm compared to 
unheated BSA with Tween 80 samples (Figure 4.11). Once again, a bimodal 
size distribution by intensity was detected by DLS. 
Figure 4.12 shows particle size distribution by intensity for heated BSA (10 
mg/ml) with Brij 35 present at concentrations below, around and above its 
CMC. 
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(A) 
 
(B) 
 
(C) 
 
Figure 4.12. Particle size distribution by intensity obtained for heated 
samples (66°C) for BSA (10 mg/ml) with: (A) Brij 35 below CMC; (B) Brij 
35 around CMC; (C) Brij 35 above CMC. 
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From Figure 4.12 there is a notable increase in the intensity of the most 
intense peak compared to unheated samples of BSA with Brij 35 present. 
Also the main peak has shifted to the right indicating an increase in particle 
size diameter to around 25 nm compared to around 8 nm diameter observed 
for unheated BSA with Brij 35 present (Figure 4.5). 
In Figure 4.13 DLS measurements obtained for heated BSA (10 mg/ml) with 
Pluronic F-68 present at concentrations below, around and above its CMC 
are presented.  
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(A) 
 
(B) 
 
(C) 
 
Figure 4.13. Particle size distribution by intensity obtained for heated 
(66°C) samples for BSA (10 mg/ml) with: (A) Pluronic F-68 below CMC; 
(B) Pluronic F-68 around CMC; (C) Pluronic F-68 above CMC. 
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Similar results showing an increase in main peak intensity and diameter (nm) 
were observed for heated BSA with Pluronic F-68 present compared to 
unheated samples  (Figure 4.6). However heated BSA with Pluronic F-68 
below CMC gave a trimodal distribution with a middle peak at 227.5 nm 
diameter and a very low intensity of 1.8 % (Figure 4.13). 
The particle size diameter (nm) of the main peak with greatest intensity for 
heated BSA (10 mg/ml) with below, around and above CMC levels of Tween 
20, Tween 80, Brij 35 and Pluronic F-68 surfactants are summarised in Table 
4.2 and Figure 4.14. 
Table 4.2. Particle size diameter (nm) of the peak with greatest intensity 
(Peak 1) for heated BSA (10 mg/ml) with below, around and above CMC 
levels of Tween 20, Tween 80, Brij 35 and Pluronic F-68 surfactants. 
HEATED SAMPLES PEAK POSITION WITH 
GREATEST INTESITY DIAMETER 
(nm) 
BSA (10mg/ml)  26.99 
Tween 20 below CMC 26.99 
 around CMC 26.33 
 above CMC 24.22 
Tween 80  below CMC 27.21 
 around CMC 27.51 
 above CMC 26.22 
Brij 35  below CMC 25.12 
 around CMC 26.08 
 above CMC 23.28 
Pluronic F-68 below CMC 25.41 
 around CMC 25.17 
 above CMC 26.10 
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Figure 4.14. Particle size diameter (nm) of the peak with greatest 
intensity (Peak 1) for heated BSA (10 mg/ml) with below, around and 
above CMC levels of Tween 20, Tween 80, Brij 35 and Pluronic F-68 
surfactants. 
In the presence of Tween 20 below and around CMC the particle size for 
main intensity peak increased considerably compared to heated surfactant 
free BSA. This showed that BSA aggregates more strongly in the presence of 
Tween 20 below and around CMC concentrations. Analysing particle size 
diameter of the main peak for heated samples, it can be seen that the 
greatest increase in the size of the highest intensity peak diameter was found 
for the sample containing Tween 20 at above its CMC (24.2 nm) and for the 
sample containing Brij 35 at above its CMC (23.3 nm) when compared to the 
heated BSA surfactant free sample (Figure 4.14). It is likely that due to the 
heat treatment the protein unfolded leading to an increase in particle size 
comparing to fresh BSA samples.  
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Statistical analysis using the t-test showed that the difference between 
heated surfactant free BSA (10 mg/ml) and Tween 20 around and above 
CMC, Tween 80, Brij 35 and Pluronic F-68 at all concentrations, was 
statistically significant at the 95 % level (P<0.05).  
Figure 4.15 illustrates the comparison of the diameter (nm) of the main peak 
for heated BSA with Tween 20, Tween 80, Brij 35 and Pluronic F-68 
surfactants present. 
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Figure 4.15. A plot of the highest intensity peak diameter (nm) obtained 
at below (1), around (2) and above (3) CMC levels for Tween 20, Tween 
80, Brij 35 and Pluronic F-68 surfactants.  
In general there is a decrease in the measured size diameter as the Tween 
20 concentration increases. Both Tween 80 and Brij 35 had produced an 
increase in main peak diameter at around CMC and then a noticeable 
decrease in diameter (nm) at high CMC levels. The results show that 
Pluronic F-68 at around its CMC yielded particle diameters slightly decreased 
which then increased again at high concentration (Figure 4.15).  
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4.4.3 Particle size distribution measurements for aged BSA-surfactant 
systems 
 
Figure 4.16 shows particle size distribution data by intensity for aged (See 
Chapter 2, Section 2.2.2) BSA (10 mg/ml). 
As shown by the size distribution profiles, the main peak diminishes relative 
to the larger particle size populations. For example, a main peak at 1271 nm 
diameter is now observed on storage with a 68.2 % intensity suggesting that 
in aged BSA (10 mg/ml) many large particulates are present. There is a 
notable reduction in intensity of the most intense peak (compared to fresh 
BSA, Figure 4.1).  There is an increase in peak width and intensity for the 
aged sample indicating that the BSA sample has physically changed.  
 
Figure 4.16. Particle size distribution by intensity for aged BSA (10 
mg/ml). 
Aged BSA samples in the presence of different concentrations of Tween 20 
surfactant showed an increase in particle size (Figure 4.17). It is difficult to 
quantify, since precisely because the particles are so large, they scatter the 
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light very strongly and even though they represent two-thirds of the total 
protein scattering intensity, they in fact are present in very low amounts 
(Arakawa et al., 2007).  
 Only observed at Tween 20 concentrations around CMC (Figure 4.17 (B)) 
there is a small peak at around 7 nm with a low intensity of 5.2 %.  
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(A) 
 
(B) 
 
(C) 
 
Figure 4.17. Particle size distribution by intensity obtained for aged 
BSA (10 mg/ml) with: (A) Tween 20 below CMC; (B) Tween 20 around 
CMC; (C) Tween 20 above CMC. 
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In the presence of Tween 80 above its CMC concentration just one peak at 
100 % intensity with diameter at 1028 nm (Figure 4.18 (C)) was observed by 
DLS. Aged samples of BSA with Tween 80 below its CMC gave distributions 
showing bimodal peaks (Figure 4.18 (A)). Aged BSA with Tween 80 
concentrations at around its CMC produced three peaks (Figure 4.18 (B)). 
Similarly, as observed for aged BSA with Tween 20 data presented in Figure 
4.17,  large particulates are present for BSA with Tween 80 concentrations 
below, around and above its CMC and that the most intense peak, comparing 
to fresh samples (Figures 4.2 and 4.3) has shifted to the right indicating an 
increase in particle size.  
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(A) 
 
(B) 
 
(C) 
 
Figure 4.18. Particle size distribution by intensity obtained for aged 
BSA (10 mg/ml) with: (A) Tween 80 below CMC; (B) Tween 80 around 
CMC; (C) Tween 80 above CMC. 
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Figure 4.19 shows intensity particle size distribution data for aged BSA (10 
mg/ml) with different Brij 35 concentration. As shown by the distribution 
profiles, the main peak with highest intensity is around 1000 nm diameter for 
the three concentrations employed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  110 
(A) 
 
(B) 
 
(C) 
 
Figure 4.19. Particle size distribution by intensity obtained for aged 
BSA (10 mg/ml) with: (A) Brij 35 below CMC; (B) Brij 35 around CMC; (C) 
Brij 35 above CMC. 
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The DLS data returned peaks of the highest intensity for aged BSA with 
added Pluronic F-68 at around 700 nm diameter for concentrations below 
and around CMC (Figure 4.20 (A) and (B)) and 1219 nm for BSA with F-68 
below CMC system. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  112 
(A) 
 
(B) 
 
(C) 
 
Figure 4.20. Particle size distribution by intensity obtained for aged 
BSA (10 mg/ml) with: (A) Pluronic F-68 below CMC; (B) Pluronic F-68 
around CMC; (C) Pluronic F-68 above CMC. 
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Particle size diameter (nm) of the main peak with greatest intensity for aged 
BSA (10 mg/ml) with below, around and above CMC levels of Tween 20, 
Tween 80, Brij 35 and Pluronic F-68 surfactants are summarised in Table 4 
and Figure 23.  
Table 4.3. Particle size diameter (nm) of the peak with greatest intensity 
(Peak 1) for aged BSA (10 mg/ml) with below, around and above CMC 
levels of Tween 20, Tween 80, Brij 35 and Pluronic F-68  surfactants. 
AGED SAMPLES PEAK POSITION WITH 
GREATEST INTESITY DIAMETER 
(nm) 
BSA (10mg/ml)  1271 
Tween 20 below CMC 1284 
 around CMC 1200 
 above CMC 1023 
Tween 80  below CMC 1177 
 around CMC 779 
 above CMC 1028 
Brij 35  below CMC 613 
 around CMC 1067 
 above CMC 931 
Pluronic F-68 below CMC 773 
 around CMC 714 
 above CMC 1219 
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Figure 4.21. Particle size diameter (nm) of the peak with greatest 
intensity (Peak 1) for aged BSA (10 mg/ml) with below, around and 
above CMC levels of Tween 20, Tween 80, Brij 35 and Pluronic F-68 
surfactants. 
Comparing the particle size diameter of the main intensity peak for aged 
samples, it can be seen that highest intensity peak diameter in nm slightly 
increased for Tween 20 at concentrations below CMC compared to aged 
BSA alone (10 mg/ml) sample. All other surfactants lowered the particle 
diameter in nm with the greatest decrease seen for Brij 35 at a concentration 
below its CMC (613 nm diameter).   
Statistical analysis using a t-test indicated that the difference between aged 
surfactant-free BSA (10 mg/ml) and Tween 20, Tween 80, Brij 35 and 
Pluronic F-68 surfactants at below, around and above CMC levels, was 
statistically significant at the 95 % level (P<0.05). 
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Figure 4.22 illustrates the comparison of the diameter in nm of the main 
(highest intensity) peak at below, around and above CMC levels for Tween 
20, Tween 80, Brij 35 and Pluronic F-68 surfactants. 
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Figure 4.22. A plot of the highest intensity peak diameter (nm) obtained 
at below (1), around (2) and above (3) CMC levels for Tween 20, Tween 
80, Brij 35 and Pluronic F-68 surfactants. 
Data presented in Figure 4.22 shows that all aged four surfactants at below, 
around and above CMC failed to prevent increases in the levels of larger 
particles forming. 
 
 
4.4.4 Particle size distribution measurements for freshly prepared 
IgG2-surfactants systems 
 
Figure 4.23 illustrates size distribution histogram for fresh immunoglobulin 
IgG2 (10 mg/ml) sample. The reported size of native IgG is around 10 nm 
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(Song et al, 2001; Bermudez et al 2004), which is significantly lower 
compared to the 14.44 nm size of the variant obtained in this data for IgG2.  
Figure 4.23 also indicates the presence of larger aggregates present in the 
IgG2 sample at 4532 nm diameter. However, the larger aggregates only 
represent a small fraction of the total number of molecules (~2 %). The 
presence of these large particles is common and has been previously 
reported (Bermudez et al., 2004). 
 
Figure 4.23. Particle size distribution by intensity obtained for freshly 
prepared IgG2 (10 mg/ml). Average n=3. 
Comparison between Figure 4.23 and Figures 4.24 – 4.26 shows that IgG2 in 
the presence of different concentrations of Tween 20, Tween 80 and Brij 35 
surfactants indicate a small increase in calculated particles size from 14.4 nm 
at its native state to the average of 15.2 nm diameter. It is also clear from 
Figures 4.24 – 4.26, that the presence of surfactant at any of the tested 
concentrations acts to remove the presence of the larger particles.  
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Figure 4.24. Particle size distribution by intensity obtained for IgG2 (10 
mg/ml) with: (A) Tween 20 below CMC; (B) Tween 20 around CMC; (C) 
Tween 20 above CMC. 
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Figure 4.25. Particle size distribution by intensity obtained for IgG2 (10 
mg/ml) with: (A) Tween 80 below CMC; (B) Tween 80 around CMC; (C) 
Tween 80 above CMC. 
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Figure 4.26. Particle size distribution by intensity obtained for IgG2 (10 
mg/ml) with: (A) Brij 35 below CMC; (B) Brij 35 around CMC; (C) Brij 35 
above CMC. 
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Similar results were observed for fresh IgG2 with Pluronic F-68 surfactant 
(Figure 4.27). 
Fresh IgG2 with Pluronic F-68 at concentrations below CMC produced an 
increase in diameter at 15.3 nm, also F-68 at concentrations around CMC 
slightly increased diameter to 14.7 nm comparing to freshly prepared IgG2-
surfactant free samples (Figure 4.23). 
The high concentration of Pluronic F-68 produced an increase in size to 16.1 
nm diameter. Data in Figure 4.27 (C) also indicates some larger aggregates 
are present with a diameter of 4569 nm and the peak intensity of 1.6% for 
this sample. 
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Figure 4.27. Particle size distribution by intensity obtained for IgG2 (10 
mg/ml) with: (A) Pluronic F-68 below CMC; (B) Pluronic F-68 around 
CMC; (C) Pluronic F-68 above CMC. 
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Particle size diameter (nm) of the main peak with greatest intensity for fresh 
IgG2 (10 mg/ml) with below, around and above CMC levels of Tween 20, 
Tween 80, Brij 35 and Pluronic F-68 surfactants are summarised in Table 4.4 
and Figure 4.28.  
Table 4.4. Particle size diameter (nm) of the peak with greatest intensity 
(Peak 1) for fresh IgG2 (10 mg/ml) with below, around and above CMC 
levels of Tween 20, Tween 80, Brij 35 and Pluronic F-68 surfactants. 
FRESH SAMPLES PEAK POSITION WITH 
GREATEST INTESITY DIAMETER 
(nm) 
IgG2 (10 mg/ml)  14.44 
Tween 20 below CMC 15.25 
 around CMC 15.31 
 above CMC 15.04 
Tween 80  below CMC 14.69 
 around CMC 16.20 
 above CMC 15.40 
Brij 35  below CMC 15.04 
 around CMC 15.02 
 above CMC 15.00 
Pluronic F-68 below CMC 15.30 
 around CMC 14.69 
 above CMC 16.09 
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Figure 4.28. Particle size diameter (nm) of the peak with greatest 
intensity (Peak 1) for fresh IgG2 (10 mg/ml) with below, around and 
above CMC levels of Tween 20, Tween 80, Brij 35 and Pluronic F-68 
surfactants. 
On analysing the particle size diameter of the main intensity peak for fresh 
IgG2 – surfactant samples, it can be seen that highest intensity peak 
diameter is increased for all four surfactants at all concentration levels. The 
highest increase in diameter (nm) was detected for Tween 80 around CMC at 
16.20 nm and Pluronic F-68 above CMC at 16.09 nm diameter (Table 4.4, 
Figure 4.28).  
Statistical analysis using a t-test showed that the increase in diameter (nm) 
for all four surfactants at below, around and above CMC levels was 
statistically significant at the 95 % level (P<0.05). 
Figure 4.29 illustrates the comparison of the diameter in nm of the main 
(highest intensity) peak at below, around and above CMC levels for Tween 
20, Tween 80, Brij 35 and Pluronic F-68 surfactants. 
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Figure 4.29. A plot of the highest intensity peak diameter (nm) obtained 
at below (1), around (2) and above (3) CMC levels for Tween 20, Tween 
80, Brij 35 and Pluronic F-68 surfactants. 
From Figure 4.29 it can be seen that all four surfactants at different 
concentrations in relation to their CMC produce different particle size 
diameters (nm) for the highest intensity peak.  There is a gradual decrease in 
the measured particles size diameter (nm) as the Brij 35 surfactant 
concentration increases. Tween 20 and Tween 80 surfactants produced the 
highest diameter (nm) at around CMC, where Pluronic F-68 gave its lowest 
particle size diameter at around its CMC. 
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4.4.5 Particle size distribution measurements for heated IgG2-
surfactant systems 
 
Figure 4.30 illustrates particle size distribution by intensity for heated (see 
Chapter 2 Section 2.2.1) immunoglobulin IgG2 (10 mg/ml) samples.  The 
particle size of heat stressed IgG2 sample increased by more than double 
that of the starting material (Figure 4.23). As shown by the size distribution 
histograms, the difference arises from an increase in the diameter from 14.4 
nm for fresh IgG2 to 37.3 nm for heat stressed sample. Also it is noticeable 
that heat stressed IgG2 doesn’t have larger aggregates present comparing to 
fresh sample.  
It also has been previously reported that heat treatment of native IgG induces 
strong aggregation which results in precipitation of the protein (Vermeer et 
al., 2000). 
 
Figure 4.30. Particle size distribution by intensity obtained for heated 
(60°C) IgG2 (10 mg/ml). 
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Figure 4.31 shows that heat treatment of IgG2 in the presence of different 
levels of Tween 20 led to an increase of the populations of larger particles 
comparing to freshly prepared samples. 
The monoclonal sample containing Tween 20 at around its CMC showed a 
monomodal distribution with a peak diameter of 41.9 nm (Figure 4.31 (B)).  At 
lower levels a trimodal distrubution was obtained: Peak 1: 51.9 nm, Peak 2: 
15.6 nm and Peak 3: 5036.0 nm. The monoclonal sample containing Tween 
20 at above its CMC gave a DLS output which was bimodal with Peak 1 at 
46.9 nm and Peak 2 at 13.1 nm. 
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(A) 
 
(B) 
 
(C) 
 
Figure 4.31. Particle size distribution by intensity obtained for heated 
IgG2 (10 mg/ml) with: (A) Tween 20 below CMC; (B) Tween 20 around 
CMC; (C) Tween 20 above CMC. 
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DLS histograms for heated samples containing the higher than CMC level of 
Tween 80 showed that greater numbers of larger particles were forming 
(Figure 4.32 (C)). Also samples at levels below and around CMC of Tween 
80 produced an increase in particle size after heat stress (Figure 4.32 (A), 
(B)). 
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(A) 
 
(B) 
 
(C) 
 
Figure 4.32. Particle size distribution by intensity obtained for heated 
IgG2 (10 mg/ml) with: (A) Tween 80 below CMC; (B) Tween 80 around 
CMC; (C) Tween 80 above CMC. 
  
  130 
 (A) 
 
(B) 
 
(C) 
 
Figure 4.33. Particle size distribution by intensity obtained for heated 
IgG2 (10 mg/ml) with: (A) Brij 35 below CMC; (B) Brij 35 around CMC; 
(C) Brij 35 above CMC. 
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The Brij 35 surfactant produced similar results to Tween 80 (Figure 4.33 (C)). 
Heated IgG2 systems with Pluronic F-68 present gave an increase in particle 
size with all concentrations (Figure 4.34). 
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(A) 
 
(B) 
 
(C) 
 
Figure 4.34. Particle size distribution by intensity obtained for heated 
IgG2 (10 mg/ml) with: (A) Pluronic F-68 below CMC; (B) Pluronic F-68 
around CMC; (C) Pluronic F-68 above CMC. 
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The particle size diameter (nm) obtained using DLS of the peak with greatest 
intensity for heated IgG2 (10 mg/ml) with below, around and above CMC 
levels of Tween 20, Tween 80, Brij 35 and Pluronic F-68 surfactants are 
summarised in Table 4.5 and Figure 4.35. 
 
Table 4.5. Particle size diameter (nm) of the peak with greatest intensity 
(Peak 1) for heated IgG2 (10 mg/ml) with below, around and above CMC 
levels of Tween 20, Tween 80, Brij 35 and Pluronic F-68. 
HEATED SAMPLES PEAK POSITION WITH 
GREATEST INTESITY DIAMETER 
(nm) 
IgG2 (10mg/ml)  37.25 
Tween 20 below CMC 51.95 
 around CMC 41.85 
 above CMC 46.96 
Tween 80  below CMC 51.98 
 around CMC 39.78 
 above CMC 66.13 
Brij 35  below CMC 45.39 
 around CMC 43.67 
 above CMC 40.99 
Pluronic F-68 below CMC 26.46 
 around CMC 19.58 
 above CMC 46.56 
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Figure 4.35. Particle size diameter (nm) of the peak with greatest 
intensity (Peak 1) for heated IgG2 (10 mg/ml) with below, around and 
above CMC levels of Tween 20, Tween 80, Brij 35 and Pluronic F-68 
surfactants. 
On analysing the particle size diameter of the main peak for heated samples, 
it can be seen that the highest intensity peak diameter increased for all 
Tween 20, Tween 80 and Brij 35 levels and for Pluronic F-68 at above its 
CMC comparing to heated IgG2-surfactant free sample. The highest increase 
in diameter (nm) was detected for Tween 80 above its CMC and the lowest 
for Pluronic F-68 around its CMC.  Relative to data for all other samples, F-
68 at the two lower concentrations, suggested a protective effect against heat 
stress. 
Statistical analysis using a t-test showed that the difference between heated 
surfactant free IgG2 (10 mg/ml) and Tween 20, Tween 80, Brij 35 and 
Pluronic F-68 surfactants at all CMC levels, was statistically significant at the 
95 % level (P<0.05). 
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Figure 4.36 illustrates the comparison of the diameter in nm of the main peak 
at below, around and above CMC levels for Tween 20, Tween 80, Brij 35 and 
Pluronic F-68 surfactants. 
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Figure 4.36. A plot of the highest intensity peak diameter (nm) obtained 
at below (1), around (2) and above (3) CMC levels for heated IgG2 with 
Tween 20, Tween 80, Brij 35 and Pluronic F-68 surfactants. 
Figure 4.36 shows that all surfactants differ in particle size diameter for 
highest intensity peak. Brij 35 showed a gradual decrease in diameter (nm) 
with concentration. Surfactants Tween 80 and Pluronic F-68 showed 
increases in diameter at above CMC levels. Tween 20 produced its highest 
particle size diameter at below its CMC. 
4.4.6  Particle size distribution measurements for aged IgG2-surfactants 
  
Shown in Figure 4.37 is a size distribution histogram for aged (See Chapter 
2, Section 2.2.2) IgG2 (10 mg/ml).  
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Figure 4.37. Particle size distribution by intensity obtained for aged 
samples for IgG2 (10 mg/ml). 
Data shows the monomodal peak 13.8 nm diameter, which is slightly lower to 
the one obtained for freshly prepared IgG2 samples (Figure 4.23). 
In the presence of Tween 20 (Figure 4.38), Tween 80 (Figure 4.39), Brij 35 
(Figure 4.40) and Pluronic F-68 (Figure 4.41) a size distribution of a 
monomodal peak at around 14-15 nm diameter was obtained.  
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(A) 
 
(B) 
 
(C) 
 
Figure 4.38. Particle size distribution by intensity obtained for aged 
samples for IgG2 (10 mg/ml) with: (A) Tween 20 below CMC; (B) Tween 
20 around CMC; (C) Tween 20 above CMC. 
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(A) 
 
(B) 
 
(C) 
 
Figure 4.39. Particle size distribution by intensity obtained for aged 
samples for IgG2 (10 mg/ml) with: (A) Tween 80 below CMC; (B) Tween 
80 around CMC; (C) Tween 80 above CMC. 
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(A) 
 
(B) 
 
(C) 
 
Figure 4.40. Particle size distribution by intensity obtained for aged 
samples for IgG2 (10 mg/ml) with: (A) Brij 35 below CMC; (B) Brij 35 
around CMC; (C) Brij 35 above CMC. 
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(A) 
 
(B) 
 
(C) 
 
Figure 4.41. Particle size distribution by intensity obtained for aged 
samples for IgG2 (10 mg/ml) with: (A) Pluronic F-68 below CMC; (B) 
Pluronic F-68 around CMC; (C) Pluronic F-68 above CMC. 
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Particle size diameters (nm) of the main peak with greatest intensity for aged 
IgG2 (10 mg/ml) with below, around and above CMC levels of Tween 20, 
Tween 80, Brij 35 and Pluronic F-68 surfactants are summarised in Table 4.6 
and Figure 4.42. 
Table 4.6. Particle size diameter (nm) of the peak with greatest intensity 
(Peak 1) for aged IgG2 (10 mg/ml) with below, around and above CMC 
levels of Tween 20, Tween 80, Brij 35 and Pluronic F-68 surfactants. 
AGED SAMPLES PEAK POSITION WITH 
GREATEST INTESITY DIAMETER 
(nm) 
IgG2 (10mg/ml)  13.84 
Tween 20 below CMC 14.06 
 around CMC 14.20 
 above CMC 13.86 
Tween 80  below CMC 13.55 
 around CMC 15.72 
 above CMC 14.77 
Brij 35  below CMC 14.21 
 around CMC 14.33 
 above CMC 14.48 
Pluronic F-68 below CMC 15.52 
 around CMC 13.38 
 above CMC 15.60 
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Figure 4.42. Particle size diameter (nm) of the peak with greatest 
intensity (Peak 1) for aged IgG2 (10 mg/ml) with below, around and 
above CMC levels of Tween 20, Tween 80, Brij 35 and Pluronic F-68 
surfactants. 
Analysing particle size diameter of the main peak for aged samples, it can be 
seen that highest intensity peak diameter in nm was obtained for Tween 80 
around (15.72 nm) and Pluronic F-68 above (15.6 nm) comparing to aged 
IgG2 surfactant free sample. The highest decrease was obtained for Pluronic 
F-68 around concentrations.  
Statistical analysis using a t-test showed that the difference between aged 
surfactant free IgG2 (10 mg/ml) and Tween 20 below and around CMC, 
Tween 80, Brij 35, Pluronic F-68 at all CMC levels, was statistically significant 
at the 95 % level (P<0.05). Analysis between aged surfactant free IgG2 and 
Tween 20 above CMC showed no statistical significance. 
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Figure 4.43 illustrates the comparison of the diameter of the main highest 
intensity peak at below, around and above CMC levels for Tween 20, Tween 
80, Brij 35 and Pluronic F-68 surfactants. 
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Figure 4.43. A plot of the highest intensity peak diameter (nm) obtained 
at below (1), around (2) and above (3) CMC levels for aged Tween 20, 
Tween 80, Brij 35 and Pluronic F-68 surfactants. 
Figure 4.43 shows that DLS measured size of all aged surfactant systems at 
each concentration in relations to their CMC differs. There is a gradual 
increase in diameter when Brij 35 concentration increases. The presence of 
Tween 20 and Tween 80 surfactant produced their highest particle size when 
their concentration was around their CMC. At its highest concentration 
Pluronic F-68 produced its largest particle size for the aged samples.  
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4.5 General Discussion 
 
Dynamic Light scattering measurements have been performed to study the 
effect of different CMC concentrations of Tween 20, Tween 80, Brij 35 and 
Pluronic F-68 surfactants on bovine serum albumin BSA and immunoglobulin 
IgG2 particle size. 
The DLS results showed that BSA and IgG2 with different surfactants at 
below, around and above CMC concentrations produced different levels of 
particle size growth. The reported size of native BSA is 7.83 nm (Yu et al, 
2011), which is similar to the 7.69 nm obtained for freshly prepared BSA for 
this study. BSA with added Tween 20, Tween 80 and Brij 35 surfactants at all 
concentrations and Pluronic F-68 at below and above its CMC, yielded 
trimodal distributions with the main peak consistently around 8 nm diameter.  
DLS analysis of fresh samples of IgG2 surfactant free produced a bimodal 
distribution with a main peak at 14.44 nm diameter, which is significantly 
higher than the 10 nm reported for native IgG (Song et al., 2001, Bermundez 
et al., 2004). DLS results for the IgG2 in the presence of all four non-ionic 
surfactants produced a low increase in particle size.  
Heat treatment of BSA and IgG2 surfactant free samples and in the presence 
of Tween 20, Tween 80, Brij 35 and Pluronic F-68 surfactants, led to an 
increase in the populations of larger particles compared to the freshly 
prepared samples. Under heat stress, main peak diameter (nm) dramatically 
increased. For BSA (10 mg/ml) samples it reached 27.2 nm with Tween 80 at 
concentrations of around CMC, where IgG2 (10 mg/ml) produced a maximum 
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diameter of 66.1 nm diameter in the presence of Tween 80 at a concentration 
above its CMC. 
On storing BSA (10 mg/ml) and BSA-surfactant samples, the original main 
peak diminished and larger particles size populations formed compared to 
freshly prepared and heat stressed solutions. The increased levels of 
aggregates after storing BSA samples has been previously reported 
(Krishnan, 2009). 
DLS data for aged IgG2-surfactant systems showed a monomodal peak at 
around 14 nm diameter and was relatively unchanged to that obtained for 
fresh IgG2 samples with all surfactants.  
Compared to BSA, IgG2 did not aggregate under storage conditions. 
Obviously storing and heat stress bears the potential to generate aggregates 
and particles, but this depends on protein and surfactant type and 
concentration (Schmidt, 2009). 
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Chapter 5 
Light Obscuration (HIAC) and Micro-flow Imaging 
(MFI) applied for subvisible particulate analysis of 
BSA and Igg2 with Tween 20, Tween 80, Brij 35 and 
Pluronic F-68 surfactants at below, around and above 
CMC levels  
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5.1   Introduction 
 
Recent commentaries have stressed a need for characterizing sub-visible 
particle populations in protein drug formulations (Carpenter et al., 2008). 
Particles of primary concern are protein aggregates in the size range from 
approximately 0.1 µm to 50 µm. A complication in measuring protein 
particulates in many formulations is the simultaneous presence of other 
particle types such as silicone oil micro-droplets, air bubbles, and extrinsic 
contaminants. A measurement method which could isolate different particle 
sub-populations and allow an accurate characterization and quantification of 
sub-visible particles in protein formulation is highly desirable. These 
challenges led to an interest in Light obscuration (HIAC) and Micro-flow 
imaging (MFI) techniques. 
Light obscuration (HIAC) and micro-flow imaging (MFI) are two commercially 
available particle-counting techniques able to characterize sub-visible 
particles in the range of 2 µm to 100 µm. Both methods have been recently 
reviewed (Narhi et al., 2009; Mahler et al, 2009) and used in work 
summarized in recent publications to study protein solutions (Kiese et al., 
2010; Tyagi et al., 2009; Demeule et al, 2010; Sharma et al., 2010; Wuchner 
et al 2010). Micro-flow imaging has received a lot of attention for the 
characterization of protein formulations in the past few years (Sharma et al., 
2010; Wuchner et al., 2010), while light obscuration analysis showed 
promising results for the quantification of sub-visible particles in carefully 
chosen conditions (Ives et al, 2007).  
  
  148 
The use of Light obscuration and MFI for characterizing sub-visible particles 
in protein formulations has been applied to a variety of formulation and 
aggregate types which might be encountered in the development and 
manufacturing of bio-pharmaceuticals. Mechanistic approaches have been 
lacking.  
 
5.2    Objective 
 
The main objective is to characterize and quantify particles in BSA and IgG2 
surfactant free solutions, and in BSA and IgG2 solutions with Tween 20, 
Tween 80, Brij 35 and Pluronic F-68 surfactants present at concentrations 
below, around and above their CMC levels, using light obscuration (HIAC) 
and micro-flow imaging (MFI) measurements. 
 
5.3 Experimental 
 
5.3.1 Light obscuration (HIAC) measurements 
 
The concentration of BSA and IgG2 samples used in HIAC experiments was 
5 mg/ml. All HIAC measurements were performed as described in Chapter 2, 
Section 2.2.5.  
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5.3.2 Micro-Flow Imaging (MFI) measurements 
 
 
Micro-flow imaging (MFI) measurements were performed as described in 
Chapter 2, section 2.2.6.  The concentration of BSA and IgG2 samples used 
in MFI experiments was 10 mg/ml.  
 
5.4 Results and Discussion 
 
5.4.1 Light Obscuration (HIAC) measurements 
 
5.4.1.1 Light Obscuration measurements for fresh, heated and aged 
BSA surfactant free and BSA with Tween 20, Tween 80, Brij 35 and 
Pluronic F-68 surfactants at below, around and above CMC levels 
 
Light obscuration (HIAC) analysis assesses the size of individual sub-visible 
particles and provides a particle size distribution.  
Figure 5.1 illustrates particle concentration per ml measured for fresh, heated 
and aged BSA samples (See Chapter 2, Section 2.2 for preparation of 
samples). 
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Figure 5.1. Particle concentrations measured by HIAC for fresh, heated 
and aged BSA samples. Data are expressed as the mean ± Std. 
Deviation. * P<0.05, ** P<0.01, *** P<0.001; significant difference in 
particles per ml compared with fresh BSA samples.  
From Figure 5.1, HIAC analysis shows that heat stressed and aged BSA 
surfactant free formulations produced greater levels in terms of the amount of 
particles per ml greater than or equal to 2 µm compared to that determined 
for fresh BSA samples.  
A slight increase in the number of particles ≥ 2 µm is detectable for heated 
BSA solutions, whereas, for size ranges ≥ 5 µm, ≥ 10 µm and ≥ 25 µm, 
heating did not induce an increase in the number of particles detected 
compared to fresh and aged BSA samples. 
The total number of particles greater than or equal to 5 µm, 10 µm and 25 
µm, respectively measured after storage (6913.3 ± 34.4 particles ≥ 5 µm, 
2050.7 ± 88.6 particles ≥ 10 µm, 192.0 ± 4.0 particles ≥ 25 µm per ml) 
exceeds the number of particles of the same size determined after heat 
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stress (3035.3 ± 114.3 particles ≥ 5 µm, 408.0 ± 11.1 particles ≥ 10 µm, 34.0 
± 5.3 particles ≥ 25 µm per ml). 
One-way ANOVA analysis showed a significant effect of heat treatment and 
storage on the number of particles per ml at the size ranges of ≥ 2 µm, ≥ 5 
µm, ≥ 10 µm and ≥ 25 µm. Post-hoc tests, Bonferroni correction showed a 
significant increase in the number of particles per ml for the size range ≥ 2 
µm at 0.05 level (P<0.05) for heated samples and at 0.01 level (P<0.01) for 
aged samples when compared to fresh BSA samples. 
For the ≥ 5 µm and the ≥ 10 µm size range, Bonferroni statistical results 
showed that the mean decrease is significant at 0.001 level (P<0.001) for 
both heated and aged BSA samples. At the size range ≥ 25 µm heated BSA 
samples showed a statistically significant decrease (P<0.001), whereas aged 
BSA samples produced no statistically different particle numbers compared 
to fresh ones. Also at the size range ≥ 50 µm there was no significant 
difference in the number of particles per ml between samples (Figure 5.1). 
Figure 5.2 shows number of particles in a size range of ≥ 2 µm, ≥ 5 µm, ≥ 10 
µm, ≥ 25 µm, ≥ 50 µm and ≥ 100 µm per ml measured by Light Obscuration 
for fresh BSA with Tween 20, Tween 80, Brij 35 and Pluronic F-68 
surfactants at below, around and above their CMC levels. 
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Figure 5.2. Particle concentrations in size ranges: (A) ≥ 2 µm and ≥ 5 
µm, (B) ≥ 10 µm and ≥ 25 µm, (C) ≥ 50 µm and ≥ 100 µm per ml measured 
by HIAC for fresh BSA samples with Tween 20, Tween 80, Brij 35 and 
Pluronic F-68 surfactants at below, around and above CMC levels. Data 
are expressed as the mean ± Std. Deviation. 
In fresh formulations of BSA containing Tween 20 at concentrations below 
and around CMC, Brij 35 at below and around its CMC and Pluronic F-68 at 
below its CMC, an increase in the number of particles ≥ 2 µm is detectable. 
For samples containing Tween 20 above its CMC, for all Tween 80 levels, for 
Brij 35 above its CMC, and for Pluronic F-68 at around and above its CMC, 
the number of particles at this size range has decreased (Figure 5.2 A). 
BSA formulations containing Tween 20 at below and around its CMC and 
formulations containing Brij 35 below its CMC showed an increase in the 
number of particles per ml greater than or equal to 10 µm (compared to fresh 
surfactant free BSA samples shown in Figure 5.1). 
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Formulations of BSA with Tween 20 and Tween 80 levels around their CMC 
and formulations of Brij 35 below its CMC, produced a slight increase in the 
number of particles ≥ 10 µm (Figure 5.2 A). 
The number of particles per ml greater than or equal to 25 µm, 50 µm and 
100 µm, in protein solutions of BSA with all four surfactants at below, around 
and above CMC levels has decreased by particle count compared to freshly 
prepared BSA surfactant free samples (Figure 5.2 B and C). 
In general, freshly prepared BSA solutions with Tween 80 at all CMC levels 
contained significantly lower levels of particles than BSA solutions containing 
Tween 20, Brij 35 and Pluronic F-68 surfactants and surfactant free BSA 
samples (Figure 5.2). 
Figure 5.3 shows particle count per ml measured for heated BSA with Tween 
20, Tween 80, Brij 35 and Pluronic F-68 surfactants at below, around and 
above their CMC levels.  
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Figure 5.3. Particle concentrations in size ranges: (A) ≥ 2 µm and ≥ 5 
µm, (B) ≥ 10 µm and ≥ 25 µm, (C) ≥ 50 µm and ≥ 100 µm per ml measured 
by HIAC for heated BSA samples with Tween 20, Tween 80, Brij 35 and 
Pluronic F-68 surfactants at below, around and above CMC levels. Data 
are expressed as the mean ± Std. Deviation. 
  
  156 
Heat stressed BSA formulations show an increase in the number of particles 
per ml greater than or equal to 2 µm with Tween 20 surfactant above CMC 
level.  Also at the particle size range ≥ 5 µm, samples of BSA with Tween 20 
above and with Tween 80 around their CMC have increased particle counts 
compared to other surfactants and heat stressed surfactant free BSA (Figure 
5.3 A; Figure 5.1). 
Heated BSA formulations with Tween 20 levels below, around and above its 
CMC show an increase in the number of particles greater than or equal to 10 
µm compared to other surfactants. 
At particle size ≥ 25 µm, heated BSA with Tween 20 below (36.7 ± 13.6 
particles) and around its CMC (59.3 ± 11.4 particles), and with Tween 80 
around its CMC (169.3 ± 39.5 particles) produced the highest level of 
particles per ml (Figure 5.3 B). For particles ≥ 50 µm the formulation 
containing Tween 20 around (6.0 ± 2.0 particles) its CMC and for the sample 
with Tween 80 around its CMC (3.3 ± 4.2 particles) both produced an 
increase in particle count compared to the other surfactants and heated BSA 
surfactant free samples (Figure 5.3 C). 
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Figure 5.4. Particle concentrations in size ranges: (A) ≥ 2 µm and ≥ 5 
µm, (B) ≥ 10 µm and ≥ 25 µm, (C) ≥ 50 µm and ≥ 100 µm per ml measured 
by HIAC for aged BSA samples with Tween 20, Tween 80, Brij 35 and 
Pluronic F-68 surfactants at below, around and above CMC levels. Data 
are expressed as the mean ± Std. Deviation. 
Figure 5.4 shows that in aged formulations of BSA containing all four 
surfactants at their different CMC levels, a decrease in the number of 
particles ≥ 2 µm was detected compared to aged surfactant-free BSA. 
The number of particles ≥ 5 µm measured for aged BSA with Tween 20 
around CMC, Tween 80 below CMC and Brij 35 above CMC has a noticeable 
increase (Figure 5.4 A). Considering particle counts for size ranges of ≥ 10 
µm and ≥ 25 µm, the aged formulation with Tween 20 at around its CMC has 
significantly a higher number of particles compared to the other  surfactants 
and surfactant free aged BSA formulations (Figure 5.4 B).  
  
  159 
Figure 5.4 (C) shows that particle count  ≥ 50 µm for aged BSA with Tween 
20 around its CMC and for Tween 80 above its CMC exceeded that of the 
aged surfactant free BSA solution shown in Figure 5.1. 
It can be clearly seen that particle levels vary for the fresh, heated and aged 
BSA samples and for the Tween 20, Tween 80, Brij 35 and Pluronic F-68 
surfactant formulations (Figures 5.2 – 5.4).  
Figures 5.5 to 5.8 illustrate how the particle counts per ml for the different 
size ranges of ≥ 2 µm, ≥ 5 µm, ≥ 10 µm, ≥ 25 µm, ≥ 50 µm and ≥ 100 µm 
change after heat stress and aging of BSA solutions with each surfactant. 
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Figure 5.5.  Particle concentrations at size ranges of: (A) ≥ 2 µm, (B) ≥ 5 
µm, (C) ≥ 10 µm, (D) ≥ 25 µm, (E) ≥ 50 µm and (F) ≥ 100 µm measured by 
HIAC for fresh, heated and aged BSA with Tween 20 at below, around 
and above its CMC. Data are expressed as the mean ± Std. Deviation. * 
P<0.05, ** P<0.01, *** P<0.001; significant difference in particles per ml 
compared with fresh BSA with Tween 20 samples.  
One-way ANOVA analysis, Bonferroni correction showed a significant effect 
of heat stress and aging samples for BSA with Tween 20 surfactant at below, 
around and above its CMC for particle counts ≥ 2 µm. The mean difference is 
significant (P<0.001) compared to the fresh samples (Figure 5.5 A). 
Considering the particle count per ml of particles ≥ 5 µm, statistical analysis 
showed that the difference is significant (P<0.001) between fresh and 
heated, and between fresh and aged BSA with Tween 20 levels belows and 
around CMC.  The mean difference is also significant (P<0.05) for BSA with 
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Tween 20 concentrations above CMC. Figure 5.5 (B) illustrates these 
findings. 
Similar statistical analysis was obtained for the particle counts per ml, sized 
at ≥ 10 µm. The statistical difference between fresh and heat stressed, fresh 
and aged BSA with Tween 20 below its CMC was significant (P<0.001). For 
the BSA sample with Tween 20 at around its CMC, a significant difference 
between fresh and heated samples was observed (P<0.001) and also was 
observed between fresh and aged samples (P<0.01). Higher CMC 
concentrations of Tween 20 with BSA showed statistical difference at 0.01 
level (P<0.01) between fresh and heated, fresh and aged samples (Figure 
5.5 C). 
For particle count data of size ≥ 25 µm, the Bonferroni test showed that the 
difference in particle count is significant (P<0.01) between fresh and heated 
BSA with Tween 20 below its CMC and also significant (P<0.05) between 
fresh and aged BSA with Tween 20 below its CMC. No significant difference 
in particle count was detected between fresh and heated samples of BSA 
with Tween 20 around its CMC. The mean difference was significant at 0.05 
level (P<0.05) between fresh and aged samples of BSA with Tween 20 
around its CMC. One-way ANOVA, Bonferroni test, showed statistical 
difference (P<0.001) between fresh and heated samples particle count and 
between fresh and aged BSA (P<0.05) particle count for the BSA sample 
containing Tween 20 above its CMC (Figure 5.5 D). 
For particle sizes ≥ 50 µm and ≥ 100 µm no statistical difference in particle 
count was detected between fresh and heat stressed, and between fresh and 
aged BSA samples with Tween 20 present below its CMC. Post-hoc analysis 
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showed no statistical difference between fresh and heated BSA samples with 
Tween 20 at around its CMC (P>0.05) at these size ranges. Particle counts 
significantly different (P<0.001) were calculated between heated and aged 
BSA with Tween 20 around its CMC for particles ≥ 50 µm (Figure 5.5 F). 
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Figure 5.6.  Particle concentrations at size ranges of: (A) ≥ 2 µm, (B) ≥ 5 
µm, (C) ≥ 10 µm, (D) ≥ 25 µm, (E) ≥ 50 µm and (F) ≥ 100 µm measured by 
HIAC for fresh, heated and aged BSA with Tween 80 at below, around 
and above its CMC. Data are expressed as the mean ± Std. Deviation. * 
P<0.05, ** P<0.01, *** P<0.001; significant difference in particles per ml 
compared with fresh BSA with Tween 80 samples.  
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One-way ANOVA analysis, Bonferroni correction showed a significant effect 
of heat stress and aging samples of BSA with Tween 80 surfactant present at 
levels below and around its CMC on particle count of particles ≥ 2 µm. The 
mean difference was significant (P<0.001) between fresh and heated BSA 
with Tween 80 below and around its CMC. The difference was statistically 
significant (P<0.01) for BSA with Tween 80 present at around its CMC 
between fresh and aged samples and for BSA with Tween 80 at above CMC 
between fresh and heat stressed samples. There was no statistical 
significance between fresh and aged samples of BSA with Tween 80 at high 
concentrations (Figure 5.6 A).  
For particle count data of size ≥ 5 µm, statistical analysis showed that the 
particle count difference is significant (P<0.001) between fresh and heated, 
fresh and aged BSA with below, around and above CMC Tween 80 
concentrations (Figure 5.6 B). 
Similar statistical analysis was obtained for the particle size range of ≥ 10 
µm. The statistical difference between fresh and heat stressed, fresh and 
aged BSA with Tween 80 below, around and above CMC was significant 
(P<0.001). However statistical analysis showed no significance between 
fresh and aged BSA with Tween 80 present below its CMC (Figure 5.6 C).  
For particle count data of size ≥ 25, Bonferroni test analysis showed that the 
count difference is significant (P<0.01) between fresh and heated BSA with 
Tween 80 below and above CMC and the difference is statistically significant  
(P<0.001) between fresh and aged BSA samples with Tween 80 above its 
CMC. The mean difference was significant (P<0.05) between fresh and aged 
BSA samples with Tween 80 present at around CMC. No significant 
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difference was detected between fresh and heated samples of BSA with 
Tween 80 around CMC (Figure 5.6 D).  
For particle count data of size ≥ 50 µm a statistical difference (P<0.05) was 
detected between samples of fresh and heated BSA with Tween 80 below its 
CMC and between fresh and aged BSA samples with Tween 80 above its 
CMC (Figure 5.6 E). 
For particle count data of size ≥ 100 µm no statistical difference was detected 
between fresh and heat stressed, fresh and aged BSA for samples 
containing Tween 80 at all concentrations employed (Figure 5.6 F). 
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Figure 5.7.  Particle concentrations at size ranges of: (A) ≥ 2 µm, (B) ≥ 5 
µm, (C) ≥ 10 µm, (D) ≥ 25 µm, (E) ≥ 50 µm and (F) ≥ 100 µm measured by 
HIAC for fresh, heated and aged BSA with Brij 35 at below, around and 
above its CMC. Data are expressed as the mean ± Std. Deviation. * 
P<0.05, ** P<0.01, *** P<0.001; significant difference in particles per ml 
compared with fresh BSA with Brij 35 samples.  
One-way ANOVA analysis, using the Bonferroni correction, showed a 
significant effect of heat stress and aging of BSA in the presence of Brij 35 
surfactant at below, around and above its CMC on particle numbers ≥ 2 µm. 
The mean difference is significant (P<0.001) compared to fresh samples 
(Figure 5.7 A). 
For particle count data of size ≥ 5 µm, statistical analysis showed that the 
difference is significant (P<0.001) between fresh and heated, and between 
fresh and aged BSA with Brij 35 present below and around its CMC, and also 
between fresh and heated BSA with Brij 35 present at a level above CMC. 
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The mean difference between fresh and aged BSA with Brij 35 present above 
CMC is significant at 0.05 level (P<0.05). Figure 5.7 (B) illustrates these 
findings. 
For particle count data of size ≥ 10 µm, the statistical difference between 
fresh and heat stressed, fresh and aged BSA with Brij 35 below, around and 
above its CMC was significant (P<0.001) (Figure 5.7 C).  
For particle count data of size ≥ 25 µm, Bonferroni correction test showed 
that the difference is significant (P<0.001) between fresh and heated BSA 
with Brij 35 present below its CMC (P<0.05) and between fresh and heated 
BSA with Brij 35 present at around and above its CMC. No significant 
difference was detected between fresh and aged samples of BSA with Brij 35 
present at above its CMC. The mean difference was significant (P<0.01) 
between fresh and heated BSA samples with Brij 35 present below CMC 
sand between fresh and aged BSA samples with Brij 35 present at around its 
CMC. One-way ANOVA, Bonferroni test analysis showed a statistical 
difference (P<0.05) between fresh and aged BSA with Brij 35 used at below 
CMC (Figure 5.7 D).  
For particle count data of size ≥ 50 µm no statistical difference was detected 
between fresh and heat stressed, and between fresh and aged BSA with Brij 
35 below and around its CMC. Post-hoc analysis showed a significant 
difference level (P<0.05) between fresh and aged BSA samples with Brij 35 
present above CMC (Figure 5.7 E). 
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Figure 5.8.  Particle concentrations at size ranges of: (A) ≥ 2 µm, (B) ≥ 5 
µm, (C) ≥ 10 µm, (D) ≥ 25 µm, (E) ≥ 50 µm and (F) ≥ 100 µm measured by 
HIAC for fresh, heated and aged BSA with Pluronic F-68 present at 
below, around and above its CMC. Data are expressed as the mean ± 
Std. Deviation. * P<0.05, ** P<0.01, *** P<0.001; significant difference in 
particles per ml compared with fresh BSA with Pluronic F-68 samples.  
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One-way ANOVA analysis, Bonferroni correction, showed a significant effect 
of heat stress and aging samples for BSA with Pluronic F-68 surfactant 
present at below and around its CMC on particle count data for particles ≥ 2 
µm particles. The mean difference is significant (P<0.001) compared to fresh 
samples. For the same particle size data, the mean difference between fresh 
and heated BSA samples with Pluronic F-68 above its CMC is statistically 
significant (P<0.01).  There is no statistical difference (P>0.05) between fresh 
and aged BSA samples with Pluronic F-68 above its CMC (Figure 5.8 A). 
For particle count data of size  ≥ 5 µm and ≥ 10 µm, statistical analysis 
showed that the difference is statistically significant (P<0.001) between fresh 
and heated BSA with Pluronic F-68 present at all levels and between fresh 
and aged  BSA samples with Pluronic F-68 present below and around CMC. 
The mean difference in particle data is significant (P<0.01) between fresh 
and aged BSA samples with Pluronic F-68 employed above its CMC. Figure 
5.8 (B and C) illustrates these findings. 
For particle count data of size ≥ 25 µm, Bonferroni test analysis showed that 
the difference is statistically significant (P<0.001) between fresh and heated, 
and between fresh and aged BSA samples with Pluronic F-68 present at 
around CMC and significantly different (P<0.01) between fresh and aged 
BSA with Pluronic F-68 used below its CMC. No significant difference 
(P>0.05) was detected between fresh and heated BSA samples with Pluronic 
F-68 used below its CMC and between fresh and heated, fresh and aged 
BSA with Pluronic F-68 present at above CMC levels. (Figure 5.8 D).  
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For particle count data of size ≥ 50 µm, no statistical difference (P>0.05) was 
detected between fresh and heat stressed, and between fresh and aged BSA 
samples with Pluronic F-68 at above CMC (Figure 5.8 E). 
 
5.4.1.2 Light Obscuration measurements for fresh, heated and aged 
IgG2 surfactant free and IgG2 with Tween 20, Tween 80, Brij 35 and 
Pluronic F-68 surfactants at below, around and above CMC levels 
 
Figure 5.9 illustrates particle concentration per ml measured for fresh, heated 
and aged IgG2 surfactant free samples. 
1
10
100
1000
10000
100000
2 μm 5 μm 10 μm 25 μm 50 μm 100 μm
Size Range (μm)
P
a
rt
ic
le
s
 /
m
l
fresh heated aged
***
***
***
***
***
**
***
NS
NS
*
 
Figure 5.9. Particle concentrations measured by HIAC for fresh, heated 
and aged IgG2 samples. Data are expressed as the mean ± Std. 
Deviation. * P<0.05, ** P<0.01, *** P<0.001; significant difference in 
particles per ml compared with fresh IgG2 samples.  
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Heated IgG2 formulations show an increase in the number of particles per ml 
at all particle size ranges compared to fresh and aged IgG2 samples (Figure 
5.9). 
Both heated and aged samples caused the formation of immunoglobulin 
aggregation to a similar extent. The total number of particles greater or equal 
to 2 µm, 5 µm, 10 µm, 25 µm and 50 µm, respectively measured after heat 
stress (43334.0 ± 84.6 particles ≥ 2 µm, 41570.0 ± 44.5 ≥ 5 µm, 34748.0 ± 
61.0 ≥ 10 µm, 2227.3 ± 111.3 ≥ 25 µm and 6 ± 2.0 ≥ 50 µm) and aged 
samples (4460.7 ± 21.4 particles ≥ 2 µm, 670.7 ± 13.3 ≥ 5 µm, 189.3 ± 7 ≥ 10 
µm, 14.7 ± 3.1 ≥ 25 µm) exceeded the number of particles found for the 
same size range of freshly prepared samples. 
One-way ANOVA analysis showed a significant effect of heat treatment and 
storage on particles count at the size ranges of ≥ 2 µm, ≥ 5 µm, ≥ 10 µm. 
Post-hoc tests, Bonferroni correction analyses showed a significant increase 
in particle concentration at the size ranges ≥ 2 µm and ≥ 5 µm  (P<0.001) for 
heated and aged samples compared to fresh IgG2 samples. 
For particle count data of size  ≥ 10 µm, Bonferroni statistical results showed 
that the mean increase is significant (P<0.001) for heated IgG2 samples and 
aged (P<0.01) IgG2 samples. For particle count data of size ≥ 25 µm, heated 
IgG2 samples showed a statistically significant increase (P<0.001), whereas 
aged IgG2 samples showed no statistical difference (P>0.05) compared to 
fresh samples. Moreover, for particle count data of size ≥ 50 µm there was 
no significant difference in particle count for heated samples, but there was a 
significant difference (P<0.05) between fresh and aged IgG2 samples (Figure 
5.9). 
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Figure 5.10 illustrates the quantity of particles in a size range of ≥ 2 µm, ≥ 5 
µm, ≥ 10 µm, ≥ 25 µm, ≥ 50 µm and ≥ 100 µm measured by Light 
Obscuration for fresh IgG2 with Tween 20, Tween 80, Brij 35 and Pluronic F-
68 surfactants present . 
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Figure 5.10. Particle concentrations in size ranges: (A) ≥ 2 µm and ≥ 5 
µm, (B) ≥ 10 µm and ≥ 25 µm, (C) ≥ 50 µm and ≥ 100 µm per ml measured 
by HIAC for fresh IgG2 samples with Tween 20, Tween 80, Brij 35 and 
Pluronic F-68 surfactants present at below, around and above their 
CMC levels. Data are expressed as the mean ± Std. Deviation. 
In formulations of fresh IgG2 containing Brij 35 around CMC, a slight 
increase in the number of particles ≥ 2 µm and ≥ 5 µm was detectable 
(6880.0 ± 50.5 particles ≥ 2 µm and 122.0 ± 37.0 particles ≥ 5 µm per ml), 
compared to fresh IgG2 surfactant free solutions (540.0 ± 33.0 particles ≥ 2 
µm and 110.7 ± 29.1 particles ≥ 5 µm per ml). 
Fresh IgG2 formulations with Tween 20, Tween 80 and Pluronic F-68 
surfactants at all levels and for samples containing Brij 35 below and above 
CMC, showed lower particle counts at all particle size classifications (Figure 
5.10). 
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Figure 5.11. Particle concentrations in size ranges: (A) ≥ 2 µm and ≥ 5 
µm, (B) ≥ 10 µm and ≥ 25 µm, (C) ≥ 50 µm and ≥ 100 µm measured by 
HIAC for heated IgG2 samples with Tween 20, Tween 80, Brij 35 and 
Pluronic F-68 surfactants at below, around and above their CMC levels. 
Data are expressed as the mean ± Std. Deviation. 
Heated IgG2 formulations containing Tween 20 at around its CMC revealed a 
slight decrease in the number of particles at ≥ 2 µm (43047.3 ± 485.5 
particles) whereas IgG2 with Tween 20 present at below and above its CMC, 
and with Tween 80, Brij 35 and Pluronic F-68 present at below, around and 
above their respective CMC showed noticeable increases in particle numbers 
compared to heated immunoglobulin without any surfactant present (Figure 
5.11 A). 
A similar effect was noted for the data of particles ≥ 5 µm where IgG2 with 
Tween 20 present at around, Tween 80 present at above, Brij 35 at above 
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and Pluronic F-68 present at above their CMC levels showed decreases in 
particle counts. 
All four surfactants at below, around and above their CMC showed a 
decrease in particle count at ≥ 10 µm, ≥ 25 µm and ≥ 50 µm particle size 
classes (Figure 5.11 B and C). 
Figure 5.12 illustrates particle concentrations for aged IgG2 with Tween 20, 
Tween 80, Brij 35 and Pluronic F-68 surfactants. 
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Figure 5.12. Particle concentrations in size ranges: (A) ≥ 2 µm and ≥ 5 
µm, (B) ≥ 10 µm and ≥ 25 µm, (C) ≥ 50 µm and ≥ 100 µm per ml measured 
by HIAC for aged IgG2 samples with Tween 20, Tween 80, Brij 35 and 
Pluronic F-68 surfactants present at below, around and above their 
CMC. Data are expressed as the mean ± Std. Deviation. 
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For aged IgG2 formulations containing Tween 80 below its CMC, Brij 35 
below its CMC and Pluronic F-68 around its CMC, a decrease in the number 
of particles ≥ 2 µm was detected (Figure 5.12 A). 
IgG2 formulations with Tween 20 around and above its CMC, Tween 80 
around and above its CMC, and Pluronic F-68 above its CMC, an increase in 
the number of particles ≥ 5 µm was detected. Solutions with Tween 20 
present below, Tween 80 present below, Brij 35 present below, around and 
above and Pluronic F-68 present below and around their respective CMC’s 
did not induce formation of large aggregates. 
For particle count data of size ≥ 10 µm only Tween 20 at around CMC 
produced an increase in particle count. Particle count data for Tween 80, Brij 
35 and Pluronic F-68 surfactants at particle size ≥ 10 µm, and all surfactants 
at particle sizes ≥ 25 µm and ≥ 50 µm contained significantly fewer particles 
than aged surfactant free IgG2 samples (Figure 5.12 B and C). 
Figures 5.13 to 5.16 illustrate how the particle counts with different size 
ranges of ≥ 2 µm, ≥ 5 µm, ≥ 10 µm, ≥ 25 µm, ≥ 50 µm and ≥ 100 µm change 
after heat stress and aging of IgG2 with each surfactant at below, around and 
above their respective CMC levels. 
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Figure 5.13.  Particle concentrations at size ranges of: (A) ≥ 2 µm, (B) ≥ 
5 µm, (C) ≥ 10 µm, (D) ≥ 25 µm, (E) ≥ 50 µm measured by HIAC for fresh, 
heated and aged IgG2 with Tween 20 below, around and above its CMC 
levels. Data are expressed as the mean ± Std. Deviation. * P<0.05, ** 
P<0.01, *** P<0.001; significant difference in particles per ml compared 
with fresh IgG2 with Tween 20 samples.  
One-way ANOVA analysis, post-hoc Bonferroni correction showed a 
significant effect of heat stress and aging on samples for IgG2 with Tween 20 
surfactant at below, around and above its CMC for particle count data of size  
≥ 2 µm. The mean difference is significant (P<0.001) compared to fresh 
samples (Figure 5.13 A). 
For particle count data of size ≥ 5 µm and ≥ 10 µm, statistical analyses 
showed that the difference is significant (P<0.001) between fresh and 
heated, and between fresh and aged IgG2 with Tween 20 present at around 
and above CMC and also between fresh and heated IgG2 with Tween 20 
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present below CMC. The mean difference is significant (P<0.01) between 
fresh and aged IgG2 with Tween 20 below CMC. Figure 5.13 (B) and (C) 
illustrates these findings. 
For particle count data of size ≥ 25, Bonferroni test analysis showed that the 
difference is statistically significant (P<0.001) between fresh and heated IgG2 
samples with Tween 20 present at around and above CMC and between 
fresh and aged samples of IgG2 with Tween 20 present around CMC  
(P<0.05). No significant difference was detected between fresh and heated, 
and between fresh and aged samples of IgG2 with Tween 20 below CMC 
and between fresh and aged Tween 20 above CMC (Figure 5.13 D). 
For particle count data of size ≥ 50 µm no statistical difference (P>0.05) was 
detected between fresh and aged IgG2 with Tween 20 around and above its 
CMC. Post-hoc analysis showed significant difference (P<0.001) between 
fresh and heated IgG2 with Tween 20 added above CMC and was also 
significantly different between fresh and heated samples of IgG2 with Tween 
20 present at around CMC (P<0.01) (Figure 5.13 E). 
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Figure 5.14.  Particle concentrations at size ranges of: (A) ≥ 2 µm, (B) ≥ 
5 µm, (C) ≥ 10 µm, (D) ≥ 25 µm, (E) ≥ 50 µm measured by HIAC for fresh, 
heated and aged IgG2 with Tween 80 present below, around and above 
CMC. Data are expressed as the mean ± Std. Deviation. * P<0.05, ** 
P<0.01, *** P<0.001; significant difference in particles per ml compared 
with fresh IgG2 with Tween 80 samples.  
Illustrated in Figure 5.14, one-way ANOVA analysis, using Bonferroni 
correction showed a significant effect of heat stress and aging on samples for 
IgG2 with Tween 80 surfactant present at below, around and above CMC 
levels for at particle count data obtained at ≥ 2 µm. The mean difference is 
significant (P<0.001) for Tween 80 at levels around and above CMC 
compared to fresh samples. The difference between fresh and heated 
samples is statistically significant (P<0.001) and between fresh and aged 
samples (P<0.01) of IgG2 with Tween 80 present at levels below CMC 
(Figure 5.14 A). 
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For particle count data of size ≥ 5 µm, statistical analysis showed that heat 
treatment had a significant effect (P<0.001) for IgG2 samples containing 
Tween 80 below, around and above CMC, whereas aging effect had no 
significant effect (P>0.05) for these samples (Figure 5.14 B). 
For particle count data of size ≥ 10 µm, heat treatment had a significant 
effect on count number (P<0.001) compared to fresh samples. The difference 
between fresh and aged samples of IgG2 with Tween 80 present below and 
around CMC was statistically significant (P<0.01). Aging treatment had no 
significant effect on particle counts of this size for the IgG2 sample with 
Tween 80 present above CMC when compared to the initial sample (Figure 
5.14 C).  
For particle count data of size ≥ 25 µm, Bonferroni test analysis showed that 
heat treatment had a statistically significant effect (P<0.001) only in the 
presence of Tween 80 at low concentration. No significant heat effect was 
detected for IgG2 in the presence of Tween 80 at around and above its CMC. 
Comparing fresh and aged IgG2 with Tween 80 levles below, around and 
above CMC, no significance difference in particle count was shown (Figure 
5.14 D). 
For particle count data of size ≥ 50 µm no statistical difference (P>0.05) was 
detected between fresh and aged IgG2 samples containing Tween 80 at 
levels below, around and above its CMC (Figure 5.14 E). 
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Figure 5.15.  Particle concentrations at size ranges of: (A) ≥ 2 µm, (B) ≥ 
5 µm, (C) ≥ 10 µm, (D) ≥ 25 µm, (E) ≥ 50 µm measured by HIAC for fresh, 
heated and aged IgG2 with added Brij 35 below, around and above its 
CMC level. Data are expressed as the mean ± Std. Deviation. * P<0.05, ** 
P<0.01, *** P<0.001; significant difference in particles per ml compared 
with fresh IgG2 with Brij 35 samples.  
Figure 5.15 illustrates statistical analysis results for fresh, heated and aged 
IgG2 with Brij 35 present. One-way ANOVA analysis, Bonferroni test, showed 
a significant effect of heat stress for IgG2 with Brij 35 surfactant present at 
levels below, around and above CMC on the production of particles of size  ≥ 
2 µm. The mean difference is significant (P<0.001) comparing the above 
samples’ to fresh sample data. There is no significant difference between 
data for fresh and aged IgG2 samples with Brij 35 added at below CMC 
(Figure 5.15 A). 
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For particle count data of size ≥ 5 µm and ≥ 10 µm statistical analysis 
showed that the difference is significant (P<0.001) between data for fresh 
and heated samples of IgG2 with Brij 35 below, around and above its CMC 
and between data from samples of fresh and aged IgG2 with Brij 35 present 
at above CMC for count data of particles ≥ 10 µm. There is no statistical 
difference between fresh and aged IgG2 data for particles of ≥ 5 µm with Brij 
35 present (Figure 5.15 B and C).  
For particle count data of size ≥ 25, Bonferroni test analysis showed that heat 
treatment effect on particle count is statistically significant (P<0.01) for IgG2 
with Brij 35 present at below and around CMC when compared to unheated 
samples. Aging does not statistically increase particle level for IgG2 with Brij 
35 (Figure 5.15 D).  
For particle count data of size ≥ 50 µm no statistical difference (P>0.05) was 
detected between fresh and heated, and between fresh and aged samples of 
IgG2 with Brij 35 (Figure 5.15 E).  
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Figure 5.16.  Particle concentrations at size ranges of: (A) ≥ 2 µm, (B) ≥ 
5 µm, (C) ≥ 10 µm, (D) ≥ 25 µm, (E) ≥ 50 µm measured by HIAC for fresh, 
heated and aged IgG2 samples with Pluronic F-68 added below, around 
and above CMC level. Data are expressed as the mean ± Std. Deviation. 
* P<0.05, ** P<0.01, *** P<0.001; significant difference in particles per ml 
compared with fresh IgG2 with Pluronic F-68 samples.  
From results presented in Figure 5.16 (A) for particle counts of particles with 
size ≥ 2 µm, one-way ANOVA analysis, post-hoc Bonferroni test, showed a 
significant difference (P<0.001) between fresh and heated samples of IgG2 
with Pluronic F-68 present at around and above CMC. The mean difference 
is also significant at (P<0.01) between fresh and aged IgG2 samples with 
Pluronic F-68 above CMC. No statistical difference was observed between 
fresh and aged samples with Pluronic F-68 at below and around CMC 
(Figure 5.16 A). 
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For particle count data of size ≥ 5 µm, statistical analysis showed that heat 
stress is statistically significant (P<0.001) on particle number for IgG2 
samples with Pluronic F-68 present at below, around and above CMC.  Aging  
has no statistically significant effect on particle count (Figure 5.16 B). 
For particle count data of size ≥ 10 µm, the difference is significant (P<0.001) 
between fresh and heat stressed samples of IgG2 with Pluronic F-68 at 
below, around and above CMC. Significance at the same statistical level was 
found between the particle counts of fresh and aged IgG2 with Pluronic F-68 
at above CMC. Figure 5.16 (C) illustrates these findings. 
For particle count data of size ≥ 25 µm particles per ml, Bonferroni test 
showed that particle count difference is statistically significant (P<0.001) 
between fresh and heated samples of IgG2 with Pluronic F-68 below its CMC 
and significant (P<0.01) between fresh and heated IgG2 samples with 
Pluronic F-68 above CMC. No significant difference is detected between data 
obtained for samples of fresh and heated IgG2 with Pluronic F-68 around 
CMC and between the same for fresh and aged samples of IgG2 with 
Pluronic F-68 (Figure 5.16 D). 
For particle count data of size ≥ 50 µm no statistical difference (P>0.05) was 
detected in particle count between fresh and aged samples of IgG2 with 
Pluronic F-68 at below and above CMC levels. Post-hoc analysis showed a 
significant difference (P<0.001) between data for samples of fresh and 
heated IgG2 with Pluronic F-68 below its CMC (Figure 5.16 E). 
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5.4.2 Micro-flow imaging (MFI) measurements 
 
5.4.2.1 Micro-flow measurements for fresh, heated and aged BSA 
surfactant free and BSA with Tween 20, Tween 80, Brij 35 and Pluronic 
F-68 surfactants at below, around and above CMC levels 
 
Micro-flow imaging (MFI) analysis assesses sub-visible particle count per ml, 
particle size and morphological characteristics for protein particles. The 
methods used are as described in Chapter 2, Section 2.2. 
BSA (10 mg/ml) particles and aggregates were observed to be high in 
number and heterogeneous in shape, ranging from small dense fibres to 
large ribbon like aggregates (Figure 5.17). 
Particle size (µm) BSA (10 mg/ml) 
≥ 2     
≥ 10 
    
 
≥ 25 
    
 
≥ 50 
    
Figure 5.17. Representative micro-flow imaging (MFI) example images 
for BSA (10 mg/ml) particles. 
 
Figure 5.18 shows particle concentration per ml measured for fresh, heated 
and aged BSA (10 mg/ml) samples. 
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Figure 5.18. Particle concentrations measured by MFI for fresh, heated 
and aged BSA samples. Data are expressed as the mean ± Std. 
Deviation. * P<0.05, ** P<0.01, *** P<0.001; significant difference in 
particles per ml compared with fresh BSA samples.  
Heat stressed and aged BSA surfactant free formulations produced data with 
greater numbers of particles per ml of sizes greater than or equal to 10, 25, 
50 and 100 µm than that determined for the fresh BSA sample (Figure 5.18). 
One-way ANOVA analysis showed a significant effect of heat treatment and 
storage on the number of particles determined per ml of size ≥ 2 µm, ≥ 10 
µm, ≥ 25 µm, ≥ 50 µm and ≥ 100 µm. Post-hoc tests, Bonferroni correction 
showed a significant increase in the number of particles per ml of sizes ≥ 25 
µm and ≥ 50 µm (P<0.001) for heated and aged samples compared to fresh 
BSA. 
For particle count data of size ≥ 10 µm size range Bonferroni statistical 
results showed that the mean increase is significant (P<0.001) for aged BSA 
samples, but there was no statistical significance between fresh and heated 
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samples (P>0.05). For particle count data of size ≥ 100 µm heated BSA 
samples showed a statistically significant increase in particle count 
(P<0.001), whereas aged BSA samples had statistical significance at a lower 
level (P<0.05) when compared to fresh samples (Figure 5.18).  
Figure 5.19 shows the number of particles for size ranges of ≥ 2 µm, ≥ 10 
µm, ≥ 25 µm, ≥ 50 µm and ≥ 100 µm per ml measured by Micro-Flow 
Imaging for  fresh samples of BSA with added Tween 20, Tween 80, Brij 35 
and Pluronic F-68 surfactants. 
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Figure 5.19. Particle concentrations in size ranges: (A) ≥ 2 µm and ≥ 10 
µm, (B) ≥ 25 µm, ≥ 50 µm and ≥ 100 µm per ml measured by MFI for fresh 
BSA samples with added Tween 20, Tween 80, Brij 35 and Pluronic F-68 
surfactants at levels below, around and above their CMC. Data are 
expressed as the mean ± Std. Deviation. 
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Data obtained for formulations of BSA containing Tween 20 at below and 
around CMC showed an increase in the number of particles ≥ 2 µm 
compared to fresh BSA surfactant free formulations (Figure 5.19 A). 
BSA formulations with Tween 20, Brij 35 and Pluronic F-68 at all 
concentrations, and formulations containing Tween 80 at concentrations 
around and above CMC showed an increase in the number of particles per 
ml of size greater than or equal to 10 µm compared to fresh surfactant-free 
BSA samples (Figure 5.19). 
For particle count data of size greater than or equal 25 µm, BSA with Tween 
20 and Pluronic F-68 at all concentrations, and with Tween 80 below its 
CMC, produced an increase in particle count compared to BSA surfactant 
free samples (Figure 5.19 B). For particle count data of size ≥ 50 µm, BSA 
solutions with Tween 20 and Tween 80 below their CMC and Pluronic F-68 at 
all concentrations showed an increase in particle count. For particle count 
data of size ≥ 100 µm, an increase in particle count was detected for samples 
containing Tween 80 and Brij 35 below their CMC and for Pluronic F-68 
samples at around and above its CMC when compared to BSA surfactant 
free solution. 
Figure 5.20 shows particle count per ml data measured for heated BSA with 
Tween 20, Tween 80, Brij 35 and Pluronic F-68 surfactants present at below, 
around and above CMC.  
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Figure 5.20. Particle concentrations in size ranges: (A) ≥ 2 µm and ≥ 10 
µm, (B) ≥ 25 µm, ≥ 50 µm and ≥ 100 µm per ml measured by MFI for 
heated BSA samples with added Tween 20, Tween 80, Brij 35 and 
Pluronic F-68 surfactants at below, around and above their CMC levels. 
Data are expressed as the mean ± Std. Deviation. 
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Heat stressed BSA (10 mg/ml) formulations showed a slight increase in the 
number of particles per ml greater than or equal to 2 µm for formulations 
containing Tween 20 above its CMC and containing Tween 80 below and 
around its CMC level. Data obtained when the other surfactants were 
employed showed a decrease in particle count for particles ≥ 2 µm when 
compared to the heated BSA surfactant free sample. 
For particle count data of size ≥ 10 µm, BSA with Tween 20 above and 
Tween 80 below their CMC showed an increase in particle count compared 
to the other surfactants and heat stressed surfactant free BSA (Figure 5.20 
A, Figure 5.18). 
Heated BSA formulations with Tween 80 below and around its CMC and 
Pluronic F-68 below its CMC showed an increase in the number of particles 
greater than or equal to 25 µm, 50 µm and 100 µm compared to other 
surfactants and a BSA surfactant free sample (Figure 5.20 B). 
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Figure 5.21. Particle concentration for size ranges: (A) ≥ 2 µm and ≥ 10 
µm, (B) ≥ 25 µm, ≥ 50 µm and ≥ 100 µm measured by MFI for aged BSA 
samples with Tween 20, Tween 80, Brij 35 and Pluronic F-68 surfactants 
at below, around and above their CMC levels. Data are expressed as the 
mean ± Std. Deviation. 
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For aged formulations of BSA containing Tween 20 at above its CMC, data 
showed an increase in particle count for particles ≥ 2 µm (Figure 5.21 A).   
For particle count data of size ≥ 10 µm, samples with Tween 80 and Pluronic 
F-68 showed a slight increase in particle count compared to other surfactant 
and aged BSA surfactant free samples.  
The number of ≥ 25 µm particles measured for the aged BSA sample with 
Tween 80 above its CMC was lower compared to the remainder of the 
surfactants and surfactant free samples which showed an increase in particle 
count per ml (Figure 5.18). For particle count data of size ≥ 50 µm, samples 
of  aged BSA with Tween 20 above, Tween 80 around, Brij 35 below and 
around, and Pluronic F-68 around and above their respective CMC, all 
showed an increased particle count number compared to to aged surfactant 
free BSA (Figure 5.21 B). 
For particle count data of size ≥ 100 µm samples of aged BSA with Brij 35 
below and around its CMC and Pluronic F-68 above its CMC displayed an 
increase in particle count compared to the other surfactants and aged BSA 
surfactant free formulations. 
Figures 5.22 to 5.25 illustrate how particle count data of size of ≥ 2 µm, ≥ 10 
µm, ≥ 25 µm, ≥ 50 µm and ≥ 100 µm are affected by heat stress and aging of 
BSA with each surfactant at below, around and above its CMC levels. 
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Figure 5.22.  Particle concentrations at size ranges of: (A) ≥ 2 µm, (B) ≥ 
10 µm, (C) ≥ 25 µm, (D) ≥ 50 µm measured by MFI for fresh, heated and 
aged BSA with added Tween 20 below, around and above its CMC level. 
Data are expressed as the mean ± Std. Deviation. * P<0.05, ** P<0.01, *** 
P<0.001; significant difference in particles per ml compared with fresh 
BSA with Tween 20 samples.  
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One-way ANOVA analysis, using the Bonferroni correction, showed a 
significant effect of the effect of heat stress and aging samples of BSA with 
added Tween 20 surfactant at below, around and above its CMC on particle 
count at a particle size range ≥ 2 µm particles. The mean difference in 
particle count is significant (P<0.001) between fresh and heated BSA 
samples with Tween 20 added below and above its CMC, and is also 
significant (P<0.05) between fresh and heated BSA samples with Tween 20 
added at around CMC (Figure 5.22 A). 
For particle count data of size ≥ 10 µm p, statistical analysis showed that the 
difference in count is significant (P<0.01) between fresh and heated BSA 
samples with Tween 20 present below its CMC. The mean difference is also 
significant (P<0.001) between data obtained for fresh and heated samples of 
BSA with Tween 20 present at around and above its CMC (Figure 5.22 B). 
For particle count data of size ≥ 25, Bonferroni test analysis showed that the 
count difference is statistically significant (P<0.001) between fresh and 
heated BSA with Tween 20 present at below and around its CMC and also 
significant (P<0.01) between fresh and heated BSA samples with Tween 20 
present at around its CMC and similarly significant between fresh and aged 
BSA with Tween 20 added below and around its CMC (Figure 5.22 C). 
For particle count data of size ≥ 50 µm no statistical difference (P>0.05) was 
detected between fresh and heated BSA samples with Tween 20 present at 
around and above its CMC. Post-hoc analysis showed a significant difference 
(P<0.001) between particle counts of fresh and aged BSA samples with 
Tween 20 present at above its CMC and also a significant difference  
  
  214 
(P<0.01) between fresh and heated samples , and fresh and aged samples 
of BSA with Tween 20 present below its CMC (Figure 5.22 D). 
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Figure 5.23.  Particle concentrations at size ranges of: (A) ≥ 2 µm, (B) ≥ 
10 µm, (C) ≥ 25 µm, (D) ≥ 50 µm and (E) ≥ 100 µm measured by MFI for 
fresh, heated and aged BSA with added Tween 80 below, around and 
above its CMC level. Data are expressed as the mean ± Std. Deviation. * 
P<0.05, ** P<0.01, *** P<0.001; significant difference in particles per ml 
compared with fresh BSA with Tween 80 samples.  
Figure 5.23 illustrates results from a One-way ANOVA analysis for fresh, 
heated and aged BSA samples in the presence of with Tween 80. Bonferroni 
correction analysis showed a significant effect of the effect of heat stress and 
aging treatment on the particle count of BSA samples with Tween 80 
surfactant present at below, around and above its CMC for particles ≥ 2 µm 
particles per ml. The mean difference in particle count was (P<0.001). The 
particle count difference between fresh and aged Tween 80 samples with 
below and around CMC levels is significant (P<0.05). No significant 
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difference is detected between fresh and heated BSA samples with Tween 
80 present at levels below and around its CMC (Figure 5.23 A). 
For particle count data of size ≥ 10 µm, statistical analysis showed that heat 
treatment had a significant effect (P<0.01) for BSA samples with Tween 80 
present at around its CMC , whereas for BSA samples with Tween 80 below 
and above its CMC, heat stress had a more significant effect (P<0.001). 
Aging of samples of BSA with Tween 80 present below and around its CMC 
showed a significant effect (P<0.01) and also showed significance for 
samples with Tween 80 above its (P<0.001) level when comparing particle 
counts with that of the fresh samples (Figure 5.23 B). 
For particle count data of size ≥ 25 µm shown in Figure 5.23 C, Bonferroni 
test results showed that heat treatment has a statistically significant effect 
(P<0.001) only for samples including Tween 80 at below CMC 
concentrations. Aging has statistically significant effect at the 0.01 level for 
BSA with Tween 80 present at around and above its CMC  
For particle count data of size ≥ 50 µm no statistical difference (P>0.05) was 
detected between the particle counts of fresh and aged BSA samples with 
Tween 80 below its CMC and between fresh and heated BSA samples with 
Tween 80 above its CMC. Both heat treatment and aging had a significant 
effect (P<0.001) on particle count for BSA samples with Tween 80 present at 
around its CMC (Figure 5.23 D). 
For particle count data of size ≥ 100 µm, post-hoc test analysis showed that  
heat stress has a statistically significant effect (P<0.001) for samples with 
Tween 80 present at around its CMC. Aging has a significant effect at the 
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0.01 level (P<0.01) for samples of BSA with Tween 80 present at below its 
CMC (Figure 5.23 E). 
(A) 
≥2 µm
1.0
10.0
100.0
1000.0
10000.0
100000.0
1000000.0
Brij 35 below Brij 35 around Brij 35 above
P
a
rt
ic
le
s
/m
l
Fresh
Heated
Aged
**
NS
*** *** *** **
 
(B) 
≥10 µm
1.0
10.0
100.0
1000.0
10000.0
100000.0
Brij 35 below Brij 35 around Brij 35 above
P
a
rt
ic
le
s
/m
l
Fresh
Heated
Aged
NS
***
NS
 ***
NS
***
 
 
 
 
  
  219 
(C) 
≥25 µm
1.0
10.0
100.0
1000.0
10000.0
Brij 35 below Brij 35 around Brij 35 above
P
a
rt
ic
le
s
/m
l
Fresh
Heated
Aged
NS
***
NS
*** ***
**
 
(D) 
≥50 µm
1.0
10.0
100.0
1000.0
Brij 35 below Brij 35 around Brij 35 above
P
a
rt
ic
le
s
/m
l
Fresh
Heated
Aged
NS
***
**
***
**
***
 
 
 
 
 
 
  
  220 
(E) 
≥100 µm
0.1
1.0
10.0
100.0
Brij 35 below Brij 35 around Brij 35 above
P
a
rt
ic
le
s
/m
l
Fresh
Heated
Aged
NS
**
NS
**
NS
NS
 
Figure 5.24.  Particle concentrations at size ranges of: (A) ≥ 2 µm, (B) ≥ 
10 µm, (C) ≥ 25 µm, (D) ≥ 50 µm and (E) ≥ 100 µm measured by MFI for 
fresh, heated and aged BSA with added Brij 35 at below, around and 
above its CMC. Data are expressed as the mean ± Std. Deviation. * 
P<0.05, ** P<0.01, *** P<0.001; significant difference in particles per ml 
compared with fresh BSA with Brij 35 samples.  
One-way ANOVA analysis, Bonferroni test results illustrated in Figure 5.24 
show the significant effect of heat stress on particle count for BSA samples 
with Brij 35 surfactant present at below, around and above its CMC for  
particles ≥ 2 µm. The mean difference in count is significant at the 0.001 level 
(P<0.001) for BSA samples with Brij 35 present at around and above its 
CMC. The particle count difference between fresh and aged BSA samples 
with Brij 35 present at above its CMC is significant at the 0.01 level (P<0.01) 
and for samples of BSA with Brij 35 at around its CMC the count difference is 
significant at the 0.01 level (P<0.01) (Figure 5.24 A). 
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For particle count data of size ≥ 10 µm, statistical analysis showed a 
significant difference (P<0.001) between fresh and aged samples of BSA 
with Brij 35 at concentrations below, around and above its CMC. There is no 
significant difference between the particle counts of fresh and heated BSA 
with Brij 35 present at below, around and above its CMC (Figure 5.24 B).  
For particle count data of size ≥ 25 µm particles, Bonferroni test analysis 
showed that the effect of heat treatment on particle count is statistically 
significant at the 0.01 level (P<0.01) for BSA samples with Brij 35 above at 
levels above its CMC.  No statistical difference was observed between fresh 
and heated BSA with Brij 35 present at concentrations below and around its 
CMC. Aging treatment produced a statistically significant effect on particle 
count (P<0.001) for samples of BSA with Brij 35 at levels below, around and 
above its CMC (Figure 5.24 C).  
For particle count data of size ≥ 50 µm no statistical difference (P>0.05) on 
count was detected between fresh and heated BSA samples with Brij 35 at 
below CMC. Aging treatment produced a statistically significant effect at the 
0.001 level (P<0.001) for samples of BSA with Brij 35 at levels below, around 
and above its CMC (Figure 5.24 D). 
For particle count data of size ≥ 100 µm statistical analysis showed no 
statistical difference between fresh and heated BSA samples with Brij 35. 
Aging of samples produced a significant effect on particle count at the 0.01 
level (P<0.01) for BSA samples with Brij 35 present at below and around its 
CMC compared to fresh samples (Figure 5.24 E). 
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Figure 5.25.  Particle concentrations at size ranges of: (A) ≥ 2 µm, (B) ≥ 
10 µm, (C) ≥ 25 µm, (D) ≥ 50 µm and (E) ≥ 100 µm measured by MFI for 
fresh, heated and aged BSA with added Pluronic F-68 at concentrations 
below, around and above its CMC. Data are expressed as the mean ± 
Std. Deviation. * P<0.05, ** P<0.01, *** P<0.001; significant difference in 
particles per ml compared with fresh BSA with Pluronic F-68 samples.  
Figure 5.25 illustrates the results of heat treatment and aging effects on  BSA 
with added Pluronic F-68 surfactant. 
For particle count data of size ≥ 2 µm, one-way ANOVA analysis,  Bonferroni 
test showed a significant difference at the 0.01 level (P<0.01) between fresh 
and heated BSA sample particle count with Pluronic F-68 present at around 
and above its CMC. The difference in mean count is significant at the 0.001 
level (P<0.001) between fresh and aged BSA samples with Pluronic F-68 
added below, around and above its CMC compared to fresh samples (Figure 
5.25 A). 
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For particle count data of size ≥ 10 µm, statistical analysis showed that the 
effects of heat stress and aging are statistically significant at 0.001 level 
(P<0.001) for BSA samples with Pluronic F-68 present at below CMC. Aging 
treatment was statistically significant at the 0.01 level (P<0.01) for BSA 
samples with Pluronic F-68 present at around CMC (Figure 5.25 B). 
For particle count data of size ≥ 25 µm Bonferroni test analysis showed that 
the difference is statistically significant at the 0.001 level (P<0.001) between 
fresh and heated BSA samples with Pluronic F-68 present at around its CMC 
and significant at the 0.01 level (P<0.01) for BSA samples with Pluronic F-68 
added below and above its CMC. The mean difference in particle count is 
significant at the 0.01 level (P<0.01) between fresh and aged samples of 
BSA with added Pluronic F-68 at below, around and above its CMC (Figure 
5.25 C). 
For particle count data of size ≥ 50 µm, the mean particle count difference is 
significant at the 0.001 level (P<0.001) between fresh and heat stressed 
samples of BSA with added Pluronic F-68 at below and around its CMC. Also 
significant at the same level was the count difference between fresh and 
aged samples with Pluronic F-68 present at below its CMC. No statistical 
difference (P>0.05) was detected between fresh and aged BSA samples with 
Pluronic F-68 added at around and above its CMC. Figure 5.25 (D) illustrates 
these findings. 
For particle count data of size ≥ 100 µm size range no statistical difference 
(P>0.05) was detected between the particle count of fresh and heated BSA 
with Pluronic F-68 at above its CMC and between fresh and aged BSA 
samples with Pluronic F-68 below and above its CMC. Post-hoc analysis 
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showed a significant difference at the 0.01 level (P<0.01) between the 
particle count data for fresh and heated BSA samples with Pluronic F-68 
present at below and around its CMC and between fresh and aged samples 
including Pluronic F-68 at around its CMC (Figure 5.25 E). 
 
5.4.2.2 Micro-flow measurements for fresh, heated and aged IgG2 
surfactant free and IgG2 with Tween 20, Tween 80, Brij 35 and Pluronic 
F-68 surfactants present at below, around and above their CMC levels 
 
Figure 5.26 shows particle concentration per ml measured for fresh, heated 
and aged IgG2 (10 mg/ml) samples. 
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Figure 5.26. Particle concentrations measured by MFI for fresh, heated 
and aged IgG2 samples. Data are expressed as the mean ± Std. 
Deviation. * P<0.05, ** P<0.01, *** P<0.001; significant difference in 
particles per ml compared with fresh IgG2 samples.  
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Heated IgG2 (10 mg/ml) samples show their highest increase in particle 
count per ml for the size class ≥ 2 µm size range (50216.8 ± 1614.1 particles 
per ml). Heat stressed and aged IgG2 surfactant free formulations show 
increased numbers of particles per ml of a size greater than or equal to 2 and 
10 µm than that determined for fresh IgG2 samples (Figure 5.26). 
One-way ANOVA analysis showed a significant effect on particle count of 
heat treatment and storage on particles of the size ranges of ≥ 2 µm, ≥ 10 
µm, ≥ 25 µm and ≥ 50 µm. Post-hoc tests, using the Bonferroni correction, 
showed a significant increase (P<0.001) in particle count for particles sized  ≥ 
2 µm, ≥ 10 µm, ≥ 25 µm and ≥ 50 µm for heated IgG2 samples compared to 
data for fresh samples. 
For particle count data of size ≥ 2 µm and ≥ 10 µm, Bonferroni statistical 
analysis results showed that the mean particle count increase is significant at 
0.05 level (P<0.05) for aged IgG2 samples, but there was no statistically 
significant difference between fresh and aged IgG2 samples (P>0.05) particle 
count at ≥ 25 µm and ≥ 50 µm size ranges (Figure 5.26).  
Figure 5.27 shows the number of particles in a size range of ≥ 2 µm, ≥ 10 
µm, ≥ 25 µm, ≥ 50 µm and ≥ 100 µm measured by Micro-Flow Imaging for 
fresh IgG2 with added Tween 20, Tween 80, Brij 35 and Pluronic F-68 
surfactants at below, around and above their CMC levels. 
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Figure 5.27. Particle concentrations in size ranges of ≥2 µm, ≥ 10 µm 
and ≥ 25 µm per ml measured by MFI for fresh IgG2 samples with added 
Tween 20, Tween 80, Brij 35 and Pluronic F-68 surfactants at below, 
around and above their CMC levels. Data are expressed as the mean ± 
Std. Deviation. 
In fresh formulations of IgG2 containing Tween 20 at below, around and 
above its CMC, Tween 80 at around and above its CMC, Brij 35 at below and 
around its CMC and Pluronic F-68 at below its CMC, an increase in the 
number of particles ≥ 2 µm was determined.  For Tween 80 at below CMC 
lelvels, Brij 35 at concentrations above its CMC and Pluronic F-68 at 
concentrations around and above its CMC a decrease in particle count of this 
size was observed compared to fresh IgG2 surfactant free samples (Figure 
5.27). 
IgG2 formulations with Tween 20 present at levels below and above CMC 
and Pluronic F-68 present below its CMC showed an increase in particle 
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count of particles greater than or equal to 10 µm compared to the fresh 
surfactant-free IgG2 sample (Figure 5.26). 
For particle count data of size ≥ 25 µm, IgG2 samples with all four 
surfactants have a decreased particle count compared to that obtained for 
fresh IgG2 surfactant free samples. For particle count data of size ≥ 50 µm 
and ≥ 100 µm no particles were observed.  
Figure 5.28 shows particle count data measured for heated IgG2 with Tween 
20, Tween 80, Brij 35 and Pluronic F-68 surfactants at below, around and 
above their CMC.  
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Figure 5.28. Particle concentrations in size range: (A) ≥ 2 µm and ≥ 10 
µm; (B) ≥ 25 µm, ≥ 50 µm and ≥ 100 µm per ml measured by MFI for 
heated IgG2 samples with Tween 20, Tween 80, Brij 35 and Pluronic F-
68 surfactants at below, around and above their CMC levels. Data are 
expressed as the mean ± Std. Deviation. 
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Heat stressed IgG2 (10 mg/ml) formulations showed an increase in the 
number of particles greater than or equal to 2 µm with Tween 20 and 
Pluronic F-68 at below, around and above their CMC, Tween 80 below and 
above its CMC and Brij 35 below and around its CMC compared to heated 
IgG2 surfactant free samples.  
For particle count data of size ≥ 10 µm and ≥ 25 µm, IgG2 with Pluronic F-68 
above its CMC produced a slight increase in particle count compared to 
heated IgG2 surfactant free samples. All other surfactants produced 
decreases in particle count at these size ranges (Figure 5.28 A and B).  
Heated IgG2 formulations with Tween 20 present at below and around CMC 
Tween 80 above its CMC and Pluronic F-68 below and above its CMC, all 
showed an increase in the number of particles greater than or equal to 50 
µm. For particle count data of size ≥ 100 µm, only formulations of heated 
IgG2 solutions with Tween 20 at below and above its CMC and Tween 80 at 
around and above its CMC produced an increase in particle count per ml. For 
all other surfactant samples, no particles were detected at this size range 
(Figure 5.28 B). 
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Figure 5.29. Particle concentrations in size range: (A) ≥ 2 µm and ≥ 10 
µm; (B) ≥ 25 µm, ≥ 50 µm and ≥ 100 µm per ml measured by MFI for aged 
IgG2 samples with added Tween 20, Tween 80, Brij 35 and Pluronic F-68 
surfactants at below, around and above their CMC. Data are expressed 
as the mean ± Std. Deviation. 
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All four surfactant samples at any concentration on aging produced an 
increase in the number of particles at ≥2 µm and ≥10 µm (Figure 5.29 A). 
The increase in the number of ≥ 25 µm particles was measured for aged 
IgG2 with Tween 20 present at all CMC concentrations, and for Tween 80 
and Brij 35 at around and above their CMC .  The particle count of particles 
at ≥ 50 µm for IgG2 with Tween 20 present at around and above and for Brij 
35 present at around their CMC increased (Figure 5.29 B).  
For particle count data of size ≥ 100 µm, aged IgG2 with Tween 20 and Brij 
35 around their CMC produced an increase comparing to other surfactants 
and aged IgG2 surfactant free formulations (Figures 5.26 and 5.29 B). 
Figures 5.30 to 5.33 illustrate how particle count over the size ranges ≥ 2 µm, 
≥ 10 µm, ≥ 25 µm, ≥ 50 µm and ≥ 100 µm changed after heat stress and 
aging of IgG2 with each surfactant at below, around and above CMC levels. 
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Figure 5.30.  Particle concentrations at size ranges of: (A) ≥ 2 µm, (B) ≥ 
10 µm, (C) ≥ 25 µm, (D) ≥ 50 µm and (E) ≥ 100 µm measured by MFI for 
fresh, heated and aged IgG2 with Tween 20 at concentrations below, 
around and above CMC. Data are expressed as the mean ± Std. 
Deviation. * P<0.05, ** P<0.01, *** P<0.001; significant difference in 
particles per ml compared with fresh IgG2 with Tween 20 samples.  
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One-way ANOVA analysis, post-hoc Bonferroni correction, showed a 
significant effect of heat stress on particle count data for IgG2 samples with 
Tween 20 surfactant at below, around and above its CMC levels for particles 
≥ 2 µm. The mean difference in particle count was significant at the 0.001 
level (P<0.001) for IgG2 samples with Tween 20 present at below, around 
and above its CMC on comparing fresh and heated samples. Significance 
was observed at the 0.01 level (P<0.01) between particle count data for IgG2 
with Tween 20 present at around its CMC and at the 0.05 level (P<0.05) 
between fresh and aged IgG2 samples with Tween 20 present below and 
above its CMC (Figure 5.30 A). 
For particle count data of size ≥ 10 µm, statistical analysis showed that the 
difference in count is significant at the 0.001 level (P<0.001) between fresh 
and heated and between fresh and aged IgG2 with Tween 20 present below 
CMC. The difference in count is significant at a 0.01 level (P<0.01) for IgG2 
samples with Tween 20 present at around its CMC. Also the mean difference 
in count is significant at the 0.01 level (P<0.01) between fresh and aged IgG2 
samples with Tween 20 present above its CMC. Figure 5.30 (B) illustrates 
these findings. 
For particle count data of size ≥ 25 µm, Bonferroni test analysis showed that 
the difference in particle count is statistically significant at the 0.001 level 
(P<0.001) between fresh and heated IgG2 samples with Tween 20 
concentrations below, around and above CMC and at a 0.01 level (P<0.01) 
between fresh and aged IgG2 samples with Tween 20 present at around 
CMC (Figure 5.30 C). 
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For particle count data of size ≥ 50 µm no statistical difference (P>0.05) was 
detected between fresh and aged samples of IgG2 with Tween 20 present at 
below CMC measurements. Post-hoc analysis showed a significant 
difference at 0.001 level (P<0.001) between the particle counts of fresh and 
heated IgG2 samples with Tween 20 at below and around CMC and 
significance at 0.01 level (P<0.01) was detected between fresh and heated, 
and fresh and aged samples with Tween 20 present above its CMC (Figure 
5.30 D). 
For particle count data of size ≥ 100 µm, heat stress showed a significant 
effect on particle count at the level of 0.01 level (P<0.01) for samples with 
Tween 20 below and above its CMC. No significant effect was detected by 
aging samples containing Tween 20 below and above its CMC (Figure 5.30 
E). 
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Figure 5.31.  Particle concentrations at size ranges of: (A) ≥ 2 µm, (B) ≥ 
10 µm, (C) ≥ 25 µm, (D) ≥ 50 µm and (E) ≥ 100 µm measured by MFI for 
fresh, heated and aged IgG2 with Tween 80 present below, around and 
above CMC. Data are expressed as the mean ± Std. Deviation. * P<0.05, 
** P<0.01, *** P<0.001; significant difference in particles per ml 
compared with fresh IgG2 with Tween 80 samples.  
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One-way ANOVA analysis, Bonferroni correction, showed a significant effect 
of heat stress on particle count for IgG2 samples with Tween 80 surfactant 
present at below, around and above CMC for particles ≥ 2 µm particle size. 
The difference in count was significant at 0.001 level (P<0.001) for samples 
containing Tween 80 below, around and above its CMC. The difference in 
count between fresh and aged samples containing Tween 80 below, around 
and above CMC was significant at the 0.01 level (P<0.01) (Figure 5.31 A). 
For particle count data of size ≥ 10 µm, statistical analysis showed that heat 
treatment had significant effect on particle count at the 0.001 level (P<0.001) 
for IgG2 samples with Tween 80 present below and around its CMC. For 
IgG2 samples with Tween 80 above its CMC the statistical difference was 
reduced to the 0.01 level (P<0.01) between fresh and heated samples. Aging 
of IgG2 with Tween 80 present at around and above CMC produced a 
significant effect at 0.001 level (P>0.001) on particle numbers compared to 
fresh samples (Figure 5.31 B). 
For particle count data of size ≥ 25 µm, Bonferroni test analysis showed that 
heat treatment had a statistically significant effect on particle count at the 
0.001 level (P<0.001)  for IgG2 samples with Tween 80 present at all levels 
tested. Aging had a statistically significant effect at 0.001 level on the particle 
count for samples with Tween 80 at around CMC and at a significance level 
of 0.01 for samples with Tween 80 present above CMC (Figure 5.31 C). 
For particle count data of size ≥ 50 µm no statistical difference (P>0.05) was 
detected between fresh and aged IgG2 with Tween 80 below and above 
CMC. Both heat treatment and aging had significant effects at the 0.01 level 
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(P<0.01) for IgG2 samples with Tween 80 at around its CMC concentration 
(Figure 5.31 D). 
For particle count data of size ≥ 100 µm, post-hoc test results showed that  
heat treatment has statistically significant effect on particle count at a 0.01 
level (P<0.01) for samples with Tween 80 around CMC and at a 0.05 level 
(P<0.05) for samples with Tween 80 present above CMC. Aging has no 
significant effect on particle count IgG2 with Tween 80 present at around and 
above CMC (Figure 5.31 E). 
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Figure 5.32.  Particle concentrations at size ranges of: (A) ≥ 2 µm, (B) ≥ 
10 µm, (C) ≥ 25 µm, (D) ≥ 50 µm and (E) ≥ 100 µm measured by MFI for 
fresh, heated and aged IgG2 with Brij 35 below, around and above CMC 
levels. Data are expressed as the mean ± Std. Deviation. * P<0.05, ** 
P<0.01, *** P<0.001; significant difference in particles per ml compared 
with fresh IgG2 with Brij 35 samples.  
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One-way ANOVA analysis, Bonferroni test data showed a significant effect of 
heat stress and aging on particle numbers ≥ 2 µm for IgG2 samples with Brij 
35 surfactant present at below, around and above CMC. Between fresh and 
heated IgG2 samples with Brij 35 present below and around CMC, the mean 
count difference was significant at the 0.001 level (P<0.001). The difference 
in count,  between fresh and aged IgG2 with Brij 35 present below and above 
CMC was significant at the 0.01 level (P<0.01) and for IgG2 with Brij 35 
present at around CMC a 0.001 level (P<0.001) significance was determined 
(Figure 5.32 A). 
For particle count data of size ≥ 10 µm particles, statistical analysis showed 
that the count difference is significant at a 0.001 level (P<0.001) between 
fresh and heated IgG2 samples with Brij 35 present at below and around 
CMC. Also between fresh and aged IgG2 samples with Brij 35 present at 
below and above CMC the difference in particle count was found to be  
significant at 0.001 level (P<0.001) (Figure 5.32 B). 
For particle count data of size ≥ 25 µm size range, Bonferroni test analysis 
showed that heat treatment effect on count is statistically significant at a 0.01 
level (P<0.01) for IgG2 samples with Brij 35 at around CMC and the effect is 
significant at a 0.001 level (P<0.001) for IgG2 samples with Brij 35 present at 
below, around and above CMC samples comparing to fresh ones. Aging 
treatment has a statistically significant effect at the 0.001 level (P<0.001) for 
IgG2 with Brij 35 present at around CMC (Figure 5.32 C).  
For particle count data of size ≥ 50 µm no statistical difference (P>0.05) was 
detected between fresh and heated and fresh and aged IgG2 with Brij 35 
present at levels below CMC. Heat treatment had a statistically significant 
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effect at the 0.01 level (P<0.01) for IgG2 samples with Brij 35 at around and 
above CMC. Aging had a significant effect at the 0.001 level (P<0.001) for 
samples with Brij 35 around CMC and at the 0.05 level (P<0.05) for samples 
containing Brij 35 above its CMC (Figure 5.32 D). 
For particle count data of size ≥ 100 µm statistical analysis showed no 
statistical difference (P>0.05) between fresh and heated IgG2 with Brij 35 at 
around its CMC. Aging samples produced a significant effect on count at the 
0.01 level (P<0.01) for samples of IgG2 with Brij 35 present at around CMC 
(Figure 5.32 E). 
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Figure 5.33.  Particle concentrations at size ranges of: (A) ≥ 2 µm, (B) ≥ 
10 µm, (C) ≥ 25 µm, (D) ≥ 50 µm measured by MFI for fresh, heated and 
aged IgG2 with Pluronic F-68 below, around and above CMC levels. 
Data are expressed as the mean ± Std. Deviation. * P<0.05, ** P<0.01, *** 
P<0.001; significant difference in particles per ml compared with fresh 
IgG2 with Pluronic F-68 samples.  
Figure 5.33 illustrates the effect of heat and aging treatments on IgG2 with 
Pluronic F-68 samples. 
For particle count data of size ≥ 2 µm particles size range, one-way ANOVA 
analysis,  Bonferroni test showed a significant difference at the 0.001 level 
(P<0.001) between fresh and heated samples of IgG2 with Pluronic F-68 
present at below, around and above CMC. The mean count difference was 
significant at the 0.001 level (P<0.001) between fresh and aged IgG2 
samples with Pluronic F-68 at around and above CMC and at the 0.01 level 
(P<0.01) for samples containing Pluronic F-68 below its CMC (Figure 5.33 
A). 
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For particle count data of size ≥ 10 µm, statistical analysis showed that the 
heat stress effect on particle count is statistically significant at 0.001 level 
(P<0.001) for IgG2 samples with Pluronic F-68 present at below, around and 
above CMC. Aging treatment had a statistically significant effect on count at 
0.01 level (P<0.01) for IgG2 samples with Pluronic F-68 above CMC and at 
0.001 level (P<0.001) for samples containing Pluronic F-68 at below and 
around CMC (Figure 5.33 B). 
For particle count data of size ≥ 25 µm and ≥ 50 µm  size Bonferroni test 
analysis showed that the difference in particle count is statistically significant 
at the 0.001 level (P<0.001) between fresh and heated IgG2 samples with 
Pluronic F-68 present below, around and above its CMC. No significant count 
difference was detected between samples of fresh and aged IgG2 with 
Pluronic F-68 present below, around and above CMC samples (Figure 5.33 
C and D). 
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5.5 General discussion 
 
Based on the results obtained from Light Obscuration (HIAC) and Micro-flow 
Imaging (MFI) analysis, heat treatment and storage stress showed a 
significant effect on BSA and IgG2 protein particle size stability.  
BSA surfactant free samples after storage treatment showed slightly higher 
numbers and statistically significantly different values of particles than those 
obtained after heat stress when compared to freshly prepared BSA.  Also 
both heat stress and storage treatments induced an increase in particle count 
per ml for IgG2 surfactant free samples at particle size ranges from ≥ 2 µm to 
≥ 10 µm. For particle count data of size ≥ 25 µm measured by both HIAC and 
MFI methods, heat treatment produced higher, more statistically significant 
increases in particle count, whereas storage showed no statistical difference 
at this size range for IgG2 surfactant free samples.  
Considering the effect of different surfactant type and concentration on BSA 
protein particle size stability as explored by HIAC and MFI experiments, all 
four surfactants at above their CMC produced a decrease in particle count of 
particles ≥ 2 µm. On heating and storage, Tween 80 at above its CMC, Brij 
35 at above its CMC and Pluronic F-68 at around and above its CMC showed 
the highest decrease in particle count of size ≥ 2 µm compared to BSA 
surfactant free samples.  
For particle count data of size ≥ 5 µm to ≥ 10 µm, the addition of the 
surfactant Brij 35 at around and above its CMC produced the lowest particle 
count level compared to the other surfactants and BSA surfactant free 
formulations. Very similar results were obtained for size ranges ≥ 25 µm, ≥ 50 
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µm and ≥ 100 µm. The use of surfactant Brij 35 at around and above its CMC 
is the most effective in bringing about a particle count decrease. 
According to results obtained from HIAC and MFI analysis for IgG2 samples, 
considering the ≥ 2 µm size range, the most effective surfactant was Brij 35 
above its CMC. This surfactant showed the highest decrease in particle count 
per ml after both heat and storages stress when compared to the other 
surfactants and IgG2 surfactant free samples. 
For particle count data of size ≥ 10 µm, Tween 20, Tween 80, Brij 35 and 
Pluronic F-68 at high CMC concentration effectively reduced the particle 
count per ml. For particle count data of size ≥ 25 µm, ≥ 50 µm and ≥ 100 µm 
the surfactant Brij 35 used above its CMC level showed the highest decrease 
in particle count after heating and storage. 
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Chapter 6 
General Discussion 
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6.1 General discussion 
 
The overall aim of this project was to identify improved methods of particle 
characterisation within protein formulations and enhance understanding of 
the mechanisms of particle formation.  
The development of liquid therapeutic protein drugs imposes the requirement 
of specific stabilisation agents to prevent protein aggregation in order to meet 
quality attributes and provide an acceptable drug shelf life for at least 2 years 
stored at 2-8°C. Non-ionic surfactants are used to avoid protein adsorption 
and the formation of protein aggregates. Depending on the protein and 
excipient used the stabilisation effect is quite different and cannot be 
predicted to date (Garidel et al., 2009). One reason for this is the lack of 
understanding of the process of particle formation and the influence of 
different surfactant type and concentration in relation to CMC and the 
consequent effect on protein stability and protein size stability.   
In this thesis Bovine serum albumin BSA and immunoglobulin IgG2 were 
studied in order to asses the effect of Tween 20, Tween 80, Brij 35 and 
Pluronic F-68 at concentrations below, around and above their CMC on the 
protein conformational stability and protein size stability. The selection of the 
proteins and the different levels of Tween 20, Tween 80, Brij 35 and Pluronic 
F-68 surfactants was reported in Chapters 1 and 2. 
In Chapter 3 the effect of Tween 20, Tween 80, Brij 35 and Pluronic F-68 
surfactants on conformational stability of BSA and IgG2 was investigated. 
Single protein-surfactant free and protein-surfactant solutions were examined 
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for thermal stability employing HSDSC. Thermal stability was assessed by 
both unfolding and re-folding experiments.  
Thermal unfolding experiments revealed that for surfactant free BSA (10 
mg/ml) a single unfolding peak at Tm of 66.91 ± 0.085°C was observed, 
which was similar to the published value of 67°C (Nishimura et al., 2001). 
Moreover, results showed that conformational stability of the protein BSA 
was dependent on Tween 20, Tween 80, Brij 35 and Pluronic F-68 
surfactants. The presence of the surfactants induced Tm to shift to lower 
unfolding temperatures for BSA, with the interactions of Brij 35 at a 
concentration around CMC being stronger compared to other types and level 
of surfactants.   
Thermal unfolding experiments for surfactant free immunoglobulin IgG2 (10 
mg/ml) showed two unfolding peaks, where Tm1 was 69.38 ± 0.057°C and 
Tm2 was at 77.53 ± 0.113°C, which is the result of the melting of two 
independent domains of immunoglobulin as described in Chapter 3, Section 
3.4.2. Two unfolding endotherms were previously reported (Tischenko et al., 
1998, Kravchuk et al.,1998,  Tischenko et al., 2003). 
Thermal unfolding experiments indicated a very weak surfactant-
immunoglobulin IgG2 interaction, compared to much stronger interactions for 
the bovine serum albumin-surfactant systems. However, the presence of Brij 
35 at a concentration below its CMC and Pluronic F-68 at a concentration 
around its CMC induced a shift in the unfolding transition Tm1 to lower 
temperatures. Similarly, the presence of Tween 80 below its CMC, Brij 35 
below and around its CMC and Pluronic F-68 at around it CMC induced the 
IgG2 unfolding temperature Tm2 to shift to a lower temperature. 
  
  254 
In general, thermal unfolding experiments for both BSA and IgG2 with 
surfactant systems revealed that the conformational stabilisation in BSA and 
IgG2 solutions was surfactant type and concentration dependent. The 
interactions between protein and surfactants have been previously studied by 
several workers including Putnam (1948), Steinhardt and Reynolds (1969), 
Jones et al. (1991), Ananthapadamanabhan (1993) and Vermeer and Norde 
(2000). The nature of the protein-surfactant interaction was reported to be 
very complex and it was emphasised that surfactant binding may lead to 
partial denaturation of proteins and sometimes even complete unfolding, but 
then again it depends on surfactant. In order to prevent such surfactant-
induced unfolding, better understanding of the binding characteristics is 
required. 
Experiments conducted to look at how the proteins refold in the presence of 
surfactants (Chapter 3), revealed that the transitions for BSA and IgG2 with 
all four surfactants were irreversible and no thermal transitions were noted on 
subsequent scans of the same samples after cooling. It has been previously 
reported that unfolded proteins can easily aggregate during the refolding 
process as they go through the various intermediate states. Thermally 
induced protein unfolding is often followed or accompanied by immediate 
aggregation due to exposure of the hydrophobic residues (Wang et al., 
2010). 
Experiments in Chapter 4 were designed to investigate how particle size 
distribution measurements as determined by Dynamic Light Scattering (DLS) 
were affected by the presence and concentration of Tween 20, Tween 80, 
Brij 35 and Pluronic F-68 surfactants in relation to surfactant CMC.  
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Additionally, heat treatment and storage effects on particle size distribution 
for different surfactant concentration were investigated.   
Dynamic Light Scattering (DLS) has been widely utilised in the area of 
protein characterisation, including bovine serum albumin (Adel et al. 2008) 
and immunoglobulin G (Ahrer et al. 2006, Bermundez and Forciniti 2004).  
Protein alone solutions of BSA and IgG2 as well as protein-surfactant 
combinations were employed. From DLS experimental data represented in 
Chapter 4, it had been observed that for fresh BSA – surfactant systems, the 
presence of Tween 20 at above CMC produced the lowest increase in 
particle diameter (nm) compared to other surfactants, whereas for IgG2 – 
surfactant systems, the presence of all surfactants brought an increase in 
particle size.  However the lowest increase was observed for Tween 80 at a 
concentration below and Pluronic F-68 at a concentration below their CMC. 
To establish the heat treatment stability of the samples, BSA alone and BSA 
– surfactant systems were heated at 66°C.  Solutions containing IgG2 alone 
and IgG2 – surfactant systems were heated to 60°C (Chapter 2, Section 
2.2.1) to promote stress change within the samples. It has been previously 
reported that heat treatment of BSA and IgG induces strong aggregation 
which results in precipitation of the proteins (Padlan, 1997, Vermeer and 
Norde, 2000). However, the presence of Tween 20 above its CMC and Brij 
35 above its CMC produced the highest relative decrease in particle size 
diameter of the BSA – surfactant systems.   For IgG2-surfactant systems, the 
presence of Pluronic F-68 at below and around its CMC, showed a 
decreased in diameter on heating compared to IgG2 alone and the other 
surfactant systems.  
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To establish the storage stability of the samples, both fresh samples of BSA 
and IgG2 alone and with the four surfactants present were stored for 8 weeks 
in the fridge (Chapter 2, Section 2.2.2). DLS results indicated that all BSA – 
surfactant systems on storage displayed larger sized particles.  The greatest 
increase in particle size diameter was observed for BSA in the presence of 
Tween 80 at around its CMC, Brij 35 below its CMC and Pluronic F-68 below 
and around itsCMC. Interestingly IgG2 – surfactant systems displayed a 
different behaviour. Only IgG2 systems with Tween 80 present below its 
CMC and Pluronic F-68 at around its CMC showed an increase in particle 
size with storage.  
Globally considering the data presented in Chapter 4, it can be said, that for 
both BSA and IgG2 alone the aggregate growth is much stronger than when 
certain surfactants at different concentrations are added to the systems. For 
the protein size stability of BSA in solution, results showed that the presence 
of Tween 20 above its CMC was preferable, because of the fewer aggregate 
formed for initial and heated BSA samples. Considering the data for initial 
IgG2 formulations; the presence of Tween 20 below its CMC and Pluronic F-
68 at around its CMC were preferable. In terms of minimising heat stress 
Pluronic F-68 below and around its CMC performed well. The presence of 
Tween 80 at below and Pluronic-68 at around its CMC gave the best 
performance in terms of lower particle growth for the aged samples of IgG2. 
Dynamic light scattering experiments revealed that particle formation strongly 
depends on surfactant type and concentration  The difference between the 
behaviour of BSA and IgG2 in this study, and the difference in the results for 
the different stress approaches in the presence of the surfactants samples 
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could be due to the fact, that either the CMC concentration of Tween 20, 
Tween 80, Brij 35 and Pluronic F-68 surfactants are not sufficient to stabilize 
or because the stress methods used: heating and storage are too rigorous to 
enable surfactants to exhibit there full stabilizing effect (Mahler et al., 2005). 
All four surfactants used in this study, namely Tween 20, Tween 80, Brij 35 
and Pluronic F-68, are non-ionic surfactants. The ability of a surfactant to 
participate in a specific biological/biochemical function is related to its 
structure. Non-ionic surfactants are characterised by uncharged hydrophilic 
head groups. These surfactants are mild and non-denaturating because they 
disrupt protein-lipid and lipid-lipid interactions. Short chain (i.e., C7 – C10) 
non-ionic surfactants are typically more deactivating than longer chain (i.e., 
C12 – C14) non-ionic surfactants (Seddon et al., 2004; le Maire et al., 2000). A 
pertinent question to ask is how is surfactant function in formulations affected 
by the structure of the hydrophobic group? The hydrophobic tail of a 
surfactant allows the molecule to partition into the apolar lipid bilayer during 
the solubilisation of membrane proteins. It also masks the hydrophobic 
portions of the membrane proteins once they have been solubilised and thus 
prevents protein aggregation. Although the hydrophilic head group and 
hydrophobic tail each affect the properties of the surfactant molecule 
differently. Together their total effect is known as the Hydrophilic-Lipophilic 
Balance (HLB), which is defined by a number that ranges from 0 to 40. In 
general, an HLB number <10 indicates that a surfactant has low solubility in 
water while an HLB number between 10 and 20 indicates that the detergent 
is readily soluble in water (Anatrace Inc., 2008). 
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The values of HLB for Tween 20, Tween 80, Brij 35 and Pluronic F-68 are 
shown in table 6.1. 
Table 6.1 Hydrophilic-Lipophilic Balance values for Tween 20, Tween 
80, Brij 35 and Pluronic F-68 surfactants (Anatrace, 2006; Griffin, 1954; 
Sigma Aldrich). 
Surfactant type HLB value 
Tween 20 16.7 
Tween 80 15 
Brij 35 16.9 
Pluronic F-68 29 
 
All four surfactants used in this work are conferred with a high HLB (greater 
than about 12) value and Tween 20, Tween 80, Brij 35 and Pluronic F-68 
surfactants are predominantly hydrophilic and water-soluble.  Trends relating 
HLB value to surfactant benefit in terms of protein size stabilisation are not 
readily discernable. 
Dynamic Light Scattering requires limited sample preparation and provides a 
relatively quick analysis time. However, the use of DLS often has to be 
combined with other analytical techniques as the higher sensitivity of the 
instrument to larger particles can make analysis of some solutions 
problematic. This is particularly so if larger particles or dust are present.  
In Chapter 5, the preliminary experimental work focussed on sub-visible 
particle count by employing Light Obscuration (HIAC) and Micro-Flow 
Imaging (MFI) measurements. In the recently published commentary, it was 
noted that there are critical gaps in the detection and control of sub-visible 
particles, especially in the size range from 0.1 µm to 10 µm and that it is 
important to be able to effectively monitor and control these particles during 
formulation development (Carpenter et al., 2008; Sharma et al., 2010).  In 
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Chapter 5, the effect of Tween 20, Tween 80, Brij 35 and Pluronic F-68 
surfactants at concentrations below, around and above their CMC level on 
BSA and IgG2 proteins’ size stability was investigated.  
Results showed that heat shock and storage treatment had a significant 
effect on particle formation of BSA and IgG2 surfactant free solutions. 
According to the results obtained from HIAC and MFI analysis in Chapter 5, 
BSA surfactant-free samples after storage treatment showed slightly higher 
and statistically significantly different particle counts and distribution than that 
after heat stress when compared to freshly prepared BSA. Also both heat 
stress and storage treatments induced an increase in particle count for IgG2 
surfactant free samples for particles of sizes ≥ 2 µm to ≥ 10 µm.  For particles 
≥ 25 µm, measured by both HIAC and MFI methods, heat treatment 
produced a statistically significant increase in particle count, whereas storage 
treatment showed no statistical difference at this size range for IgG2 
surfactant free samples. 
On considering the results obtained for the different surfactants on BSA and 
IgG2 protein particle size stability as explored by HIAC and MFI experiments, 
it can be noted, that the presence of Brij 35 at above its CMC was the most 
effective.  The high concentration of Brij 35 decreased particle count at all 
size ranges for fresh, heated and aged samples when compared to other 
surfactants and surfactant free systems of both proteins. However, this might 
be due to Brij 35 being in excess at high concentrations. Surfactant – protein 
ratio should be considered.  
In Chapter 5 BSA and IgG2 proteins were investigated by HIAC and MFI 
methods. It is prudent to compare the results obtained from the two methods.  
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Figures 6.1 and 6.2 present the comparative particle count data obtained for 
HIAC and MFI methods for fresh BSA and IgG2 solutions respectively. 
Results are reported as an average ± standard deviation.  
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Figure 6.1. Comparison of particle count per ml measured by HIAC and 
MFI methods for fresh BSA protein.  
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Figure 6.2. Comparison of particle count per ml measured by HIAC and 
MFI methods for fresh IgG2 protein.  
Both instruments were expected to show similar particle counts. However, 
from Figures 6.1 and 6.2, it can be seen, that generally Light Obscuration 
(HIAC) reported lower particle counts data than Micro-flow imaging, 
especially at the size range of ≥ 2 µm. It has been previously published by 
Demeule et al., 2010, Huang et al., 2009, Sharma et al., 2010, that Light 
Obscuration technique tended to report lower particle count numbers per ml 
than MFI (Demeule et al., 2010; Huan et al., 2009, Sharma et al., 2010). 
However both HIAC and MFI techniques showed similar trends regarding 
particle count values. Using statistical analysis the Pearson correlation test 
showed that there was no relationship between HIAC and MFI methods for 
BSA and IgG2 particle count per ml (P>0.05). However, there was a strong 
relationship at the 0.01 level (P<0.01) between the data obtained for the 
HIAC and MFI methods from the fresh and heated BSA-surfactant 
formulations for particles ≥ 2 µm. Pearson correlation analysis also showed 
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that there was a significant relationship at the 0.05 level (P<0.05) between 
the particle count data for particles ≥ 50 µm obtained by the two methods for 
aged BSA – surfactant systems.  For the particle count data for particles ≥ 25 
µm the same level of significance was determined between the two methods 
for initial and aged IgG2-surfactant systems. Figures 6.3 to 6.8 represent the 
scatter plots between HIAC and MFI for fresh, heated and aged BSA and 
IgG2 – surfactant systems for particle count data at ≥ 2 µm, ≥ 10 µm, ≥ 25 
µm and ≥ 50 µm.  
 
  ≥ 2 µm    ≥ 10 µm 
 
  ≥ 25 µm    ≥ 50 µm 
 
Figure 6.3. Scatter plots of particle count per ml at ≥ 2 µm, ≥ 10 µm, ≥ 25 
µm and ≥ 50 µm as measured by HIAC and MFI for fresh BSA – 
surfactant formulations.  
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Figure 6.4. Scatter plots of particle count per ml at ≥ 2 µm, ≥ 10 µm, ≥ 25 
µm and ≥ 50 µm as measured by HIAC and MFI for heated BSA – 
surfactant formulations.  
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Figure 6.5. Scatter plots of particle count per ml at ≥ 2 µm, ≥ 10 µm, ≥ 25 
µm and ≥ 50 µm measured by HIAC and MFI for aged BSA – surfactant 
formulations.  
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Figure 6.6. Scatter plots of particle count per ml at ≥ 2 µm, ≥ 10 µm, ≥ 25 
µm and ≥ 50 µm as measured by HIAC and MFI for fresh IgG2 – 
surfactant formulations.  
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Figure 6.7. Scatter plots of particle count per ml at ≥ 2 µm, ≥ 10 µm, ≥ 25 
µm and ≥ 50 µm as measured by HIAC and MFI for heated IgG2 – 
surfactant formulations.  
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Figure 6.8. Scatter plots of particle count per ml at ≥ 2 µm, ≥ 10 µm, ≥ 25 
µm and ≥ 50 µm as measured by HIAC and MFI for aged IgG2 – 
surfactant formulations.  
In recent studies, Huang et al., 2009 and Sharma et al., 2010, compared the 
sizing and counting accuracy of HIAC and MFI and found that while the two 
methods gave similar results, MFI detected significantly more particles than 
HIAC. Both articles considered that the difference in Light Obscuration and 
Micro-flow Imaging measurements might be due to the under-estimation of 
sub-visible particles by the light obscuration technique (Huang et al., 2009; 
Sharma et al., 2010). 
The different analytical methods applied in this thesis provide different 
aspects and insight into BSA and IgG2 conformational stability and protein 
size stability. The Tm value measured by High Sensitivity Differential 
Scanning calorimetry HSDSC was used as a stability indicator. DLS analysis 
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was used for detection of small sized aggregates in the range of 1 – 450 nm 
size. The Light Obscuration (HIAC) and Micro-flow Imaging (MFI) techniques 
were used in this study to detect large aggregates of 2 – 100 µm. The 
question is do these different methods have any relationship between each 
other? Does Tm predict particle formation measured by DLS, HIAC and MFI? 
Does level of small particle size measured by DLS predict levels of larger 
aggregates measured by HIAC and MFI? 
Statistical data analysis using Pearson Correlation (See Chapter 2, Section 
2.2.7) was used to describe the relationship between HSDSC temperature Tm 
and main peak diameter (nm) measured by DLS for fresh, heated and aged 
BSA and IgG2 surfactant systems (Figures 6.9, 6.10 and 6.11). 
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Figure 6.9. The Pearson Correlation Coefficient between HSDSC 
unfolding temperature Tm and main peak diameter (nm) measured by 
DLS for: (1) fresh, (2) heated and (3) aged BSA with Tween 20, Tween 
80, Brij 35 and Pluronic F-68 surfactants. 
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Figure 6.10. The Pearson Correlation Coefficient between HSDSC 
unfolding temperature Tm1 and main peak diameter (nm) measured by 
DLS for: (1) fresh, (2) heated and (3) aged IgG2 with Tween 20, Tween 
80, Brij 35 and Pluronic F-68 surfactants. 
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Figure 6.11. The Pearson Correlation Coefficient between HSDSC 
unfolding temperature Tm2 and main peak diameter (nm) measured by 
DLS for: (1) fresh, (2) heated and (3) aged IgG2 with Tween 20, Tween 
80, Brij 35 and Pluronic F-68 surfactants. 
The Pearson Correlation Coefficient was closest to +1.00 for heated BSA 
with Pluronic F-68 surfactant and aged BSA with Brij 35 and Pluronic F-68 
surfactant and was closest to -1.00 for heated BSA with Tween 80 (Figure 
6.9). Such values would denote the perfect linear relationship and that both 
variables rise and fall sympathetically. However for all fresh, heated and 
aged BSA – surfactants systems the statistical significance failed to meet the 
0.05 (P>0.05) criteria, and confirmed that temperature Tm measured by 
HSDSC and main peak diameter (nm) measured by DLS were uncorrelated 
(zero correlation).  
On analysing the correlation between IgG2 – surfactant systems Tm1 and 
main peak diameter, the Pearson Correlation Coefficient was found to be 
+0.992 for aged IgG2 with Pluronic F-68 surfactant (Figure 6.10). However, 
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for fresh, heated and aged IgG2 – surfactants systems the statistical 
significance failed to meet the 0.05 (P>0.05) criteria, and confirmed that 
temperature Tm1 and main peak diameter have zero correlation. 
There was no statistically significant relationship detected for IgG2 – 
surfactant system data between main peak diameter (nm) and temperature 
Tm2 (Figure 6.11), except aged IgG2 with Pluronic F-68 surfactant showed 
significance (P<0.05) between main peak diameter and temperature Tm2. 
The Pearson Correlation Coefficient was found to be +0.998, which tells us 
that both variables rise and fell sympathetically.  
In general, the results from statistical data analysis identified that Tm 
measured by HSDSC can not predict the formation of smaller particle size 
particles measured by DLS.  
To probe if there is any relationship between Tm and the particle count data 
at ≥ 2 µm, ≥ 5 µm, ≥ 10 µm, ≥ 25 µm and ≥ 50 µm size ranges measured by 
HIAC and MFI, a statistical data analysis using the Pearson correlation test 
was used to measure the “degree of linearity” and relationship between these 
variables.  
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Figure 6.12. The Pearson Correlation Coefficient measured between Tm 
(HSDSC) and particle count (HIAC) for fresh BSA with Tween 20, Tween 
80, Brij 35 and Pluronic F-68 surfactants at (1) ≥ 2 µm, (2) ≥ 5 µm, (3) ≥ 
10 µm, (4) ≥ 25 µm, (5) ≥ 50 µm and (6) ≥ 100 µm particle size ranges.  
The Pearson Correlation Coefficient was found to be -0.992 for fresh BSA 
with Brij 35 at ≥ 5 µm size range, -0.995 for Tween 80 at ≥ 25 µm particle 
size range. The magnitude of the coefficient was close to its maximum -1.00 
(which would denote a perfect relationship), however the significance value 
was greater than 0.05 (P>0.05), confirming that there was no relationship 
between Tm and particle count for these surfactants. The Pearson Correlation 
Coefficient was at -1.00 for fresh Tween 80 at ≥ 2 µm particle size range 
(Figure 6.12). The correlation between Tm and particle count for this 
surfactant is significant at the 0.05 level (P<0.05). For all other initial protein-
surfactant solutions, Tm measured by HSDSC and particle count measured 
by HIAC are uncorrelated (Figure 6.12). 
 
  
  273 
-1.5
-1
-0.5
0
0.5
1
1.5
0 1 2 3 4 5 6 7
Particle size range
P
e
a
rs
o
n
 C
o
rr
e
la
ti
o
n
 C
o
e
ff
ic
ie
n
t
Tween 20
Tween80
Brij 35
Pluronic F-68
 
Figure 6.13. The Pearson Correlation Coefficient measured between Tm 
(HSDSC) and particle count (HIAC) for heated BSA with Tween 20, 
Tween 80, Brij 35 and Pluronic F-68 surfactants at (1) ≥ 2 µm, (2) ≥ 5 µm, 
(3) ≥ 10 µm, (4) ≥ 25 µm, (5) ≥ 50 µm and (6) ≥ 100 µm particle size 
ranges.  
For samples of heated BSA with surfactant present, the Pearson Correlation 
Coefficient is found to be -0.999 for heated BSA with Brij 35 at ≥ 25 µm size 
range and +0.999 for heated BSA with Pluronic F-68 at ≥ 100 µm particle 
size range. The significance value for both of these examples were below 
0.05 (P<0.05). This indicates evidence that Tm and particle count at these 
cases are indeed correlated. For the remainder of the heated samples a 
significance value greater than 0.05 (P>0.05) was obtained and indicated 
zero correlation (Figure 6.13).   
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Figure 6.14. The Pearson Correlation Coefficient measured between Tm 
(HSDSC) and particle count (HIAC) for aged BSA with Tween 20, Tween 
80, Brij 35 and Pluronic F-68 surfactants at (1) ≥ 2 µm, (2) ≥ 5 µm, (3) ≥ 
10 µm, (4) ≥ 25 µm, (5) ≥ 50 µm and (6) ≥ 100 µm particle size ranges.  
For samples of aged BSA with surfactant present, the Pearson Correlation 
Coefficient is found to be +0.999 for aged BSA with Pluronic F-68 and 
particle count data at ≥ 50 µm particle size range. That tells us that in this 
case both variables: Tm and particle count rise and fall sympathetically and 
that the magnitude of the coefficient is very close to maximum of +1.00, 
which would denote a perfect relationship. The significance value was quoted 
as 0.026, which is below 0.05. This indicates that in this case the correlation 
between Tm and particle count is significant at 0.05 level (P<0.05). For all 
other surfactants at different size ranges the correlation coefficient was not 
close to -1.00 or +1.00, so that indicates zero correlation between Tm and 
particle count (Figure 6.14). 
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Statistical analysis, using Pearson correlation was used to describe the 
relationship between IgG2 unfolding temperatures Tm1, Tm2 measured by 
HSDSC and particle count data for particles of size ≥ 2 µm, ≥ 5 µm, ≥ 10 µm, 
≥ 25 µm and ≥ 50 µm measured by Light Obscuration. The Pearson 
Correlation Coefficient results for fresh, heated and aged IgG2 with Tween 
20, Tween 80, Brij 35 and Pluronic F-68 are summarised in Figures 6.15-
6.20. 
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Figure 6.15. The Pearson Correlation Coefficient measured between Tm1 
(HSDSC) and particle count (HIAC) for fresh IgG2 with Tween 20, Tween 
80, Brij 35 and Pluronic F-68 surfactants at (1) ≥ 2 µm, (2) ≥ 5 µm, (3) ≥ 
10 µm, (4) ≥ 25 µm, (5) ≥ 50 µm and (6) ≥ 100 µm particle size ranges.  
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Figure 6.16. The Pearson Correlation Coefficient measured between Tm2 
(HSDSC) and particle count (HIAC) for fresh IgG2 with Tween 20, Tween 
80, Brij 35 and Pluronic F-68 surfactants at (1) ≥ 2 µm, (2) ≥ 5 µm, (3) ≥ 
10 µm, (4) ≥ 25 µm, (5) ≥ 50 µm and (6) ≥ 100 µm particle size ranges.  
The Pearson Correlation Coefficient between Tm1, Tm2 and particle count 
was found to be +1.00 for fresh IgG2  with Tween 80 at ≥ 2 µm size range 
(Figures 6.15 and 6.16). The magnitude of the coefficient is at its maximum 
+1.00, which denotes a perfect relationship between Tm1 and particle count 
and Tm2 and particle count per ml. In this case both variables rise and fall 
sympathetically. And the significance value in both these cases quoted as 
0.003. This indicates very strong evidence that these variable are indeed 
correlated at the level of the 0.01 (P<0.01). The Pearson Correlation 
Coefficient for all other fresh IgG2 with different surfactants was less than -
1.00 or +1.00 and significance value was greater than 0.05 (P>0.05), so  
Tm1, Tm2 measured by HSDSC and particle count measured by HIAC in all 
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these cases was found to be statistically uncorrelated (Figures 6.15 and 
6.16). 
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Figure 6.17. The Pearson Correlation Coefficient measured between Tm1 
(HSDSC) and particle count (HIAC) for heated IgG2 with Tween 20, 
Tween 80, Brij 35 and Pluronic F-68 surfactants at (1) ≥ 2 µm, (2) ≥ 5 µm, 
(3) ≥ 10 µm, (4) ≥ 25 µm, (5) ≥ 50 µm and (6) ≥ 100 µm particle size 
ranges.  
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Figure 6.18. The Pearson Correlation Coefficient measured between Tm2 
(HSDSC) and particle count (HIAC) for heated IgG2 with Tween 20, 
Tween 80, Brij 35 and Pluronic F-68 surfactants at (1) ≥ 2 µm, (2) ≥ 5 µm, 
(3) ≥ 10 µm, (4) ≥ 25 µm, (5) ≥ 50 µm and (6) ≥ 100 µm particle size 
ranges.  
For samples of heated IgG2 with surfactants present, the Pearson 
Correlation Coefficient between Tm1 and particle count was found to be -1.00 
for heated IgG2 with Brij 35 for particles ≥ 10 µm size and at +1.00 for IgG2 
with Tween 80 for particles ≥ 100 µm (Figure 6.17). The significance value 
for these samples were below 0.05 (P<0.05). The coefficient between Tm2 
and particle count was found to be +1.00 for Tween 80 for particles ≥ 100 µm 
(Figure 6.18). This indicates evidence that Tm1 and particle count and Tm2 
and particle count at these cases are indeed correlated. For the remainder of 
the heated samples, no significant correlation was found between Tm1 and 
particle count nor between Tm2 and particle count (Figures 6.17 and 6.18).   
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Figure 6.19. The Pearson Correlation Coefficient measured between Tm1 
(HSDSC) and particle count (HIAC) for aged IgG2 with Tween 20, Tween 
80, Brij 35 and Pluronic F-68 surfactants at (1) ≥ 2 µm, (2) ≥ 5 µm, (3) ≥ 
10 µm, (4) ≥ 25 µm, (5) ≥ 50 µm and (6) ≥ 100 µm particle size ranges.  
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Figure 6.20. The Pearson Correlation Coefficient measured between Tm2 
(HSDSC) and particle count (HIAC) for aged IgG2 with Tween 20, Tween 
80, Brij 35 and Pluronic F-68 surfactants at (1) ≥ 2 µm, (2) ≥ 5 µm, (3) ≥ 
10 µm, (4) ≥ 25 µm, (5) ≥ 50 µm and (6) ≥ 100 µm particle size ranges.  
For samples of aged IgG2 with surfactant present, the Pearson Correlation 
Coefficient for Tm1 and particle count was found to be +0.999 for aged IgG2 
with Pluronic F-68 for particles sized ≥ 100 µm (Figure 6.19). The Pearson 
Coefficient between Tm2 and particle count was +1.00 for aged IgG2 with 
Pluronic F-68 present for particles ≥ 2 µm (Figure 6.20). In both these cases, 
the variables: Tm1, Tm2 and particle count rise and fall sympathetically and 
that the magnitude of the coefficient is very close to maximum of +1.00, 
which would denote a perfect relationship. The statistical value was 
determined as 0.026 between Tm1 and particle count, which is below 0.05. 
This indicates that in this case the correlation between Tm and particle count 
is significant at 0.05 level (P<0.05). 
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The statistical significance value obtained for the correlation between Tm2 
and particle count was 0.005, which indicated that the correlation between 
those two variables is significant at 0.01 level (P<0.01). For all other 
surfactants at any particle count size, the correlation coefficient was not close 
to -1.00 or +1.00 indicating  no correlation between Tm1, Tm2 and particle 
count (Figures 6.19 and 6.20). 
The results of statistical analyses using the Pearson correlation test for Tm 
measured by HSDSC and particle count per ml measured by MFI for 
particles of size  ≥ 2 µm, ≥ 10 µm, ≥ 25 µm, ≥ 50 µm and ≥ 100 µm for fresh, 
heated and aged BSA and IgG2 surfactant systems are presented in Figures 
6.21-6.29. 
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Figure 6.21. The Pearson Correlation Coefficient measured between Tm 
(HSDSC) and particle count (MFI) at (1) ≥ 2 µm, (2) ≥ 10 µm, (3) ≥ 25 µm, 
(4) ≥ 50 µm and (5) ≥ 100 µm particle size ranges for fresh BSA with 
Tween 20, Tween 80, Brij 35 and Pluronic F-68 surfactant.  
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The Pearson Correlation Coefficient between Tm and particle count of 
particles size ≥ 10 µm was found to be -0.999 for fresh BSA with Pluronic F-
68 present. The magnitude of the coefficient is close to its maximum -1.00, 
which denotes a perfect relationship between Tm and particle count 
measured by MFI, and the correlation is significant at the 0.05 level (P<0.05). 
The significance value for all other surfactants and counts of different particle 
size ranges was greater than 0.05 (P>0.05), and thus there was not 
significant (Figure 6.21). 
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Figure 6.22. The Pearson Correlation Coefficient measured between Tm 
(HSDSC) and particle count (MFI) for heated BSA with Tween 20, Tween 
80, Brij 35 and Pluronic F-68 surfactants at (1) ≥ 2 µm, (2) ≥ 10 µm, (3) ≥ 
25 µm, (4) ≥ 50 µm and (5) ≥ 100 µm particle size ranges.  
For heated BSA with surfactant samples, the Pearson Correlation Coefficient 
is found to be -1.00 for heated BSA with Brij 35 at the ≥ 2 µm size range and 
-1.00 for heated BSA with Tween 80 at the ≥ 10 µm particle size range. The 
significance value for heated BSA with Brij 35 was below 0.01 level (P<0.01) 
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and for heated BSA with Tween 80 was below 0.05 level (P<0.05). Tm and 
particle count in these cases are indeed correlated. For the remainder of  the 
heated samples no significant correlation was found (Figure 6.22).   
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Figure 6.23. The Pearson Correlation Coefficient measured between Tm 
(HSDSC) and particle count (MFI) for aged BSA with Tween 20, Tween 
80, Brij 35 and Pluronic F-68 surfactants at (1) ≥ 2 µm, (2) ≥ 10 µm, (3) ≥ 
25 µm, (4) ≥ 50 µm and (5) ≥ 100 µm particle size ranges.  
For aged BSA with surfactant samples, the Pearson Correlation Coefficient is 
found to be -0.998 for aged BSA with Brij 35 and at +1.00 for aged BSA with 
Pluronic F-68 at the ≥ 25 µm particle size range, and at +0.999 for aged BSA 
with Pluronic F-68 at ≥ 100 µm particle size range (Figure 6.23).. The 
significance value was determined to be 0.036 for Brij 35 at ≥ 25 µm size 
range and 0.026 for Pluronic F-68 at ≥ 100 µm particle size range, which are 
below 0.05. This indicates that in these cases the correlation between Tm and 
particle count is significant at the 0.05 level (P<0.05). The significance value 
quoted as 0.008 for aged BSA with Pluronic F-68 at ≥ 25 µm, which indicated 
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that correlation is significant at the 0.01 level (P<0.01). No other significant 
correlations were found for this system between Tm and particle count 
measured by MFI (Figure 6.23). 
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Figure 6.24. The Pearson Correlation Coefficient measured between Tm1 
(HSDSC) and particle count (MFI) for fresh IgG2 with Tween 20, Tween 
80, Brij 35 and Pluronic F-68 surfactants at (1) ≥ 2 µm, (2) ≥ 10 µm, (3) ≥ 
25 µm, (4) ≥ 50 µm and (5) ≥ 100 µm particle size ranges.  
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Figure 6.25. The Pearson Correlation Coefficient measured between Tm2 
(HSDSC) and particle count (MFI) for fresh IgG2 with Tween 20, Tween 
80, Brij 35 and Pluronic F-68 surfactants at (1) ≥ 2 µm, (2) ≥ 10 µm, (3) ≥ 
25 µm, (4) ≥ 50 µm and (5) ≥ 100 µm particle size ranges.  
The Pearson Correlation Coefficient between Tm1 and particle count 
measured by MFI, at the various sizes was found to be +1.00 for fresh IgG2 
with Tween 20 at the ≥ 2 µm size range (Figure 6.24). The magnitude of the 
coefficient is at its maximum +1.00, which denotes a perfect relationship 
between Tm1 and particle count. The Correlation Coefficient between Tm2 
and particle count was found to be -0.998 for fresh IgG2 with Tween 20 at ≥ 2 
µm size range (Figure 6.25).  In this case both variables rise and fall 
sympathetically. The significance value determined for Tm1 with particle 
count was 0.009. This indicates very strong evidence that these variables are 
indeed correlated at the level of the 0.01 (P<0.01). The Pearson Correlation 
Coefficient for all other fresh IgG2 with different surfactants was less than -
1.00 or +1.00 and the significance value was greater than 0.05 (P>0.05), so  
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Tm1, Tm2 measured by HSDSC and particle count measured by MFI in these 
cases were uncorrelated (Figures 6.24 and 6.25). 
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Figure 6.26. The Pearson Correlation Coefficient measured between Tm1 
(HSDSC) and particle count (MFI) for heated IgG2 with Tween 20, Tween 
80, Brij 35 and Pluronic F-68 surfactants at (1) ≥ 2 µm, (2) ≥ 10 µm, (3) ≥ 
25 µm, (4) ≥ 50 µm and (5) ≥ 100 µm particle size ranges.  
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Figure 6.27. The Pearson Correlation Coefficient measured between Tm2 
(HSDSC) and particle count (MFI) for heated IgG2 with Tween 20, Tween 
80, Brij 35 and Pluronic F-68 surfactants at (1) ≥ 2 µm, (2) ≥ 10 µm, (3) ≥ 
25 µm, (4) ≥ 50 µm and (5) ≥ 100 µm particle size ranges.  
For heated IgG2 with surfactant samples, the Pearson Correlation Coefficient 
between Tm1 and particle count per ml was found to be +1.00 for heated 
IgG2 with Tween 20 at ≥ 10 µm size range and +0.999 for IgG2 with Tween 
80 and particle count data  ≥ 100 µm (Figure 6.26). The significance values 
for these samples were below 0.05 (P<0.05). The coefficient between Tm2 
and particle count was found to be -0.998 for Tween 20 at ≥ 10 µm, +1.00 for 
Pluronic F-68 at ≥ 50 µm and +0.999 for Tween 80 at ≥ 100 µm particle size 
range (Figure 6.27). The findings indicate that Tm1 and particle count and 
Tm2 and particle count are indeed correlated. For the other heated samples 
no significant correlation was found between Tm1 and particle count, or Tm2 
and particle count (Figures 6.26 and 6.27).  
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Figure 6.28. The Pearson Correlation Coefficient measured between Tm1 
(HSDSC) and particle count (MFI) for aged IgG2 with Tween 20, Tween 
80, Brij 35 and Pluronic F-68 surfactants at (1) ≥ 2 µm, (2) ≥ 10 µm, (3) ≥ 
25 µm, (4) ≥ 50 µm and (5) ≥ 100 µm particle size ranges. 
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Figure 6.29. The Pearson Correlation Coefficient measured between Tm2 
(HSDSC) and particle count (MFI) for aged IgG2 with Tween 20, Tween 
80, Brij 35 and Pluronic F-68 surfactants at (1) ≥ 2 µm, (2) ≥ 10 µm, (3) ≥ 
25 µm, (4) ≥ 50 µm and (5) ≥ 100 µm particle size ranges. 
For aged IgG2 with surfactant samples, the Pearson Correlation Coefficient 
for Tm1 and particle count and for Tm2 and particle count is found to be +1.00 
for aged IgG2 with Tween 80 particle count at ≥ 2 µm and at ≥ 10 µm 
(Figures 6.28 and 6.29). The significance values were below 0.01, which 
indicates that the correlation between Tm and particle count is significant at 
0.01 level (P<0.01). 
The significance value between Tm2 and particle count was 0.005, which 
indicated that correlation between those two variables is significant at 0.01 
level (P<0.01). For all other surfactants conditions the correlation coefficient 
was not close to -1.00 or +1.00, and so that indicated no significant 
correlation between Tm1, Tm2 and particle count (Figures 6.28 and 6.29). 
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To investigate if formation of larger aggregates measured by HIAC and MFI 
comply with the results of smaller particles measurements by DLS, the 
Pearson Correlation statistical test was once again employed. Tables 6.2 – 
6.5 present the results of Pearson Correlation Coefficient measured between 
main peak measured by DLS and different size range measured by HIAC 
and MFI for fresh, heated and aged BSA and IgG2 surfactant systems. 
Table 6.2. Pearson Correlation Coefficient measured between main 
peak diameter (nm) (DLS) and particle count per ml (HIAC) for fresh, 
heated and aged BSA samples.  
BSA 
samples 
≥ 2 µm ≥ 5 µm ≥ 10 µm ≥ 25 µm ≥ 50 µm 
Fresh 0.017 -0.149 -0.233 -0.245 0.263 
Heated 0.022 0.202 -0.159 0.519 0.478 
Aged 0.062 -0.178 0.502 0.519 0.336 
 
Table 6.3. Pearson Correlation Coefficient measured between main 
peak diameter (nm) (DLS) and particle count per ml (MFI) for fresh, 
heated and aged BSA samples.  
BSA 
samples 
≥ 2 µm ≥ 10 µm ≥ 25 µm ≥ 50 µm 
Fresh -0.137 0.490 0.000 -0.270 
Heated -0.147 0.311 0.241 0.845 
Aged 0.363 -0.016 -0.409 -0.269 
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Table 6.4. Pearson Correlation Coefficient measured between main 
peak diameter (nm) (DLS) and particle count per ml (HIAC) fresh, heated 
and aged IgG2 samples. (*) – Pearson Correlation is significant at 0.05 
level (P<0.05). 
IgG2 
samples 
≥ 2 µm ≥ 5 µm ≥ 10 µm ≥ 25 µm ≥ 50 µm 
Fresh -0.054 -0.328 -0.418 -0.266 -0.325 
Heated -0.171 -0.465 -0.157 -0.146 0.056 
Aged 0.573* 0.146 -0.095 -0.011 0.377 
 
Table 6.5. Pearson Correlation Coefficient measured between main 
peak diameter (nm) (DLS) and particle count per ml (MFI) for fresh, 
heated and aged IgG2 samples. (*) – Pearson Correlation is significant 
at 0.05 level (P<0.05). 
IgG2 
samples 
≥ 2 µm ≥ 10 µm ≥ 25 µm ≥ 50 µm 
Fresh 0.380 0.040 -0.109 - 
Heated 0.052 -0.110 0.235 0.189 
Aged 0.679* 0.531 0.085 -0.137 
 
The Pearson Correlations Coefficient results presented in tables 6.2-6.5 
indicated that formation of small aggregates measured by Dynamic Light 
Scattering does not correlate statistically with the results of sub-visible 
particle analysis. Only the relationship between main peak diameter (DLS) 
and particle count per ml (HIAC and MFI) particle count of size ≥ 2 µm for  
HIAC and MFI for aged IgG2 samples was significant at the 0.05 level 
(P<0.05) (Table 6.4 and 6.5; Figure 6.30 and 6.31). 
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Figure 6.30. Scatter plot for aged IgG2 samples between main peak 
diameter (nm) (DLS) and particle count per ml (HIAC) at ≥ 2 µm size 
range using Pearson correlation test.  
 
Figure 6.31. Scatter plot for aged IgG2 samples between main peak 
diameter (nm) (DLS) and particle count per ml (MFI) at ≥ 2 µm size range 
using Pearson correlation test. 
Summing up, all the methods used in this thesis are suitable as screening 
methods for proteins formulation studies, because they are reproducible and 
require small volumes of protein material. However, as it was reported by 
Mahler et al. (2005), a single technique is not sufficient to describe the 
aggregation process completely, due to the different particle sizes of 
aggregated protein (Mahler et al., 2005). The exclusive use of Dynamic Light 
Scattering analysis may even result in invalid conclusions regarding protein 
size stability. In order to analyse the amount and size of induced aggregation 
products, a combination of different, but complementary analytical techniques 
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such as HSDSC, DLS, HIAC and MFI measurements can be used in order to 
assess the extent of aggregation and different size of protein aggregates. 
However, further evaluations of other methods should be taken into 
consideration.  
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Chapter 7 
General Conclusions and Recommendations for 
Future Research 
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7.1 General Conclusions 
 
A constant challenge in the development of biopharmaceutical products is 
the phenomenon generally known as protein aggregation. In order to control 
protein aggregation, it is important to understand the cause of aggregate 
formation, and to apply appropriate analytical methods. Due to the variety of 
aggregated species, a major challenge for the analysis of protein particles is 
that no single analytical method exists to cover the entire size range and type 
in which particles may appear (Mahler et al., 2009). 
Therefore, the overall aim of this project was to identify improved methods of 
particle characterisation and enhance understanding the mechanisms of their 
formation in biopharmaceutical formulations. 
Bovine serum albumin BSA and immunoglobulin IgG2 were studied in order 
to assess the effect of Tween 20, Tween 80, Brij 35 and Pluronic F-68 below, 
around and above CMC levels on protein conformational stability and size 
stability.  
In Chapter 3 thermal unfolding experiments employing HSDSC method 
showed that for surfactant free BSA single unfolding peak at Tm of 66.91 ± 
0.085°C was observed, which was similar to the published value of 67°C 
(Nishimura et al., 2001). Also the presence of all four surfactants induced the 
Tm shifts to lower unfolding temperatures for BSA protein. Considering the 
effect of all four surfactants, Brij 35 at around CMC produced slightly stronger 
interactions with BSA. 
For surfactant free IgG2 – two unfolding peaks at Tm1=69.38 ± 0.057°C and 
Tm2=77.53 ± 0.113°C were determined. Similar unfolding temperature values 
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for IgG2 were previously reported by Tischenko et al., (1998), Kravchuk et 
al., (1998), Tischenko et al., (2003). 
To the best of the authors’ knowledge, our study is the most extensive study 
of the effect of a range of surfactants and range of concentrations on protein 
Tm. The results showed that the presence of any surfactant at different 
concentrations with immunoglobulin IgG2 was negligible. No notable 
changes of the Tm1 and Tm2 were observed.  
Thermal unfolding experiments indicated a very weak surfactant-
immunoglobulin IgG2 interaction, compared to much stronger interactions for 
the bovine serum albumin-surfactant systems. These results are consistent 
with published results by Garidel et al., (2009), who found out that the binding 
of some of the surfactants we employed on IgG2 are negligible. Also weak 
binding of some surfactants has been confirmed by fluorescence 
spectroscopic measurements done by Hoffman, 2007 (Hoffman, 2007).   
Refolding experiments revealed that the transitions for BSA and IgG2 with all 
the surfactants were irreversible and no thermal transitions were noted on 
subsequent scans of the same samples after cooling. A different 
experimental design may have produced different results. 
In Chapter 4 the role of surfactant type and concentration on BSA and IgG2 
size stability as assessed by Dynamic Light Scattering was investigated. The 
DLS measurements revealed that BSA with IgG2 with the surfactants at 
below, around and above CMC concentrations produced different levels of 
particle size growth. The reported size of native BSA is 7.83 nm (Yu et al, 
2011), which is similar to the 7.69 nm obtained for freshly prepared BSA for 
this study. BSA with added Tween 20, Tween 80 and Brij 35 surfactants at all 
  
  297 
concentrations and Pluronic F-68 at below and above its CMC, yielded 
trimodal distributions with the main peak consistently around 8 nm diameter.  
DLS results for fresh samples of IgG2 surfactant free produced a bimodal 
distribution with a main peak at 14.44 nm diameter, which is significantly 
higher than the 10 nm reported for native IgG (Song et al., 2001, Bermundez 
et al., 2004). However the IgG2 is not the same variant. DLS measurements 
for the IgG2 in the presence of all four nonionic surfactants produced a low 
increase in particle size.  
To establish the heat treatment stability of the samples, BSA alone and BSA 
– surfactant systems were heated at 66°C and IgG2 alone, IgG2 – surfactant 
systems were heated at 60°C (Chapter 2, Section 2.2.1) to promote changes 
within the samples. It has been previously reported that heat treatment of 
BSA and IgG induces strong aggregation which results in precipitation of the 
proteins (Padlan, 1997, Vermeer and Norde, 2000). However, in the 
presence of Tween 20 above CMC and Brij 35 above CMC significant 
decreases in particle size diameter for BSA – surfactant systems were 
observed. For IgG2-surfactant systems, Pluronic F-68 at concentrations 
below and around its CMC, yielded decreases in diameter compared to IgG2 
alone and other surfactant systems.  
To establish the storage stability of the samples, both fresh samples of BSA 
and IgG2 alone and proteins with Tween 20, Tween 80, Brij 35 and Pluronic 
F-68 surfactants were stored refrigerated at 4°C for 8 weeks (Chapter 2, 
Section 2.2.2) to promote changes within the samples. DLS data for all BSA 
– surfactant systems displayed particle growth.  The greatest increase in 
particle size diameter was observed for BSA samples with Tween 80 at 
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around its CMC, Brij 35 at below CMC and Pluronic F-68 at below and 
around its CMC. For IgG2 – surfactant systems an opposing effect was 
observed in that only IgG2 systems with Tween 80 present below its CMC 
and Pluronic F-68 at around its CMC showed an increase in particle size. 
Compared to BSA, IgG2 did not aggregate as readily under storage 
conditions. Storage and heat stress bears the potential to generate 
aggregates and particles, but this depends on protein and surfactant type 
and concentration (Schmidt, 2009).  
The use of DLS often has to be combined with other analytical techniques 
with higher sensitivity for measuring larger particles.  
In Chapter 5 the role of surfactant type and level on BSA and IgG2 protein 
size stability as assessed by HIAC and MFI was investigated. As was the 
case for the DLS measurements, for sub-visible particle measurements by 
HIAC and MFI the effect of heat treatment and storage stress were 
assessed. Heat treatment and storage stress showed a significant effect on 
BSA and IgG2 protein particle size stability. BSA surfactant free samples on 
storage treatment showed statistically different numbers and sizes of 
particles than those obtained after heat stress when compared to freshly 
prepared BSA.  Also both heat stress and storage treatments induced an 
increase in particle count per ml for IgG2 surfactant free samples at particle 
size ranges from ≥ 2 µm to ≥ 10 µm. For particle count data of size ≥ 25 µm 
measured by both HIAC and MFI methods, heat treatment produced higher, 
more statistically significant increases in particle count, whereas storage 
showed no statistical difference at this size range for IgG2 surfactant free 
samples.  
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Considering the effect of different surfactant type and concentration on BSA 
protein particle size stability as explored by HIAC and MFI experiments, all 
four surfactants at above their CMC produced a decrease in particle count of 
particles ≥ 2 µm. On heating and storage, Tween 80 at above its CMC, Brij 
35 at above its CMC and Pluronic F-68 at around and above its CMC showed 
the highest decrease in particle count of size ≥ 2 µm compared to BSA 
surfactant free samples.  
For particle count data of size ≥ 5 µm and ≥ 10 µm, the addition of the 
surfactant Brij 35 at around and above its CMC produced the lowest particle 
count level compared to the other surfactants and BSA surfactant free 
formulations. Very similar results were obtained for size ranges ≥ 25 µm, ≥ 50 
µm and ≥ 100 µm. The use of surfactant Brij 35 at around and above its CMC 
is the most effective in bringing about a particle count decrease. 
According to results obtained from HIAC and MFI analysis for IgG2 samples, 
considering the ≥ 2 µm size range, the most effective surfactant was Brij 35 
above its CMC. This surfactant showed the highest decrease in particle count 
per ml after both heat and storages stress when compared to the other 
surfactants and IgG2 surfactant free samples. 
For particle count data of size ≥ 10 µm, Tween 20, Tween 80, Brij 35 and 
Pluronic F-68 at high CMC concentration effectively reduced the particle 
count per ml. For particle count data of size ≥ 25 µm, ≥ 50 µm and ≥ 100 µm 
the surfactant Brij 35 used above its CMC level showed the highest decrease 
in particle count after heating and storage. 
The difference in sub-visible particle counts between the different type of 
surfactants and their CMC levels may suggest that either the concentration of 
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surfactants in the formulation was not capable in stabilizing the protein 
against the induction of aggregates via heat treatment and storage stress, or 
that aggregation caused by these stresses can not be completely prevented 
by Tween 20, Tween 80, Brij 35 and Pluronic F-68 surfactants (Mahler et al., 
2005). 
Also it was shown in previous studies that sub-visible particle count 
measured by HIAC and MFI increases in the presence of different types of 
stresses (Sluzky et al., 1991; Mahler et al., 2005; Sharma et al., 2010; 
Demeule et al., 2010). It is difficult to compare data in this thesis to the data 
published in these papers because the authors in the above publications 
have used different proteins and different surfactants to our study.  However 
the work in this thesis adds to the body of work that surfactant protein effects 
on particle formation are difficult to predict.  Additionally, different stresses 
were used in the above publications, including shear stress, horizontal 
shaking and stirring and thus the nature of particle formation will be affected 
by the type of stress as shown in this thesis too. Data from HIAC and MFI 
instruments were expected to be consistent in particle count measurements 
for each of the BSA and IgG2 surfactant formulations. However Light 
Obscuration (HIAC) reported lower particle count than Micro-flow Imaging 
(MFI), especially for the particle count at ≥ 2 µm size range. The lower 
particle count per ml measured by HIAC than MFI has been previously 
reported in recent publications (Demeule et al., 2010; Huan et al., 2009; 
Sharma et al., 2010). In Chapter 6 statistical analysis using Pearson 
Correlation test showed no strong relationship between HIAC and MFI 
methods (P>0.05) confirming the above. However, there was a strong 
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relationship at the 0.01 level (P<0.01) between the data obtained for the 
HIAC and MFI methods from the fresh and heated BSA-surfactant 
formulations for particles ≥ 2 µm. Pearson correlation analysis also showed 
that there was a significant relationship at the 0.05 level (P<0.05) between 
the particle count data for particles ≥ 50 µm obtained by the two methods for 
aged BSA – surfactant systems  
In recent studies, Huang et al., 2009 and Sharma et al., 2010, compared the 
sizing and counting accuracy of HIAC and MFI and found that while the two 
methods gave similar results, MFI detected significantly more particles than 
HIAC. These authors considered that such difference in Light Obscuration 
and Micro-flow Imaging measurements might be due to the under-estimation 
of sub-visible particles by the light obscuration technique (Huang et al., 2009; 
Sharma et al., 2010).  The results in this thesis would support their findings. 
The different analytical methods applied in this thesis provide different 
aspects and insight into BSA and IgG2 conformational stability and protein 
size stability. The Tm value measured by High Sensitivity Differential 
Scanning calorimetry HSDSC was used as a stability indicator for proteins. 
DLS analysis was used for detection of small sized aggregates in the range 
of 1 – 450 nm size. The Light Obscuration (HIAC) and Micro-flow Imaging 
(MFI) techniques were used in this study to detect large aggregates of 2 – 
100 µm. 
One aim of the thesis was to explore the relationship between the different 
analytical approaches.  For example, is the surfactant effect on thermal 
unfolding predictive of sub-micron particle formation detected by DLS or sub-
visible particle formation as determined by HIAC and MFI methods?  Or 
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indeed is DLS data predictive of larger particle formation (HIAC and MFI) on 
stressing formulations? It was hoped that where such correlations exist 
mechanistic insight into aggregation would be forthcoming. In Chapter 6 
statistical analysis via measurement of the Pearson correlation coefficient 
was applied in correlating the results from each method to obtain the 
relationship between HSDSC, DLS, HIAC and MFI measurements. Statistical 
analysis results revealed that Tm measured by HSDSC can not predict the 
smaller particle size formation as measured by DLS since there was no 
statistically significant correlation. 
Statistical analysis of the relationship between HSDSC and HIAC 
measurements in a few cases showed a reliable correlation. HSDSC 
measurements were correlated at the 0.05 significance level (P<0.05) with 
HIAC measurements of particle count for particles of size ≥ 25 µm for heated 
BSA samples with Brij 35 and particle count for particles of size ≥ 100 µm for 
BSA samples with Pluronic F-68 and particle count for particles of size ≥ 50 
µm for aged BSA samples with Pluronic F-68. 
Pearson correlation test results indicated that there was a relationship 
significant at the 0.01 level (P<0.01) between unfolding temperatures and 
particle count measured by HIAC for fresh IgG2 with Tween 80 for particles 
sized ≥ 2 µm. Likewise, a significant relationship at the 0.05 level (P<0.05) 
was found for heated IgG2 with Brij 35 present for particles ≥ 10 µm and also 
with Tween 80 present for particles ≥ 100 µm.  For aged IgG2 surfactant 
systems, unfolding temperature and particle count per ml as measured by 
HIAC was correlated at the 95% level: between Tm1 and particle count per ml 
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for particles sized ≥ 100 µm, and similarly for IgG2 with Pluronic F-68 present 
between Tm2 and particle count for particles sized ≥ 2 µm. 
Also statistical analysis showed an excellent linear relationship between 
HSDSC data and MFI count measurements for particles sized ≥ 10 µm for 
fresh BSA with Pluronic F-68 present. A similar correlation was found 
between Tm and particle count data of particles ≥ 2 µm for heated BSA with 
Brij 35 present and for particle count data of particles ≥ 10 µm for heated 
BSA with Tween 80. The Pearson correlation test showed excellent 
relationships between HSDSC data and MFI count measurements for 
particles sized ≥ 25 µm size range for aged BSA with Brij 35 or Pluronic F-68 
present.  A similar correlation was found between Tm and particle count data 
of particles sized ≥ 100 µm for aged BSA with Pluronic F-68. 
The relationship between HSDSC and MFI measurements was significant at 
0.01 level (P<0.01) for fresh IgG2 samples with Tween 20 present and 
particle count data for particle size ≥ 2 µm and for aged IgG2 with Tween 80 
present and particle count data for particle size ≥ 2 µm and ≥ 10 µm.  
The same relationship was significant at 0.05 level (P<0.05) for heated IgG2 
with Tween 20 present for size data ≥ 10 µm and Tween 80 size data ≥ 100 
µm. 
Pearson correlation coefficient results calculated for relationship between 
DLS and HIAC and MFI, indicated that the size of small aggregates 
measured by DLS is not generally predictive of the initial results obtained 
from  sub-visible particle analysis (HIAC and MFI) or on stressing. Only the 
relationship between main peak diameter (DLS) and particle count per ml 
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(HIAC and MFI) particle count of size ≥ 2 µm for  HIAC and MFI for aged 
IgG2 samples was significant at the 0.05 level (P<0.05).  
In summary, this project was able to analyse the role of different surfactant 
type and level on protein conformational stability as assessed by HSDSC and 
on protein size stability as assessed by DLS, HIAC and MFI under heat 
treatment and storage conditions.  To the best of the authors’ knowledge this 
is the first such systematic study.  It can be concluded that each protein will 
interact differently with each surfactant and that the type and concentration of 
surfactant is important for the level of particle formation and effect on 
conformational stability.  Whilst sporadic correlations existed no global 
relationships could be determined between Tm and size data and between 
DLS data and sub-visible count data.  As such from the data presented in this 
thesis no clear mechanistic insights are readily apparent as to the links 
between small aggregates and sub-visible particles and between 
conformational thermal stability and sub-visible particulate formation. This 
first systematic comparison of four structurally different surfactants on particle 
formation for BSA and IgG2 may lead to other systems being explored with 
the result that such mechanistic insights may be determined.  
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7.2 Recommendations for future research 
 
As a result of conducting the experiment in this project, possibilities and 
ideas for further research arose: 
The HSDSC unfolding temperature measurements carried out in chapter 3 
could be improved by extending the range of nonionic surfactants employed.  
Chapters 3, 4 and 5 clearly indicated that BSA and IgG2 interact differently 
towards the surfactants. It would therefore be desirable to extend the range 
of proteins and monoclonal antibodies studied. It would also be useful to 
include ionic surfactants as an alternative to the non-ionic excipients used in 
this work. 
The stress conditions in chapters 4 and 5 made it possible to determine the 
effects of heat treatment and storage on the stability of the protein-surfactant 
systems. It would seem important to repeat the experiments under different 
stress conditions such as shaking, stirring, thermal, UV and fluorescence 
light. It might be useful to characterize extensively particulates before, during 
and after the addition of the surfactants. The range and length of storage 
conditions could be extended. 
In chapter 5 HIAC and MFI techniques gave different results of particle 
growth for BSA and IgG2 surfactant systems. This difference is worthy of 
further investigation. 
All methods used in this project have their own advantages and 
disadvantages, there is no “gold standard method” for the analysis of proteins 
aggregates due to the complexity of the subject. Therefore it would be very 
useful to employ Nanoparticle Tracking Analysis (NTA) technique to compare 
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it with Dynamic Light Scattering (DLS). Also more techniques of measuring 
sub-visible particles in solutions, such additional techniques of measuring 
aggregates in solutions, such as Size Exclusion Chromatography (SEC) and 
Taylor Dispersion Analysis may be useful.  
Experiments could also explore the formation of visible particles and 
appropriate methods such as filtration and staining techniques for visible 
particle characterization. The links between sub-visible and visible particle 
formation could be explored.  
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